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ABSTRACT
This work focuses on designing specific miniprotein interactions using computational
models and then testing these designs with experiments. Miniproteins are small, autonomously-
folding proteins that are excellent for testing protein designs because they can be chemically
synthesized and computationally modeled. Despite their diminutive size, miniproteins are used
as minimal models to discern important features, such as folding and interaction specificity, in
natural proteins.
A 21-residue f3j3c homotetramer miniprotein (BBA) was computationally redesigned to
interact as a heterotetramer. Protein design calculations revealed a large/small pattern of
hydrophobic residues in the core and charge complementarity on the surface as a mechanism for
attaining heterospecificity. Solution studies showed the designed protein is a tetramer and
interacts in the same stoichiometry as its parent homotetramer. The x-ray crystal structure of the
heterotetramer revealed a structure very close to the designed structure with near-perfect
prediction of core side-chain packing. In a second round of design, the BBA heterotetramer was
stabilized to near-native stability.
Next, the coiled-coil region within the Bcr (breakpoint cluster region) oligomerization
domain was used to probe antiparallel versus parallel helix-orientation specificity in coiled coils.
Based on the Bcr sequence, it is unclear why the oligomerization domain has an antiparallel
orientation preference. The isolated Bcr coiled-coil region adopts an antiparallel orientation, so
the orientation preference must be encoded in the Bcr coiled-coil sequence itself. Coiled-coil
statistics and parallel and antiparallel model structures revealed an alanine and glutamate in the
Bcr core as candidates that may be important for helix-orientation specificity. Both residues
were mutated to leucine, a common core residue in parallel coiled coils. Based on solution
studies of the mutant, both alanine and glutamate play an important role in oligomerization
specificity, while glutamate may also be important for orientation specificity in Bcr.
Finally, interaction partners to the Bcr oligomerization domain were computationally
designed to act as dominant negative inhibitors. Four interaction partners were designed using
different design techniques and energy functions. The inhibitors were expressed in E. coli and
tested in a pull-down assay.
Thesis Supervisor: Amy E. Keating
Title: Assistant Professor of Biology
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CHAPTER ONE
Introduction
19
This chapter provides an overview of progress in protein design with an emphasis on
issues relating to specificity. In some cases, addressing specificity has been critical to success in
protein design, and in others, it has been ignored. Developing better methods for addressing
specificity will, however, be important for expanding the capabilities of protein design.
Early attempts at protein design are discussed in the first part of the introduction.
Initially, proteins were designed for conformational specificity, such that the designed protein
had native-like properties, adopted a defined fold, and did not aggregate. A protein lacking
conformational specificity sometimes becomes targeted for protein degradation (1); this protein
occupies several low-energy conformations, which often lead to molten globule states (Figure
1A). In proteins with conformational specificity, a single conformation's energy is lower than
alternative states (Figure 1B), allowing a unique structure to form.
Although designing conformational specificity is still an important problem in protein
design, scientists have recently begun focusing on designing more complex interactions by
building on protein design techniques obtained through conformational studies. The second part
of the introduction will focus on designing interaction specificity. Interaction specificity (Figure
1C & D) is defined as interaction with one protein but not a similar protein and is driven by one
protein complex having a lower energy than like complexes. Protein-protein interactions are
crucial to many biological processes, including transcription, viral entry, and signaling, making
interaction specificity a key to cellular life (2).
CONFORMATIONAL SPECIFICITY
Conformational specificity was an early problem tackled by protein design. Some of the
first designed proteins, and even some proteins designed recently, failed to adopt native-like
structures. It is not unusual for designed proteins to form molten globules or aggregate due to
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loosely packed hydrophobic cores (3). Successful strategies for attaining conformational
specificity include incorporating more specific packing interactions in the core (4-15),
considering forces beyond van der Waals (16), and modeling alternative states implicitly to
prevent aggregation (17-19). These principles provide positive and negative design elements
that increase the energy gap between desired and undesired states.
Core packing and conformational specificity
DeGrado and co-workers found core packing to be a critical element, but not sufficient,
to attain conformational specificity in a manually designed helical bundle. Linking together
elements of secondary structure and incorporating general properties thought to be important for
conformational specificity, such as helix propensity, hydrophobic/polar patterning, etc., were
insufficient to form a unique, well-folded structure in the a2B design protein (6). Although a2 B
associated as a stable four-helix bundle, it adopted a molten globule conformation due to the
many different topologies the structure could adopt (4). Conformational degeneracy was
decreased by introducing steric complementarity into a2C, the next generation design. The a2C
peptide had many qualities of a native protein, such as a cooperative thermal transition at low
temperatures, but had a molten globule state at higher temperatures (8). With the a2C design, the
molecule could still adopt two different topologies. By altering two additional interfaces,
DeGrado and co-workers introduced a metal-binding site to serve as a negative-design element
against alternative states. Even without the metal ions present, a2D (Figure 2A) had all the
hallmarks of a native protein (4, 5, 9). However, a 2D was less stable than a2B (4). To gain
conformation specificity, alternative states had to be destabilized by utilizing steric matching and
incorporating a metal-binding site.
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Core packing is important for obtaining conformational specificity, but is difficult to
design manually. Desjarlais and Handel developed a program called ROC (repacking of core) to
systematically evaluate van der Waals energies of many possible sequences using a genetic
algorithm (11). Core positions in 434 cro (11) (Figure 2B) and ubiquitin (15) (Figure 2C) were
redesigned using ROC. Within the accuracy of basic low-resolution biophysical tests, the
variants were still able to adopt well-defined conformations (11, 15). Some of the 434 cro
designs were as thermally stable as wild type, but one mutant was unfolded under equivalent
conditions and was less stable than a variant with only leucine in the core (11). Most of the
ubiquitin mutants were more stable than random hydrophobic core variants, but none were more
stable than wild-type ubiquitin.
The low stabilities seen in the ubiquitin mutants were puzzling. Johnson and Handel
solved the NMR structure of some ubiquitin mutants designed by ROC and found the low
stability was due to rotamers in less statistically favorable conformations compared to wild type
(13). Another ubiquitin mutant was in slow exchange between two conformations due to
rotamer strain caused by rare rotamers populating multiple conformations in the structure (15).
Rotamer strain may be caused by the uniform reduction in van der Waals radii, which may have
led to overpacked cores, or by the lack of a torsional strain term in the ROC design program.
The addition of a rotamer strain term or evaluating the energies with 100% van der Waals radii
also may be important to achieving conformational specificity.
Polar and charged interactions also affect conformational specificity
In the literature, the role of polar and charged residues in determining protein
conformational specificity is mixed and is likely to be context dependent. Upon replacing a
buried salt-bridge network with hydrophobic residues in the Arc repressor, Waldburger et al.
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found conformational specificity was not compromised (20), whereas Bolon and Mayo found
polar residues in E. coli thioredoxin core important for this purpose (21). Using a physics-based
energy function, an automated design study by Koehl and Levitt demonstrated that energy terms
beyond van der Waals forces, including electrostatics and environmental solvation energies,
were important for conformational specificity (16). Fold-recognition software was used to test
for the sequence's conformational specificity. The sequences were threaded onto a library
containing the target fold and a large number of non-native folds, and the difference in scores for
the target structure and other "decoy" structures was assessed. Each term of Koehl and Levitt's
energy function was needed for specificity in design, demonstrating contributions from charged
and polar residues are important in defining specificity.
Preventing protein aggregation
Protein design energy functions model physical forces that stabilize proteins, often by
increasing the number of hydrophobic residues, for which there is no penalty in many energy
functions in the absence of competing aggregation. However, greater hydrophobic content can
lead to aggregation and loss of unique structure. Therefore, a negative design component is
important to prevent extremely hydrophobic sequences.
The insoluble aggregated state is an important alternate state against which to design.
The structure of a protein's aggregated state is not known and is impossible to explicitly model
in a calculation. Rather than explicitly modeling the aggregated state, some groups attain
conformational specificity by making large approximations to minimize hydrophobics on the
surface that could cause aggregation or other undesired states. For example, hydrophobic
residues would be excluded from possible amino acids at surface positions. Others have tried to
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overcome this problem by adding terms to their energy function to crudely approximate the
effect of various states.
The Mayo group used a technique called binary patterning to obtain conformational
specificity. Exposed hydrophobic surface area was penalized by partitioning the protein into
core, boundary, and surface, allowing hydrophobic residues in the core, charged and polar
residues at the surface, and the combined core and surface set at the boundary. Binary patterning
introduces negative design against aggregation without designing against explicit states. Not
only does binary patterning potentially yield conformational specificity, it also significantly
reduces the possible sequences through which to search (19). Using this methodology, Dahiyat
and Mayo did full-sequence design on the 33a motif, and NMR studies revealed well-ordered
secondary structure (Figure 2D).
The number of boundary positions is typically overestimated in the binary patterning
method. To improve the assignment of residues to the core, surface, and boundary positions,
Marshall and Mayo calculated the solvent accessibility of a protein structure with generic methyl
acetylene side chains ( 7). At each site, positions were classified at different cutoffs based on
their solvent accessibility. A set of engrailed homeodomain variants was designed with different
solvent accessibility cutoffs and tested experimentally for stability and conformational
specificity. Variants with fewer hydrophobic residues were destabilized, whereas too many
hydrophobics caused aggregation (17). This study provided interesting insights into the trade-
offs between adding more hydrophobics (and more stability) versus conformational specificity.
Like the Mayo group, the Harbury and Handel groups also had problems with
aggregation when negative design against various alternative states was not employed (18).
Havranek and Harbury modeled an aggregated state by placing their target in a medium with a
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dielectric lower than water (22). To address aggregation, Pokala and Handel used a crude
unfolded-state model with random amino acids threaded onto 13-mer protein fragments extracted
from the PDB. Buried polar residues lacking a satisfied hydrogen bond and solvent-exposed
hydrophobic residues were given a special reference state to further address conformational
specificity, and the 13-mer unfolded state model was used for all other residue reference states
(18). Although Pokala and Handel's work has not been experimentally tested, studies by Mayo,
Handel, and Havranek used crude approximations to prevent aggregation and yield
conformational specificity.
INTERACTION SPECIFICITY
Designing interaction specificity is more complex than designing conformational
specificity, as both interaction and conformational specificity are required. Interaction
specificity is determined by the relative thermodynamic stabilities of all possible protein-protein
interactions. To obtain interaction specificity, forces stabilizing the desired protein-protein
interaction and forces that destabilize all undesired competing states must be considered. The
same general principles important for conformational specificity are also important for
interaction specificity. Negative design has been successfully used for some interaction
specificity problems where it was possible to model competing states explicitly. In other cases,
interaction specificity has been achieved by using positive design alone.
Protein-Protein and Protein-Ligand Specificity
Several interaction specificity designs have been successful without explicitly
incorporating negative design, only utilizing positive design to obtain stability and specificity.
Naturally promiscuous proteins are optimized to bind many different targets. Each of the targets
25
have different binding surfaces, so optimizing the promiscuous protein for one target is unlikely
to optimize interactions with other targets (Figure 3). Therefore, disregarding negative design in
these calculations may be a reasonable approach. Because promiscuous targets are not optimized
to specifically bind one target, stability is also increased as a result of optimization for a specific
target.
The class I PDZ domain (Figure 4A) (23) and calmodulin (Figure 4B) (24, 25) are
promiscuous proteins that bind with low specificity and high affinity to a number of targets.
Reina et al. redesigned a class I PDZ domain to bind novel class I and II sequences without using
negative design. Using the ORBIT protein design program, Shifman and Mayo optimized
calmodulin's large hydrophobic binding region to increase its specificity for binding a peptide
from the myosin light chain kinase (smMLCK) (24). Because models of undesired calmodulin
complexes contained large hydrophobic clashes, specificity of calmodulin complexes is
predominantly due to van der Waals clashes. Shifman and Mayo assumed suboptimal contacts
would be produced between calmodulin and other targets by simply optimizing for smMLCK
stability. Rather than using negative design to destabilize the undesired calmodulin complexes,
the calmodulin-smMLCK complex was stabilized by targeting buried residues on calmodulin
near smMLCK. Designed calmodulin's affinity for smMLCK was higher than that of the wild-
type calmodulin, whereas affinity for other peptides were reduced by 1.5- to 86-fold (24).
Binding specificity was further increased up to 155-fold by redesigning boundary and surface
positions on calmodulin in a subsequent calculation (25).
In their calculations, both Reina et al. and Shifman and Mayo introduced negative design
implicitly by increasing the weight of the protein-ligand interaction terms, relative to
intramolecular ligand and protein interactions. Mayo and Shifman changed the distance-
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dependent dielectric constant from 40r to 4r to improve long-range electrostatic interactions and
introduced a factor to weight the intermolecular calmodulin/target energies more heavily than
intramolecular interactions (25). The Coulombic term became much more important when
designing the boundary and surface, as salt bridges in calmodulin play a special role in target
recognition. Decreasing the dielectric helped to increase the Coulombic energy contribution and
the number of salt bridges selected. Part of the design process used by Reina relied on human
intervention to choose design sites and sequences that formed inter- rather than intramolecular
interactions (23). However, human intervention in picking the designed sequences that form
intermolecular interactions is a subjective process where other types of negative design could
also have been incorporated.
Negative design was also not necessary to redesign ligand-binding specificity of a non-
promiscuous enzyme. Looger et al. successfully redesigned various sugar-binding proteins,
including the ribose-binding protein (RBP) (Figure 4C), such that they bound specifically to
trinitrotoluene (TNT), L-lactate, or serotonin (26). Although the enzyme was only optimized for
a single target ligand, the enzyme was specific for the target ligand over the wild-type sugar and
similar ligands. Negative design was not critical because the ligand had many steric restraints in
the core, preventing similar ligands from binding with high specificity. The repulsive term in the
Lennard-Jones potential was reduced by 35%, yielding a tightly-packed binding site. In addition,
the distance-dependant dielectric of 8 for all Coulombic calculations and the explicit hydrogen-
bonding potential yielded solutions with unique charge complementarity to the ligand.
Negative design may be necessary when redesigning proteins with high-affinity and
specificity. Kortemme and co-workers redesigned specificity at the interface of DNase (colicin
E7) and its tight binding inhibitor, immunity protein (7), using a computational second-site
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suppressor strategy to ensure the designed proteins would have specificity for each other and not
the wild-type protein. Given partner A and B, the second-site suppressor design strategy is a
negative design strategy that finds sequences for partner A in the complex that would destabilize
the interface, but would be compensated for by redesigning the interface of partner B. Unlike
Shifman and Mayo and Reina et al., negative design is more critical for the DNase (colicin E7) /
17 interface because both DNase (colicin E7) and the immunity protein (17) are very specific and
bind with high affinity to each other, suggesting a highly optimized binding interface. If the
interface was merely optimized during design, sequences close to, or identical to, wild-type
would probably be selected. Both van der Waals and electrostatic interactions were critical to
obtaining the following two modes of specificity: i) polarity switch that replaced hydrogen
bonding at the interface with hydrophobics ii) steric switch where steric packing was altered.
The designed protein-protein interaction with the highest predicted affinity was found to have
good specificity in in vitro biophysical and in vivo assays, and many of the predicted side-chain
interactions were present in the designed protein x-ray crystal structure (Figure 4D) (27).
Hetero- vs. Homooligomeric Specificity
Explicit negative design has been used a great deal and found to be very important in
designing hetero- and homooligomeric specificity. Many experimental studies have led to
underlying positive and negative design "rules" for specificity that can be introduced into
proteins, particularly coiled coils. A coiled coil, shown in Figure 5A, consists of two or more c-
helices intertwined, containing a heptad repeat, HPPHPPP, where H is a hydrophobic residue,
and P is a polar residue. The heptad repeat, denoted by letters a-g, is shown in helical wheel
form in Figure 5B and C. Computational design programs have also independently found these
"rules" and used them to introduce interaction specificity.
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Interactions at a, d, e, f, and g coiled-coil positions can help define hetero- versus
homooligmeric interaction specificity through both van der Waals and electrostatic interactions.
In coiled coils, steric matching at a and d positions is a useful technique to give hetero- versus
homooligomeric specificity (28, 29). Steric matching involves packing a small amino acid
across from a large amino acid. A study by Tanaka and co-workers made a specific ABC
heterotrimer by incorporating steric matching in the core (via Trp/Ala), charge complementarity
at e and g, and an Ala at the f-position amino acid to destabilize certain states. Charge
complementarity can be used as both a negative and positive design element for and against
homo- or heterooligomers. The specificity of the Fos-Jun heterodimer (Figure 6A) is driven by
electrostatic clashes at e and g (30) and two a-position lysines (31) that destabilize the Fos
homodimer (32). Protein-protein interactions have been designed based on an understanding of
specificity gained from natural homo- versus heterooligomeric interactions. O'Shea et al. used
electrostatic clashes as an explicit negative design element to destabilize homodimeric states
(Figure 6B) (33).
Steric matching and complementary charge motifs have been found using computation to
design hetero- versus homooligomers. Using computational design, these techniques emerged as
a means for introducing heterospecificity into the BBA homotetramer in Chapter 2. Summa et
al. used charge complementarity to devise a very simple scoring function that rewarded +/-, +/+,
and -/- interactions with -1, +2, and +3 scores, respectively, to computationally design an A2B2
heterotetrameric four-helix diiron bundle (10). A similar positive and negative design strategy
was also used to design a heterotrimer (34).
Havranek and Harbury designed coiled coils to favor homodimers that did not cross
hybridize and heterodimers that did not self-associate by explicitly designing against undesired
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states in their calculations (22). The calculation also simultaneously optimized for stability. A
genetic algorithm was used to maximize the transfer energy from the homodimer target state to
the various competing states: heterodimer, unfolded, and aggregated. To include all of the states
explicitly in the design calculation, they maximized the probability of occupying the desired state
over undesired states using Boltzman probabilities. Havranek and Harbury found omitting the
aggregated state yielded sequences with fewer charged residues, making the designed protein
more prone to aggregation. If the unfolded and aggregated states were omitted, the sequences
were computationally predicted to be specific, but unstable due to polar groups in the core.
Further, if the homotetramer state was omitted from the heterotetramer design (and vice versa),
calculations suggested that specificity would be lost. The top one-hundred sequences were
clustered and examined for sources of specificity. The following four sources of specificity
emerged from the clustering: steric complementarity between Trp and Gly side chains, poor
packing of Leu at a, isoleucine at g' and a', and Glu at position d favoring basic side chains at e'
over hydrophobics. Interestingly, some sources of specificity seen in the selection are not found
in nature. The designs were biophysically characterized and were found to be specific for their
desired state, as well as stable with respect to the unfolded state.
Bolon et al. also explicitly designed against undesired states to change SspB from a
homodimer to a heterodimer (Figure 4E) (35). Repacking the SspB structure in an asymmetric
fashion, the ORBIT design code was modified to optimize the energy of the heterodimeric state
over that of the two homodimeric states. The results revealed a steric matching pattern predicted
to provide heterodimeric specificity. If SspB was designed only for stability without regard for
heterooligomeric specificity, it formed heterodimers and homodimers. Designing for specificity
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resulted in solely heterodimeric complexes (36). In the Havranek, Bolon, and BBA studies
stability was compromised to obtain the desired specificity.
Explicitly representing certain competing states for hetero- and homooligomerization
design appears to be very important for much the same reason negative design was important for
Kortemme et al's second-site suppressor strategy. Many homo- and heterooligomers have
interfaces that are already optimized for binding. Further, homo- and heterooligomeric states are
very similar; sequences optimized to favor one state will likely favor the other state, making
negative design against undesired states important to prevent the wild-type or nonspecific
sequences (as in the experiment by Bolon et al.) from being selected. Designing homo- and
heterooligomeric states makes negative design easier because the structures are already known
and each state can be explicitly represented. Steric matching, charge complementarity, and
hydrogen bonding all play important roles in favoring hetero- versus homooligmerization.
Oligomerization State Specificity
Most studies of oligomerization specificity have been done experimentally and not
computationally. Oligomerization specificity determines whether a monomer, dimer, trimer, etc.
is formed. Determinants of oligomerization specificity are still being extracted from new
mutational studies. Ideally, alternative oligomerization states would be explicitly considered in
any protein design. However, including all competing states is difficult and computationally
intractable, particularly for coiled-coil helical bundles, due to the large number of very similar
competing oligomerization states. In this section, three influences on oligomeric specificity in
core coiled-coil residues will be discussed: hydrophobic, polar, and charged interactions within
core residues of coiled coils.
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Hydrophobic core packing
Hydrophobic core packing has been found to influence the oligomerization state of coiled
coils. Minimization of cavity size in protein cores may be the driving force behind
oligomerization state specificity in some proteins. Figures 6C and 7A illustrate how the
location of Ala can lead to oligomerization specificity, consistent with minimization of cavities
in the core (37). Mutating an alanine to a leucine in a coiled coil led to loss of oligomerization
specificity in Chapter 3.
Steric clashes can also influence oligomerization state. Changing certain leucine residues
in bZIP transcription factors to other hydrophobic residues can interfere with dimerization and
DNA binding (38, 39). Biophysical characterization of certain non-functional GCN4 mutants
has shown that hydrophobic packing can lead to different oligomerization states (40-42). The
type of hydrophobic amino acids at a and d positions determine whether dimers, trimers,
tetramers, or mixtures of oligomerization states form (43). For instance, isoleucine at a and
leucine at d favor dimeric coiled coils, but isoleucine at d and leucine at a favor trimers. Crystal
structures of a coiled-coil dimer (44), trimer (40), and tetramer (43) with these sequence motifs
revealed that steric restrictions on packing were a negative design element, causing one
oligomerization state to form while excluding others (Figure 8). -branched amino acids at d
could not pack into a dimeric structure, explaining why coiled-coil trimers form instead (40, 41,
43). The results of these studies have helped design specific oligomerization states (34).
Oligomerization specificity is a particularly hard problem to tackle computationally due
to the large number of alternative states that must be considered. Changes in coiled-coil
oligomerization state can inadvertently cause changes in helix-orientation preference. Two
studies have successfully designed one oligomerization state, while using negative design to
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explicitly disfavor others. In a study by Park and Keating, amino acids at a and d positions were
targeted to design a coiled coil that had dimer over trimer specificity (or vice versa) by
1 E 1Emaximizing the energy difference between the two states (max f, f = - Ed +-E or
2 3
max f, f = -Et + - Ed) (45). f3-branched amino acids at the d position were found to favor
3 2
trimers over dimers in the computational results, confirming the experiment by Harbury. In
another study, computer-generated coiled-coil backbones with a right-handed superhelical twist
and various oligomerization states were generated using a method developed by Francis Crick
(46). Right-handed coiled coils have a repeating pattern with 11 residues, compared to 7 for
common left-handed coiled coils. Sequences were optimized for oligomeric specificity and
stability in the target conformation by i) expressing stability as the standard deviation from the
mean of all possible sequences and ii) finding sequences that ranked high on the target backbone
and low on other backbones by expressing the stability difference between states as a standard
deviation. The designed trimer and tetramer were well-folded based on biophysical experiments.
The crystal structure of the tetramer matched the designed structure well (47), but some
differences were seen in the crystal structure of the trimer (48).
Core polar interactions
Polar interactions within protein cores have also been found to be very important in
directing oligomerization state. About 20% of amino acids at a and d positions in coiled coils
are charged or polar (49). Polar interactions can be manually designed to provide specificity.
However, computationally selecting polar interactions is still very difficult, as hydrogen bonds
within protein cores are challenging to model with current energy functions.
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The position of Asn in the leucine zipper is critical to providing oligomerization
specificity. Asn residues are often found in one of the a positions of dimeric, parallel coiled
coils (50). Upon changing the a-position Asn in GCN4 to a leucine, the coiled-coil stability
increases, but a tetramer is formed, rather than a dimer (51). As seen in previous studies, Asn
decreases stability to provide oligomeric specificity. Using computational protein design, Park
and Keating also found preference for Asn in the a position of dimers versus trimers (45).
Another study moved Asn from a-position 16 to a-position 9 in the coiled coil and found the
thermal denaturation curve switched from two-state to three-state. The additional state is a
partially unfolded state that is a mixture of dimers and trimers (52). When Asn in GCN4 is
changed to aminobutyric acid (Appendix A, Figure 2), dimers and trimers form due to very
similar packing surfaces, as revealed by crystal structures of the two states (53).
Not all polar side chains promote oligomerization specificity in GCN4. Both dimers and
trimers formed when Gln was substituted for Asn (54). The crystal structure of the Gln mutant
was solved to explain the structural differences that resulted from the two very similar amino
acids. In the dimer and trimer structures, Gln 16 makes different interactions, which must yield
similar stabilities to enable both oligomerization states to form. Akey et al. substituted various
polar amino acids, Asn, Gln, Ser, and Thr, into the a and d positions of GCN4 to determine if
they yield oligomerization specificity (55). A threonine at d gave a specific trimer, and an
asparagine at a gave a specific dimer in solution. However, all other combinations of Asn, Gln,
Ser, and Thr at a and d did not yield oligomerization specificity. Four of the mutants formed
trimeric x-ray crystal structures, despite three of these not having a specific oligomerization state
in solution (55).
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Using a different GCN4 variant, two studies by the Hodges group substituted all 20
amino acids in a (42) and the d (41) positions and found slightly different results compared to
Akey et al. (55). Only a few polar residues at a and d positions were able to impart
oligomerization specificity. In the experiment by Akey et al., Gln at a did not yield
oligomerization specificity (55), but yielded trimeric oligomerization specificity in Hodge's
studies (42). Thus, the influence of polar residues in the core on oligomerization may be context
dependent.
Core charged residues
Charged residues in the coiled-coil cores have been found to impart oligomerization
specificity. In fact, charged residues are found with greater frequency in coiled-coil dimers
versus trimers (56). Higher-order oligomers impose a larger desolvation penalty on charged
residues in the core due to the larger buried surface area at a and d. In a synthetic parallel coiled
coil, a buried lysine in the a position, that could make interhelical contacts with a Glu at g' on
the opposite helix (Figure 6D), provided dimeric oligomerization specificity (57). A buried
charged group can also impart oligomerization specificity in a designed dimeric antiparallel
coiled coil. An Arg at a d position and a Glu at the g' position on the opposite helix was
sufficient to provide dimeric specificity on the designed peptide (58). At the d position, charged
residues (Lys, Arg, Ornithine (Orn), Glu, and Asp) are able to specify the dimeric
oligomerization state (41), whereas Lys, Orn, and Arg are able to provide dimerization
specificity if they are present at the a position (42). The structure of Orn is shown in Figure 4 in
Appendix A.
Like polar residues in the core, charged residues may also direct oligomerization in a
context-dependant fashion. In Chapter 3, changing a core glutamate residue to leucine caused
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the oligomerization state to change from a coiled-coil dimer to trimer. The Fos leucine zipper
(Figure 6A) has an unusual core, containing Lys or Thr at four out of five a positions. The two
lysine groups at a were substituted with norleucine (Figure 2, Appendix A), both independently
and together, and the peptides were biophysically characterized (31). One of the mutated lysines
changed the oligomerization specificity from dimer to a dimer-tetramer equilibrium, whereas the
other lysine retained its dimeric state when mutated. However, if both lysines are changed to
norleucine, a stable homotetramer forms.
Helix-Orientation Specificity
Coiled coils and helical bundles have been used as the primary means for studying
orientation specificity, thus far. The helix orientation specificity problem in coiled coils is
further complicated by oligomers with similar competing states. Understanding orientation
specificity can aid in understanding the function and mechanistic details of a coiled-coil protein
(59). Only recently has there been a large enough body of antiparallel coiled-coil crystal
structures to obtain general structure and sequence information (59).
Current understanding of orientation specificity has mainly come from experiments.
Computational design has not aided this part of the field yet, but offers a fruitful area of research.
Three main aspects of antiparallel structure have been probed for their role in determining
antiparallel orientation specificity: core hydrophobic packing, core polar and charged residues,
and charged residues at e and g positions. From these studies, general principles that direct helix
orientation have emerged and can be used to design antiparallel coiled-coils (60-64), but not
predict orientation preference in natural coiled coils.
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Hydrophobic core packing
Hydrophobic packing in the core of coiled coils has led to orientation preference.
Parallel versus antiparallel orientations yield very different packing interactions at a, d, e, and g
positions, with parallel coiled coils making a-a' and d-d' interactions and antiparallel coiled
coils making d-a' and a-d' interactions (Figure 5B and C) (59). In parallel coiled coils, a and d
residues align directly across from the opposite helix, whereas residues can align either directly
across from the opposite helix or stagger to varying degrees in antiparallel coiled coils.
Steric matching (65-68) in the core, pairing a small residue with a large residue, is the
major way packing can direct orientation preference. Alanine is found more often in the d
position of antiparallel than parallel coiled coils (50). The relative position of alanine in the core
can yield orientation specificity. Figure 7B and C illustrate how the position of alanines in the
core can direct orientation preference (66). In Chapter 3, changing an alanine to leucine in the
core of a natural antiparallel coiled coil did not affect orientation specificity, but changed the
oligomerization specificity, however. Steric matching has been used to successfully control
helix orientation in an antiparallel trimer by placing combinations of alanine and
cyclohexylalanine at a on two helices and at d on the other helix (68). The position of the
cyclohexylalanine was staggered on each of the helices, such that the layers of the three helices
would have the pattern XAA, AXA, and AAX, where X is the cyclohexylalanine.
Core polar / charged residues
Buried polar residues in the coiled-coil core can control helix orientation, whereas
charged residues in the core have not been found to have an effect. At the e and g positions,
Oakley et al. designed a GCN4 variant with Lys on one helix and Glu on the other. On one of
the helices, the position of Asn was moved such that the two asparagines could only interact in
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the antiparallel orientation. Changing the position of Asn was sufficient to change the helix
orientation from parallel to antiparallel (Figure 6E) (69). However, the Asn-Asn interaction is
not found in natural antiparallel coiled coils (59). Charged residues in the core are found in
antiparallel coiled coils, and d to g' or a to e' saltbridges may be important for controlling the
orientation. Using a model antiparallel coiled-coil system, a potential interhelical interaction
between a d-position Arg and a g'-position Glu was not enough to control helix orientation, but
did control the oligomerization state (58). Charged residues in the core may play a context-
dependent role in determining helix-orientation preference, preventing studies on model coiled-
coil systems from capturing an effect. Natural proteins provide an opportunity to study these
effects. Statistically, both parallel and antiparallel coiled coils have an equal number of Lys,
Arg, and Asp at a and d positions. However, glutamate at a d position is much more prevalent in
antiparallel coiled coils (50). In Chapter 3, a glutamate in the core of a natural antiparallel coiled
coil was found to potentially play a role in determining the coiled-coil orientation.
Charged residues at e and g
Charged residues at e and g positions in coiled coils and helical bundles can also
influence helix orientation (70-72). If a coiled coil has many potential salt bridges at e and g in
one orientation and many repulsive interactions at e and g in the other, the orientation with
favorable electrostatics will form. In one study, when e and g had equally attractive interactions,
the antiparallel orientation was more stable, indicating there may be an intrinsic preference for
coiled coils to associate in the antiparallel orientation (72). Another study demonstrated that
Coulombic interactions at e and g and a buried polar Asn-Asn interaction are nearly equal in
their importance for determining orientation specificity (Figure 6F) (70).
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CONCLUSION
The ability to design proteins with conformational and interaction specificity has
improved greatly over the past few decades. General principles regarding how charged and
hydrophobic residues influence interaction specificity have been discerned, using both
experimental and computational techniques. However, designing conformational and interaction
specificity is still very difficult.
In manual and computational protein design, both conformational and interaction
specificity design are challenging due to the inability to predict and model alterative states. If
alternative states are known, negative design elements can be incorporated to make the
alternative states unfavorable, increasing the energy between undesired and desired states.
Hetero- versus homooligomerization specificity is an example of where this can be done well.
However, oligomerization specificity (monomer, dimer, trimer, etc) is more difficult to design
because the number of possible alternative states is large. Further, oligomerization and helix-
orientation specificity are related, in that changing oligomerization specificity could also change
the helix-orientation. When designing for conformational specificity, particularly preventing
aggregation, it is hard to determine exactly what alternative models to use a priori because
proteins can associate in many different ways. Modeling the unfolded state is even more
difficult, as the structure is not known and is likely to be very sequence specific. Modeling all
possible alternative protein states becomes computationally infeasible quickly, especially as
more complex protein-protein interactions are designed. Despite these challenges,
approximations for aggregation and unfolded-state models have been reasonably successful.
The necessity to incorporate alterative models into designs seems to be dependent on the
biological function of the protein. For promiscuous proteins that interact with many different
39
proteins in the cell, negative design may not be critical. By stabilizing promiscuous proteins for
one target, other targets are destabilized. However, redesigning a protein interface that already
has high affinity and specificity will probably require negative design elements to produce a
protein that is specific for a different interaction. Thus, considering the biology and affinity of
the protein target could prove useful for protein design.
Experimental studies have probed the isolated effects of hydrophobic packing and polar
and charged residues on conformational and interaction specificity, particularly in coiled coils.
Protein design studies have incorporated these into automated algorithms, and all the forces
appear to play an important role in both types of specificity. Designing specificity using
computational methods is difficult due to the many approximations that must be made in the
energy function, particularly for electrostatics and solvation. For instance, interaction of water
molecules with surface residues is important for interaction specificity. However, water is
computationally infeasible to model explicitly, as most of the computational time would be spent
in calculating water-water interactions. Instead, continuum solvation models are used to model
the solvent as a dielectric, rather than as explicit molecules. The distance-dependent dielectric
function is an approximation of Coulomb electrostatics in a polar environment. In some of the
design calculations, the distance-dependent dielectric constant had to be changed to obtain more
intermolecular interactions.
Two more approximations made in protein design include modeling side chains using
discrete rotamer conformations and modeling fixed backbones. Side chains in high-probability
rotamers are important for conformational and interaction specificity. The rotamer
approximation can be improved by adding more rotamers, often yielding more exact results (73,
74). However, increasing the number of rotamers increases the computational time. Design
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using a fixed backbone is another approximation, as protein backbones have the ability to relax
in solution. The fixed backbone approximation often leads to small steric clashes and artificially
strained rotamers.
Improvements to energy functions, as well as faster computers will make current design
techniques more accurate. The ability to model alternative targets explicitly and implicitly will
enhance conformational and interaction specificity design. There are still many very exciting
avenues for computational protein design to follow, and improvements in designing both
conformational and interaction specificity will continue to be made.
Summary of Thesis Work
The design of a heterotetrameric BBA protein from a homotetrameric BBA is described
in Chapter 2. Experimental characterization of the BBA heterotetramer in solution and x-ray
crystallography techniques revealed that the structure is tetrameric and has a structure very close
to the designed structure. In Chapter 3, the orientation specificity of the coiled-coil region from
the breakpoint cluster region (Bcr) oligomerization domain was explored. Unusual d-position
residues were changed to leucine and were biophysically characterized to elucidate their role in
determining oligomerization and orientation specificity in Bcr. The computational design of an
antiparallel coiled-coil interaction partner for the Bcr oligomerization domain is reported in
Chapter 4.
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Figure 1. Conformational and Interaction Specificity. (A) Lack of confonnational
specificity is caused by several confonnations with similar folded energies. (B) A unique
structure is fonned when there are no kinetically accessible competing confonnations with
similar low energies. (C) If several interactions yield the same favorable energy upon binding,
all the interactions will fonn. (D) Interaction specificity occurs when there is one interaction
with a much lower energy than other potential interactions.
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Figure 2: Structures of proteins designed or redesigned for conformational specificity. (A)
a2D (lQP6). (B) phage 434 ero protein (lUBI) (C) ubiquitin (lUD7) (D) ~~a (lFSD).
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Desired Target
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Alternative Targets
Figure 3. "Fitness" surface. "Fitness" surface for (A) a desired target and (B) alternative or
undesired targets (adapted from (25». A high "fitness" indicates the protein and target are
compatible, whereas a decrease in "fitness" indicates the protein and target have become less
compatible. The asterisks indicate the starting sequence, and lines on the charts represent
changes in sequence through the optimization process. For the desired target, the sequence
changes, but the "fitness" remains the same. For the alternative target, the sequence changes and
the "fitness" decreases.
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Figure 4. Structures of proteins used to design interaction specificity. (A) PDZ domain
(lBE9) (B) calmodulin in complex with smMLCK (lCDM) (C) ribose-binding protein (2DRI)
(D) the designed DNase (colicin E7) (l UJZ) (E) SspB homodimer (lQU9). The blue and red
colors are used to differentiate different domains or proteins in protein-protein interactions, as
well as protein versus ligand interactions.
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A.
Figure 5. Coiled-coil structure and helical wheel diagram. (A) X-ray crystal structure of the
GCN4 leucine zipper. Depicting coiled coils in the helical wheel format shown above can give a
general picture regarding interactions between a. d. e, and g positions in (B) antiparallel and (C)
parallel coiled coils. Typically, a and d positions are hydrophobic, whereas e and g positions are
polar and charged.
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Figure 6. Helical wheel diagrams of coiled coils used in previous studies. (A) Fos/Jun (B)
ACID-pl and BASE-pl (Velcro) (C) N2-C2 form dimers, whereas N4-C4 form tetramers. (D)
ACID-pLL and BASE-pK (E) ACID-al and BASE-al (F) ACID-Ke and BASE-Eg
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Figure 7. Role of alanine in oligomerization and helix orientation specificity. (A) Alanine
steric matching in determining oligomerization state. When Ala is on the same layer, a dimer
forms. When the alanines are on adjacent layers, a tetramer forms. (B) and (C) Helix
orientation is driven by position of alanines in the core. The helices never orient such that all the
alanines are on the same layer.
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Figure 8. The a- and d-Iayer packing in X-ray crystal structures of dimer, trimer, and
tetramer GCN4 variants. The asterisks on the core side chains indicate the residues important
for determining oligomerization state.
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CHAPTER TWO
Design of a Heterospecific, Tetrameric,
21-Residue Miniprotein with Mixed oa/3 Structure
Reprinted from:
Ali, M.H., Taylor, C.M., Grigoryan, G., Allen, K.N., Imperiali, B., Keating, A.E., Design of a
heterospecific, tetrameric, 21-residue miniprotein with mixed alpha/beta structure. Structure
(Camb), 2005. 13(2): p. 225-34.
Collaborator Note:
Mayssam Ali solved the crystal structure of BBAhetT1, made the peptides, and performed some
of the experiments.
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ABSTRACT
The study of short, autonomously folding peptides, or "miniproteins," is important for
advancing our understanding of protein stability and folding specificity. Although many
examples of synthetic (c-helical structures are known, relatively few mixed cu3 structures have
been successfully designed. Only one mixed-secondary structure oligomer, an W/3
homotetramer, has been reported thus far. In this report, we use structural analysis and
computational design to convert this homotetramer into the smallest known c/3-heterotetramer.
Computational screening of many possible sequence/structure combinations led efficiently to the
design of short, 21-residue peptides that fold cooperatively and autonomously into a specific
complex in solution. A 1.95 A crystal structure reveals how steric complementarity and charge
patterning encode heterospecificity. The first- and second- generation heterotetrameric
miniproteins described here will be useful as simple models for the analysis of protein-protein
interaction specificity and as structural platforms for the further elaboration of folding and
function.
Abbreviations: DapBz, benzoylated L-c,-diaminopropionic acid; Abu, L-c-aminobutyric acid;
AUC, analytical ultracentrifugation
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INTRODUCTION
Miniproteins are short polypeptides, typically having fewer than 40 residues, that adopt
specific, discrete folds in aqueous solution (1). Many miniproteins have been described in the
literature, including a-helical coiled coils and helical bundles (2), mixed z/J3 motifs (3, 4, 5),
predominantly-[ motifs (6-8), and other folds (9, 10). Some of these miniproteins are derived by
reducing naturally occurring protein folds to a minimal folding core, whereas others have been
designed de novo, either by visual inspection or with the use of computational methods.
Miniproteins have served as scaffolds for ligand and metal binding, as well as for the
introduction of catalytic activity (11-13). Miniproteins, and coiled-coil miniproteins in
particular, have been successfully utilized in materials science for the introduction of nano-scale
structure and organization, often with "switchable" physical properties (14, 15).
Heterooligomeric peptides are particularly useful in these contexts, as they provide a mechanism
for integrating units with distinct properties. We are interested in designing heterooligomeric
miniproteins both for potential applications and for fundamental investigations of how protein-
protein interaction specificity is encoded in sequence and structure.
The small size of miniproteins provides several advantages for studying protein folding
and association. First, the sequence-structure relationship is simplified. There are fewer
variables available in miniproteins to encode properties of interest, and as a consequence these
variables can be more systematically dissected. Second, miniproteins can be synthesized
chemically, providing a straightforward method to test sequence variants including both natural
and non-natural amino acids. Chemical synthesis also enables the facile introduction of
biophysical probes such as fluorophores. Finally, the small size of miniproteins renders them
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amenable to computational analyses, including structure design and the simulation of protein
folding (4, 16-18).
Numerous short homooligomeric miniproteins have been described, the majority of
which are coiled coils and helical bundles. There are fewer examples of heterospecific systems,
although a number of heterodimeric (19-23), heterotrimeric (24-26), and heterotetrameric (27,
28) coiled-coil peptides have proven useful for protein engineering applications (14, 29). Coiled
coils consist of a variable number of a-helices associated in a bundle with a slight superhelical
twist. An "acid/base" strategy, in which heterospecifcity is obtained by patterning the residues at
the hydrophobic/hydrophilic interface of paired helices with complementary charged residues,
has been shown to have great utility for encoding specific structure in coiled coils (20, 28).
Steric complementarity between juxtaposed residues in the hydrophobic core has also been used
to impart heterospecificity (30, 31).
Studies of designed heterooligomeric coiled-coil miniproteins have enriched our
understanding of how specificity is achieved in naturally occurring proteins such as the
transcription factors Fos and Jun (32). The shortest heterooligomeric miniprotein previously
reported in the literature consists of 21 amino acids and forms a tetrameric coiled coil in solution
(28). It was used to test the influence of side-chain length on charge-charge interactions. At this
time, the structure of this complex has not been reported. In fact, relatively few designed
heterospecific miniproteins have been characterized by NMR or x-ray crystallography, resulting
in an incomplete understanding of the structural basis of heterospecificity (22, 33, 34).
The miniproteins BBAT1 and BBAT2 (Figure B) are 21-residue homotetramers in
which each monomer adopts a mixed 3loc (BBA) secondary structure (5, 35). BBAT1 and
BBAT2 are derived from the monomeric cd3 miniprotein BBA5 (Figure 1A), a de novo designed
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metal ion-independent zinc finger (3, 36). BBAT1 was selected from a small library of BBA5
derivatives by means of a fluorescence based quenching assay. A shortened loop between cc and
3 subunits in BBAT1 precludes intramolecular burial of the hydrophobic surfaces and results in
self-association to a homotetramer. BBAT2 is a more stable derivative of BBAT1 having D-
alanine in place of the "hinge" glycine at position 9. The x-ray crystal structure of BBAT2 was
recently reported (37), revealing a novel architecture with certain structural elements reminiscent
of a tetrameric coiled coil. As in coiled coils, the central core of the BBAT2 tetramer is formed
by association of the hydrophobic face of each monomer, including significant contributions
from the helical portion. The hydrophobic core consists of five palindromic layers, each layer
composed of one side chain from each monomer, similar to the core layers found in coiled coils.
Furthermore, both apolar and polar residues are located along the intermonomer interfaces.
Unlike a typical four-stranded coiled coil, however, the superhelical twist of BBAT2 is right-
handed, and the "knobs-into-holes" packing that characterizes coiled coils (38) is not observed.
Despite these differences, we anticipated that strategies employed in the design of
heterooligomeric coiled coils would be applicable to the design of a heterotetrameric BBA
complex.
Herein we describe the computational design and characterization of two miniprotein
complexes, BBAhetT1 and BBAhetT2. Our goal was to design pairs of short peptides that
would adopt the overall backbone structure of the BBA homotetramer, but in a heterospecific
A2B2-type complex with C2 or pseudo-C 2 symmetry. We sought a stable and highly specific
motif that could be used to probe sequence determinants of interaction specificity and that could
serve as a scaffold for further elaboration of structure or function. The design strategy was
motivated by the structure of BBAT2 and used computational methods to identify and rank
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mutations likely to impart both stability and heterospecificity. Solution characterization and a
high-resolution x-ray structure confirmed the success of our design. The evolution of the BBA
family from monomer to heterotetramer is summarized in Figure 1.
RESULTS
Computational Design
Homotetramer BBAT2 is very sensitive to mutation. Many residues in this small motif
have multiple roles in determining specificity and stability, and seemingly minor sequence
changes can lead to loss of structure or aggregation (39). We therefore adopted a stepwise
strategy whereby the effects of mutations to core and surface sites were modeled and evaluated
independently. An empirical, molecular mechanics-based energy function was used to identify
suitable sites for mutation and to evaluate sequence substitutions at the chosen sites. Each
sequence was modeled as a heterotetramer (giving EABAB), as two homotetramers (giving EAAAA
and EBBBB) and as an unfolded monomer (giving Eunfold). We sought sequences with large values
for both stability (Eunfold - EABAB) and specificity (EAAAA + EBBBB - 2 EABAB).
The hydrophobic core of BBAT2 consists of five palindromic layers. The three unique
layers are layer A (composed of residues 3 and 20), layer B (composed of residues 8 and 16), and
layer C (composed of residues 12 and 12'). To identify sites for mutation, layers B and C were
analyzed in detail. Calculations were carried out to select residues at positions 12, 8 and 16 that
would impart heterospecificity. The largest predicted specificities came from substitutions at
position 12. More qualitative analyses also indicated that position 12 was a good candidate for
mutation. For example, two leucines at this site in BBAT2 were modeled with alternate
conformations in the three crystal structures, suggesting a non-optimal fit of the side chains at
this site in the homotetramer.
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The most heterospecific sequences from the position 12 calculations systematically
suggested a "large/small" design strategy, with two monomers contributing a bulky residue that
could not be accommodated in the core of a homotetramer and two others contributing a small
side chain that could not form good packing interactions in a homotetramer. Models of many
different "large/small" combinations (e.g. Trp/Ala, Trp/Ser, Trp/Thr, Phe/Ala, Tyr/Val)
indicated that these residues could be accommodated in a heterotetramer. Two different
backbone structures for BBAT2 were used in the design calculations (see Methods). On one
backbone, Trp/Ala combinations were predicted to give the highest heterospecificity at positions
12 and 12'; on the other, Phe/Ala pairs were the most heterospecific. Phe/Ala pairs were
computed to be more stable than Trp/Ala on both backbones. Furthermore, core side chains in
the predicted L12F/L12A heterotetramer could be accommodated in statistically common
rotamers (40, 41). A peptide pair having Phe at position 12 in one chain and Ala at position 12
in the other chain was therefore selected for experimental analysis (Figure 2B).
Structural analysis, as well prior studies of BBAT2 (37), were used to select surface sites
for mutation. At the hydrophobic/hydrophilic interface, positions 13 and 18 (alanine and
glutamine, respectively, in BBAT2) were previously mutated to methionine selenoxide without
structural perturbation, suggesting that the introduction of a charged residue would be tolerated.
Position 13 is directly across from position 13 of an adjacent monomer, and distances in BBAT2
indicated that an interchain interaction would be possible at this site between residues with long
side chains. Position 18 is opposite position 11 (glutamate) of an adjacent monomer in the
homotetramer; these two sites were also selected for redesign.
Computational selection for heterospecificity at the surface sites suggested placing
residues of opposite charge at structurally opposed positions, reminiscent of similar interactions
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found in heterospecific coiled coils. The highest specificity scores were obtained for
combinations having Glu and/or Asp at positions 11, 13, and 18 of one monomer, and Arg and/or
Lys at opposing sites of adjacent monomers. Computed specificity rankings, in conjunction with
a visual examination of the structures generated by side-chain repacking, led to the selection of
Glu/Lys or Asp/Lys pairs at position 13/position 13 and position 11/position 18 sites (Figures 2D
and 2E).
Solution and Structural Characterization
Peptides A-Ala and B-Phe were synthesized, incorporating the core and surface changes
suggested by the computational analysis (Table 1). The two peptides individually exhibited very
weak circular dichroism (CD) spectra between 200 and 300 nm at 50 /tM, indicating they have
little secondary structure. By contrast, an equimolar mixture of A-Ala and B-Phe revealed an
increase in ellipticity and a qualitatively different spectrum indicative of interhelical association
(42), as observed for homotetramers BBAT1 and BBAT2. The change in secondary structure
upon mixing (Figure 3A) strongly supports the formation of a heterooligomeric complex.
Thermal melts of the A-Ala/B-Phe complex, termed BBAhetT1, showed a cooperative-
unfolding transition (Figure 3B). Furthermore, heterooligomerization was supported by a
fluorescence-quenching assay (Figure 4). The molecular weights of BBAhetT1 and of the
individual components were determined by sedimentation equilibrium analytical
ultracentrifugation (AUC) experiments (Table 2). Peptides A-Ala and B-Phe were found to be
monomeric at low concentrations, but BBAhetT1 was best described as a single tetrameric
species. A tracer sedimentation equilibrium experiment (43) further confirmed the
heterospecificity of the interaction.
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The designed combination of a "large/small" core packing motif and charge
complementarity was successful in imparting heterospecificity to BBAhetT1. However, this
complex is significantly destabilized relative to the parent homotetramer BBAT2. An analysis of
computationally predicted structures indicated that a larger side chain could be accommodated in
place of Ala in the "small" partner at position 12. Serine was predicted to result in more
favorable van der Waals interactions relative to alanine at this site, but also in an overall
reduction in stability. The non-natural amino acid L-Uc-aminobutyric acid (Abu) was predicted to
stabilize the tetramer by - 4 kcal/mol, based on estimates of van der Waals and solvation
contributions, and to retain high specificity for heterotetramerization. Peptide A-Abu, with an
Ala to Abu substitution at position 12 (Table 1), was synthesized. The CD spectrum revealed
that A-Abu has little secondary structure alone. An equimolar mixture of A-Abu and B-Phe
gave a spectrum very similar to that observed for BBAhetT1, but with greater ellipticity at 208
and 222 nm. A complex of A-Abu and B-Phe, termed BBAhetT2, exhibited a cooperative
thermal unfolding transition, and was considerably more stable to thermal denaturation than
BBAhetT1 (Figure 3B). Heterooligomerization was confirmed by fluorescence quenching
(Figure 4). AUC experiments indicated that equimolar mixtures of A-Abu and B-Phe are best
described as a single tetrameric species (Table 2). By contrast, peptides A-Abu and B-Phe are
both monomeric at 25 laM.
The 1.95 A crystal structure of BBAhetT1 was solved by molecular replacement, using
two monomers from BBAT2 as a search model (Figure 5). The overall fold (Figure 1IC) is very
similar to that of BBAT2, with an all-atom rms deviation of 1.76 A and an all-backbone atom
mls deviation of 0.71 A. The similarity of the backbone structures indicates that the calculations
were successful in indentifying an alternative sequence compatible with the precise geometry of
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the homotetramer fold. The structure confirms that BBAhetT1 is a C2-symmetric
heterotetramer, as intended. The tetramer axis coincides with a perfect two-fold screw axis in
the crystallographic symmetry. The conformations of the designed side chains and their
surrounding residues in the core are in excellent agreement with the calculated predictions
(Figure 6). On the surface, two designed salt bridges between Glu 11 on A-Ala and Lys 18 on
B-Phe are formed, with slightly different side-chain conformations than predicted. Four other
designed salt bridges are not present, but in each of these cases the designed residues participate
in inter-tetramer crystal contacts that were not represented in the calculations (Figure 6).
DISCUSSION
The design of miniproteins is challenging. Many residues in the BBA peptides play
multiple structural roles, and single point mutations can affect the overall fold or solution
properties. In our work, computational methods proved valuable for rapidly identifying
mutations that would change the interaction specificity of BBAT2 while maintaining its overall
structure. Calculations were used to identify possible sites for mutation as well as to find the
best combination of residues for stabilizing a heterotetramer relative to competing
homotetramers and the unfolded state. Despite the very large number of possible sequences, the
first set of designed peptides that we tested exhibited the desired properties. The efficiency of
this structure-based computational approach can be compared to the much slower process of
performing an experimental selection or the iterative process of testing sequences suggested by
visual inspection.
Computational protein design does have significant limitations. Modeling structural
relaxation, particularly backbone flexibility, is challenging (44-46). In the absence of a realistic
model to describe relaxation, our method predicted that sequences with large groups in the core
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would be highly destabilized and not fold as homotetramers. By contrast, our experiments
revealed that B-Phe, an example of such a peptide, nevertheless associates to some extent in
solution at high concentrations (data not shown). The strategy of designing holes in the core,
rather than steric bulk, was significantly more effective at destabilizing the homotetramer state.
Relaxation of side-chain conformations in the calculations, and the use of multiple tetramer
structures as templates in the design process, alleviated the problem of large steric clashes to
some extent.
BBAhetT1 and BBAhetT2 are both less stable than BBAT2, indicating that specificity
in this system comes from destabilization of the competing homotetramer states rather than
stabilization of the heterotetramer. Charge patterning is an effective negative design strategy in
some heterospecific coiled coils (20). However, we found that BBA peptides in which only the
surface side chains are altered (A-Leu and B-Leu, Table 1) self-associate in solution (data not
shown). Charge-charge repulsion in these systems is not sufficient to prevent the undesired
states from forming under the conditions studied. A-Leu and B-Leu do, notably, preferentially
form heterooligomers when mixed, as demonstrated by fluorescence quenching and CD
experiments (data not shown). But a significant amount of additional heterospecificity in
BBAhetT1 and BBAhetT2 is apparently derived from the core redesign and its role in
disfavoring homotetramerization.
We observed excellent agreement of the backbone and core structure of BBAhetT1 with
the computationally predicted design. The behavior of the designed charged residues in the
crystal structure is more complex than predicted by the calculations. Notably, all but one of the
computationally predicted surface residues were observed to have high temperature factors or
multiple conformations in the BBAT2 or BBAhetT1 crystal structures, suggesting that the
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conformational preferences at these sites are not absolute. In addition, most of the designed side
chains in the BBAhetT1 structure are involved in inter-tetramer interactions. At sites where
BBAhetT1 surface residues do not participate in crystal contacts, the designed salt bridges form
as predicted. Charged surface residues on BBAhetT1 are probably dynamic in solution and
influenced by lattice contacts in the crystal. Information about whether the designed salt bridges
form in solution would allow a more direct comparison with the calculations.
We used the native BBAhetT1 backbone to model the difference in energy between the
predicted and the experimental structures of the heterotetramer. We approximated the
experimental structure using native side-chain chi angles but bond lengths and angles from
CHARMM. The energy function used for design strongly favored the formation of salt bridges
between acidic and basic surface residues, as observed in the sequence-selection calculations.
Interestingly, when the side-chain conformations were relaxed by minimization and the energies
re-evaluated using more accurate electrostatics functions (see Methods), the difference between
salt-bridge forming and non-salt bridge forming configurations decreased dramatically. These
calculations support a small energy gap between structures with different numbers of salt
bridges, consistent with the alternative conformations seen in the BBA homo and heterotetramer
crystal structures.
Differences in the placement of residue Tyr 6, and other very minor differences between
the design and the BBAhetT1 structure, resulted from simplifying assumptions of the
computational method. For example, the incorrect prediction of Tyr 6 arose because the rotamer
library used did not contain all of the experimentally observed side-chain chi angles. In addition,
even slight changes in backbone geometry (e.g. the 0.5 A difference between the BBAT2 and
the BBAhetT1 backbones) made significant differences in the correct placement of rotamers and
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in salt-bridge formation. Predictive performance for Tyr 6 was improved when wild-type
rotamers were included and the sequence was modeled using the correct heterotetramer
backbone.
In conclusion, we have designed and characterized two compact, heterotetrameric, mixed
cd3 miniproteins, BBAhetT1 and BBAhetT2. Both were derived from a homotetrameric
precursor using computational screening of many possible sequence/structure combinations.
These tetramers constitute the first reported heterooligomeric cdf miniproteins, and thus
arguably the most complex miniproteins designed thus far. The BBA family of peptides has
proven to be quite remarkable. The power of small sequence changes to encode monomeric,
homotetrameric and heterotetrameric BBA variants, and to tune stability and specificity within
each class, makes this system ideal for studying basic principles of protein structure. The study
described here has established several ways that oligomerization specificity can be manipulated
in the BBA peptides. Future work is likely to suggest others, and to lead to yet more novel
architectures, activities and functions, all specified by a sequence of only 21 amino acids.
EXPERIMENTAL PROCEDURES
Computational Design
All calculations, unless stated otherwise, used symmetry-generated tetramers from the
crystal structures of two selenomethionine mutants of BBAT2 (SNA and 1SNE). In the case of
a residue having alternate conformations, the first listed conformation was used. Methionine
selenoxide residues were modeled as alanines. Allowed side-chain conformations were defined
by the backbone-dependent rotamers of Dunbrack (40, 41), using default bond lengths and
angles from CHARMM paraml9 (47). Non-standard amino acids added were: D-alanine (D-
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Ala), D-proline (D-Pro), benzoylated L-c,3-diaminopropionic acid (DapBz), and L-aC-
aminobutyric acid (Abu). The angle CH1E-CH2E-NH1, with a force constant of 100.0 and
equilibrium geometry of 109.5, and the improper dihedral NH1-H-C-CH2E, with a force
constant of 750.0, multiplicity of 0, and minimum geometry of 0.0, were added to the CHARMM
19 parameter set for DapBz (37). Rotamers of Abu were modeled using rotamers of serine (40).
Design energies were defined as the sum over all self energies plus the sum over all
unique residue-residue energies for all flexible sites. The self energies include intra-side chain
interactions, as well as interactions with the backbone and non-designed side chains; the pair-
wise energies include the interactions of a particular side chain with another side chain. The van
der Waals radii from CHARMM paraml9 were scaled by 90% to accommodate discrete rotamer
conformations. The total van der Waals energy was also scaled by 90%. Torsion energies were
computed using param 19. The pair-wise electrostatic energy was calculated using a coulombic
function with E = 4r for polar-polar interactions, 8r for polar-charged interactions, and 16r for
charged-charged interactions; for self energies E = 4r was used. Both the self and pair-wise
solvation energies were calculated using an Effective Energy Function (EEF1), (48) with
reference/free energies as published except for NH3 (-10/-10), NC2 (-7.5/-7.5), OC (-5.33/-
5.85). The unfolded state was modeled by treating each residue in turn as the central residue, X,
in a Gly-Gly-X-Gly-Gly pentapeptide. The backbone structure employed was that of residue X
and the two residues preceding and following X in the crystal structure. The side chain of
residue X was modeled as an ensemble average of all possible rotamer states, employing the
same energy function used for the folded states.
Sequences were either enumerated or sampled using a Monte Carlo search algorithm.
The Monte Carlo search algorithm employed 64 cycles of 1500 steps with a linear temperature
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gradient from 300 to 200 K. For each sequence, the side chains were placed onto one or more
backbones in an optimal configuration using a DEE/A* algorithm (49, 50). Two quantities were
evaluated: the stability (Eunfold - EABAB) and the specificity (EAAAA + EBBBB - 2EABAB).
Sequences were ranked according to these two scores, and those with high stability and
specificity on both of the backbones used were considered for further analysis. For selected
models, the energies were re-evaluated with a function including the following terms:
CHARMM param19 van der Waals energy (100% radii), Coulomb energy evaluated with a
dielectric constant of 4, polarization energy for transfer from a protein/environment dielectric of
4/4 to 4/80, and a surface tension term computed as the solvent accessible surface area multiplied
by 7 cal/moloA 2. The polarization energy was computed with a Generalized Born model (51)
that used PEP to solve for Born radii (52). A version of the energy function in which the
Generalized Born reaction field energies were substituted by EEF desolvation energies was also
used. Models were evaluated both before and after 10 steps of steepest descent minimization
(maintaining a fixed backbone) to relieve side-chain steric clashes.
Peptide Synthesis
Peptides were prepared by standard Fmoc-based solid-phase peptide synthesis as in Ali et
al. (37). Identity was confirmed by electrospray mass spectroscopy (PerSeptive Biosystems)
and purity by analytical HPLC (>95%).
Circular Dichroism
CD spectra from 300 to 200 nm were collected at 25 C in duplicate or triplicate on an
Aviv circular dichroism spectrometer Model 202 using strain-free quartz cells having a path
length of 0.1 cm and an averaging time of 5 seconds. Peptides were dissolved in degassed buffer
69
(50 mM sodium phosphate, 100 mM NaCl, pH 7.2), and concentrations were determined using
the method of Edelhoch (53). Melting experiments involved monitoring []222 using a 30 second
averaging time, 90 second equilibration time, and temperature increments of 2 C from 5 C to
80 C.
Fluorescence Quenching
Peptides were synthesized with a 3-nitrotyrosine quencher at position 6 (A-Ala and A-
Abu) or an anthranilamide fluorophore at position 20 (B-Phe). 12.5 #M samples were prepared
of fluorophore- or quencher-labeled peptides in 10 mM phosphate buffer, pH 7.2. Combination
samples comprised 12.5 M fluorophore-labeled peptide plus 12.5 jtM quencher-labeled peptide.
Data were collected at 25 C with a Jobin Yvon Horiba FluroMax-P fluorescence spectrometer
using strain-free quartz cells having a path length of 1 cm. Samples were excited at 315 nm and
emission spectra recorded from 350 to 550 nm. Comparisons were made of fluorescence at 412
nm.
Analytical Ultracentrifugation
Peptides or mixtures of peptides at equimolar concentrations, dialyzed against reference
buffer (50 mM sodium phosphate, 100 mM NaCl, pH 7.2), were spun at 25 C in a Beckman
XL-I analytical ultracentrifuge at 40,000, 45,000 and 50,000 rpm for approximately twenty-four
hours at each speed. The following concentrations were used: A-Ala, 40, 100, 266 tM; B-Phe,
25 gM; A-Abu, 50, 100, 220 tM; 1:1 A-Ala/B-Phe, 50, 150, 320 jtM; A-Abu/B-Phe, 50, 150,
320 pM. The contents of each cell were confirmed to be at equilibrium using WINMATCH prior to
increasing the speed. Data were analyzed using the programs NONLIN (54) and SEDPHAT (55, 56).
Several association models were fit, including a single ideal species, a single non-ideal species
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and different monomer-oligomer equilibria. The results reported in Table 2 are from the model
that best fits the data, as indicated. Molecular weights were determined using a partial specific
volume, v, calculated by SEDNTERP (57).
Crystallization
Crystals were grown using vapor diffusion with hanging-drop geometry from an
equimolar mixture of peptides A-Ala and B-Phe (11 mg/ml in 10 mM phosphate at pH 7.2) by
mixing 1.5 t1 of protein with an equal volume of reservoir solution (100 mM Na HEPES buffer
pH 7.5, 10% v/V i-propanol, 20% w/v PEG 4000). Bipyramidal crystals grew after
approximately one week.
X-Ray Data Collection and Phasing
Crystals were frozen in a stream of N2 gas cooled to -180 C using FMS oil (Hampton
Research) as a cryoprotectant. A 1.95 A data set was collected at the Boston University Core
Facility for Macromolecular Crystallography using a Rigaku RU-H3RHB x-ray generator with
an MSC R-Axis IV++ area detector and 2-theta stage. The DENZO and SCALEPACK packages
were used for data indexing, reduction, and scaling (58). Molecular replacement was performed
with MOLREP (59). The search model comprised a dimer generated by applying the
crystallographic symmetry operators of the BBAT2 structure (PDB ID 1 SNE).
Refinement
Manual fitting was performed using SigmaA weighted 2Fo - F composite-omit and F -
Fc electron density maps (60) in the graphics program o (61). Refinement using an MLF target
consisted of iterative rounds of minimization and simulated annealing (3000-5000 K) using
slow-cool torsional molecular dynamics followed by individual B-factor refinement and manual
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rebuilding, and was performed until Rfree ceased to decrease. Water molecules added to the
structure were checked by visual inspection of the map at each cycle of refinement. For
statistical cross-validation purposes 10% of the data was excluded from refinement as a test set
(62, 63). Topology and parameter files were created for nonstandard groups using bond lengths
and angles from the literature (37). Values for D-Ala and D-Pro were derived from their L-
enantiomers. Analysis of the Ramachandran plot defined by PROCHECK (64) showed a good final
model with 88% of residues in the most favorable regions and 12% of residues in additionally
allowed regions. Wilson plot values were calculated using the ccP4 program TRUNCATE (65)
with resolution limits 2.5 - 1.95 A. The refined structure contained 371 protein atoms and 52
solvent atoms per asymmetric unit (two monomers). Final model statistics are summarized in
Table 2. All figures were created using MOLSCRIPT (66).
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Bank (accession code XOF).
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TABLES
Table 1. Sequences of designed peptides
hairpin
Peptide 1 2 3 4 5 6 7 8
BBAT2 Ac Y R I p S Y D F
A-Ala Ac Y R I p S Y D F
B-Phe Ac Y R I p S Y D F
A-Abu Ac Y R I p S Y D F
A-Leu Ac Y R I p S Y D F
B-Leu Ac Y R I p S Y D F
BBAhetT1 = (A-Ala)2( B-Phe)2
BBAhetT2 = (A-Abu):(B-Phe)2
a = D-Ala, p = D-Pro, Z= DapBz, B=Abu
helix
9 10 11 12 13 14
a D E L A K
a D E A E K
a D K F K K
a D E B E K
a D E L E K
a D K L K K
15 16 17 18 19
L L RQA
L L R DA
L L R KA
L L R DA
L L RDA
L L RKA
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G
G
G
G
NH2
NH2
NH2
NH2
NH,
NH2
Table 2. AUC Results
Peptide A-Ala B-Phe BBAhetT1 A-Abu BBAhetT2
v2 (cm3/g)a 0.7234 0.7510 0.73721 0.7248 0.7379
MWcalc 2561 2648 10418 2575 10446
NONLIN
Best Modelb a a a b b
Sigmac 0.5012 0.5493 1.6758 0.4452 1.8010
MWobs 2616 3208 9253 2336 9938
Stoichiometryd 1.0 1.2 3.6 0.9 3.8
SEDPHAT
MWobs 2703 3193 9393 2631 9491
Stoichiometry 1.1 1.2 3.6 1.0 3.6
a. Partial specific volumes were calculated using the program SEDNTERP (57). Partial specific volumes of
complexes were approximated as the average of the partial specific volumes of the individual components.
b. Best model: a: Single species, B = 0. b: Single species, B 0.
oRT
c. Sigma is related to the molecular weight by the equation M = - o(I_- 2
MW ood. Stoichiometry is defined as obs . In the case of a mixture, MWcalc is the average of the calculated molecular
MWl 'C
weights of the components.
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Table 3. X-ray statistics
Data Collection Statistics'
Unit cell (A, °)
Space group
Wavelength (A)
Resolution (A)
Total/
unique reflections
Completeness (%)
I/c(I)
Rme.rge2 (%)
Refinement Statistics
Resolution (A)
No. of reflections working/
test set
Rwork3/Rfree (%)
Average B-factors (A2)
Wilson plot
Amino acids
Water
a= b = 41.70 c = 51.33
c = = 90 = 120
P3121
1.5418
oo- 1.95
32,475
3,881
95.7 (100.0)
24.9 (7.1)
5.8 (38.9)
17.03- 1.95
3369
380
22.2 / 24.0
32.4
37.8
55.5
RMS Deviations from Ideality
Bond lengths (A) 0.009
Angles () 1.5
Dihedral angles () 21.7
' Values for the outermost shell (2.02 -1.95 A) are shown in parentheses.
2Rmerge = -hkl Y i[ Ih1d, i-<Ihkl> I I / E hkl i Ihkl. i , where <Ira> is the mean intensity of the multiple IkI, i observations for
symmetry related reflections.
Rwork = yhklFobs - Fcalcl / Yhkl IFobsl.
4 Rfree = Y1i zrTFobs - Fcalcl / YXk IFobsl, where the test set T includes 10% of the data.
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Figure 1. The design history of the BBA heterotetramers. (A) NMR structure of BBA5, an
autonomously folding 23-mer designed to adopt the a/~ fold of a zinc finger (3, 36). (B) X-ray
crystal structure of BBAT2, a homotetrameric derivative of BBA5 (37). (C) X-ray crystal
structure of BBAhetTl, a heterotetrameric miniprotein derived from BBAT2 by computer-aided
design based on the structure of BBAT2 (this study).
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Figure 2. Design of heterospecificity. (A-C) Core redesign. (A) Four leucines at position 12
in BBAT2 pack poorly in the hydrophobic core (37). (B) Ala was predicted to pack well against
Phe in the core of a heterotetramer, and to disfavor homotetrameric states. (C) The stability of
the heterotetramer was improved and specificity was retained when Abu was substituted for Ala
in BBAbetT2. (D-E) Surface redesign. Positions 11, 18 and 13 of BBAT2 are Glu, GIn and
Ala, respectively. Calculations suggested that Asp or Lys at position 18 could form salt-bridging
interactions with Glu or Lys at position 11, and that Lys or Glu residues at position 13 on
adjacent subunits could also interact favorably, as shown. (D) and (E) are two views of the
designed complex, rotated 900 around the tetramer axis with respect to one another.
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Figure 3. Solution characterization of BBA oligomers. (A) Circular dichroism spectra of A-
Ala (o), A-Abu (*), B-Phe (A), BBAhetT1 (0), BBAhetT2 (A), and BBAT2 (*) with total
peptide concentration of 50 jiM. (B) Thermal denaturation of A-Abu, B-Phe, BBAhetT1,
BBAhetT2, and BBAT2 at 50 jM total peptide concentration; symbols as in (A).
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Figure 4. Fluorescence quenching experiments demonstrating heterospecific interactions
between A-Ala and B-Phe and A-Abu and B-Phe. Peptides were synthesized with a quencher
(A-Ala and A-Abu) or fluorophore (B-Phe) label. Combinations of A-Ala and B-Phe
(BBAhetT1) and A-Abu and B-Phe (BBAhetT2) exhibit fluorescence quenching.
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- qff
AFigure 5. Stereo view of layer C of BBAhetTl with composite omit map contoured at 1.0 cr.
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13
Figure 6. Crystal structure of BBAhetTl (dark) superimposed on the predicted designed
structure (light). Superimposed backbones are depicted as ribbons, with side chains at the
designed positions 11, 12, 13 and 18 rendered as ball-and-stick models. Residues involved in
inter-tetramer contacts are indicated with red arrows. (A) Entire backbone structure with
designed sides chains. (B) The helical region of BBAhetTl showing layer 12 and the designed
surface residues.
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CHAPTER THREE
Orientation Specificity of the Bcr Coiled-Coil
Oligomerization Domain
This work has been submitted to Biochemistry
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ABSTRACT
The Bcr oligomerization domain, from the Bcr-Abl oncoprotein, homodimerizes via an
antiparallel coiled coil with an adjacent short, helical swap domain. Inspection of the coiled-coil
sequence does not reveal obvious determinants of helix-orientation specificity, raising the
possibility that the antiparallel orientation preference is due to interactions of the swap domains.
Coiled-coil constructs containing either an N- or C-terminal cysteine were synthesized without
the swap domain. When crosslinked to adopt exclusively parallel or antiparallel orientations,
these showed similar circular dichroism spectra. The antiparallel construct was -16 °C more
stable than the parallel to thermal denaturation. Equilibrium disulfide-exchange studies
confirmed that the isolated coiled-coil homodimer shows a very strong preference for the
antiparallel orientation. We conclude that the orientation preference of Bcr is not caused by the
presence of the swap domains, but rather is directly encoded in the coiled-coil sequence. We
further explored possible determinants of orientation specificity by mutating residues in the d
position of the coiled-coil core. Some of the mutations caused a change in orientation
specificity, and all of the mutations led to the formation of higher-order oligomers. In the
absence of the swap domain, these residues play an important role in disfavoring alternate states
and are especially important for encoding dimeric oligomerization specificity.
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INTRODUCTION
The a-helical coiled coil is among the most common protein motifs found in nature and
forms the basis of a wide range of protein-protein interactions. The motif consists of two or
more c-helices packed together with a left-handed superhelical twist; the helices can associate
in either a parallel or antiparallel orientation. Coiled coils play a fundamental functional role in
many different proteins, including transcription factors, SNARE complexes, and proteins that
mediate viral membrane fusion (1, 2).
Knowledge of whether the helices in a coiled coil are arranged in a parallel or antiparallel
orientation can be critical in determining how it functions. For example, the bZip transcription
factors contain a parallel coiled-coil oligomerization domain (2, 3), but there are other DNA
binding proteins that dimerize in an antiparallel orientation (4). Determining the orientation of
coiled coils in DNA binding proteins can help in elucidating function and can establish what
surfaces are available for other proteins to bind. Structural maintenance of chromosomes (SMC)
proteins, which are involved in chromosome condensation, sister chromatid cohesion, gene
dosage, and DNA recombination, were originally expected to contain a parallel coiled-coil motif
(5-7). After electron micrographs and crystallographic analyses revealed that the helices are
actually antiparallel, however, proposed mechanisms had to be re-evaluated (8, 9). In another
example, models of coiled coil-mediated membrane fusion are strongly dependent on the
orientation of the proteins involved. Mitochondrial fusion proteins contain antiparallel coiled
coils (10), whereas SNARE coiled coils are parallel (11, 12). Viral membrane fusion proteins
contain a parallel coiled-coil trimer that forms antiparallel interactions with additional helices
(13). Understanding the orientation of the coiled coils in each of these cases has precipitated
models of membrane fusion (10, 11, 13).
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Coiled coils have been extensively studied because of their simple repeating sequence
and structure, and knowledge obtained from coiled-coil studies has been useful for understanding
general protein structure principles. The motif contains a characteristic repeating heptad pattern
of amino acids, (abcdefg)n. Hydrophobic a and d residues create a stripe down one side of the
o-helix and form the core of a coiled-coil oligomer. Frequently, charged residues at e and g
form inter- and/or intrahelical salt bridges (2). In parallel coiled coils, charge complementarity at
the e and g positions can impart heterooligomeric specificity (14, 15), and this general principle
has been expanded in the design of non-coiled coil proteins (16-18). Similarly, polar residues at
a positions in parallel coiled-coil cores, although destabilizing, can provide orientation and
oligomerization specificity (19-22). Following this finding, polar residues have been found to
impart specificity in globular folds (23-26).
Sequence elements that influence coiled-coil helix-orientation preference are not well
understood (27). Parallel and antiparallel coiled coils have very different interactions in the core,
with a to a' and d to d' for parallel, versus a to d' for antiparallel coiled coils (where the prime
indicates a residue on an opposing helix). Parallel and antiparallel coiled coils also have
different interactions on the surface, with g to e' interactions in parallel versus e to e' and g to g'
in antiparallel structures (Figure 1A and B) (27). Despite an abundance of both parallel and
antiparallel x-ray crystal structures, antiparallel examples are frequently short and intramolecular
(28), making it unclear whether the coiled-coil sequence actually encodes helix orientation in
these cases.
A handful of studies have addressed the determinants of helix-orientation specificity and
established that the a, d, e, and g residues can each play a role (27). One theory suggests
antiparallel coiled coils favor small hydrophobics in the a and d positions because they allow
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tighter van der Waals packing between the ac-helices (29), and another suggests a "steric
matching" argument in which helix orientation can be established by the juxtaposition of small
and large residues (30-33). Polar residues in the core may participate in specific hydrogen
bonding interactions in one state preferentially to another, leading to an orientation preference
(34). Charge complementarity of the surface e and g positions can also play a role in
determining helix orientation (27, 35-37). Antiparallel coiled coils have been successfully
designed by exploiting general principles, such as steric matching and charge complementarity
(35, 36, 38, 39). Nevertheless, orientation cannot be accurately predicted from amino-acid
sequence for most coiled coils.
The Bcr oligomerization domain is an example of an important natural protein for which
orientation cannot be predicted from the amino-acid sequence. The Bcr-Abl oncoprotein is
responsible for -95% of chronic myeloid leukemias (CML) (40) and 17-30% of acute
lymphoblastic leukemias (ALL) (41). The oncoprotein results from a reciprocal translocation
event between bcr, on chromosome 22, and abl, on chromosome 9 (40). Oligomerization of Bcr
relieves the autoinhibition of Abl, leading to aberrant downstream signaling (42). The Bcr
oligomerization domain contains a thirty-six residue, antiparallel coiled coil, shown in Figure 2.
Each Bcr monomer consists of a short helix, a loop, and then a long coiled-coil helix. The short
helix associates with the long coiled-coil helix on the other monomer, also in an antiparallel
fashion, forming a swap domain (43). Two such dimers further associate as a tetramer. The
oligomerization domain is required for activation of the transforming function of Abl kinase (44)
and may be an interesting target for treating disease.
The determinants of helix orientation in the Bcr coiled-coil dimers are not obvious in the
structure (43) and cannot easily be explained using known general principles. It is possible that
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the N-terminal swap domain establishes the geometry of the oligomerization interface. It is also
possible that the coiled-coil domain adopts a different structure in solution than is observed in
the crystal structure. Indeed, solution characterization and crystallographic studies of coiled
coils can sometimes yield different results, as for spectrin (45), Coil-Ser (46, 47), and an alanine-
zipper peptide (48). Domain swapped proteins have also been reported to change
oligomerization state and/or swap region depending upon crystallization conditions (49).
In the first part of this paper, we investigate the intrinsic orientation preference of the Bcr
coiled coil in solution and find that it is strongly antiparallel, even without the swap domain. To
explore the origins of this preference, computational methods, statistical analysis, and structural
evaluation were employed. In the second part, we mutated several residues in d positions that
are non-optimal for parallel coiled coils and found that these play an important role in
establishing the interaction specificity of Bcr.
MATERIALS AND METHODS
Modeling of Parallel and Antiparallel Bcr and Mutants
The Bcr crystal structure (lKlF, shown in Figure 2) was used for general structural
examination. Additionally, the Bcr sequence and numerous mutants were modeled as dimers in
both parallel and antiparallel orientations. Several different parallel and antiparallel backbones
were created using Crick's parameterization of coiled coils (50, 51). Native side chains were
placed onto these backbones in their optimal conformations with a DEE/A* algorithm, using
energies calculated with a molecular mechanics energy function, as in a previous study (17).
Structures for the mutants A38L and E52L were based on model Bcr parallel and antiparallel
structures, but side chains near the mutation site were reoptimized.
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Peptide Design, Synthesis, and Cleavage
Native and mutant Bcr peptides were synthesized using standard Fmoc synthesis and
consisted only of the Bcr coiled-coil region (residues 30-65 KIF). As in the crystal structure,
the "native" sequence had several mutations from the wildtype: Cys 38 was mutated to alanine
to prevent undesired disulfide bonds; Ile 57 was changed to alanine to disfavor the formation of
Bcr tetramers; Phe 54 was changed to serine to eliminate hydrophobic surface exposed as a
result of removing the swap domains. All mutant peptides were purchased from Bio-Synthesis,
Inc, Lewisville, TX. The peptides were acetylated and amidated to eliminate charges on the
termini, and N-terminal KWCGG or C-terminal GGC were added (as shown in Figure 1C).
Reduced peptides are indicated with "C" in their name. For example, C-BCRA38L is a peptide
with a reduced N-terminal cysteine and position 38 mutated from Ala to Leu. All mutant
peptides have Ile 31 changed to Leu. Disulfide-bonded peptides are indicated with a superscript
P or AP to indicate parallel or antiparallel helix orientation, respectively. C-BCRA38L P is the
oxidized form of C-BCRA38L, whereas BCRA38LAP indicates a construct in which C-
BCRA38L and BCRA38L-C are disulfide bonded. Cap-C-BCRA38L indicates C-BCRA38L
with the N-terminal cysteine alkylated.
Alkylation of Cysteine Thiol groups
For some experiments, thiol groups were alkylated with iodoacetamide. Peptides were
dissolved in 50 mM sodium phosphate buffer, pH 7.2, 2 mM TCEP for 30 minutes. At least a
10-fold molar excess of iodoacetamide was added to the reduced peptide. The solution was
stirred in the dark at room temperature for 2 hours. Peptides were HPLC purified following the
reaction, and the presence of the acetamide group was confirmed with electrospray mass
spectrometry to 2 Da.
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Purification and Handling
Prior to purification, peptides were either reduced in 0.2 M Tris/HCl and 100 mM DTT,
pH 8.8, for 30 minutes or oxidized in 0.2 M Tris/HC overnight to form disulfide-linked dimers.
Both the reduction and oxidation reactions were quenched by adding acetic acid to a final
concentration of 5%, yielding a final pH around 2. Reduced or oxidized peptides were purified
on a C 18 reverse phase HPLC column using a 0.1 %/min acetylnitrile/water gradient with 0.1%
trifluoroacetic acid. Samples were immediately frozen with liquid nitrogen after eluting from the
HPLC, then lyophilyzed. All peptide solutions were made in an anaerobic chamber with
degassed solvents to minimize oxygen exposure. The solutions were kept in the anaerobic
chamber until immediately before use. This careful handling procedure eliminated most
methionine oxidation problems. The purity of each peptide was confirmed to be greater than 95
percent by analytical HPLC. Masses for the native Bcr peptides were correct to within 1 Da
using electrospray mass spectrometry, and the masses for the mutant Bcr peptides were verified
by the supplier, Bio-Synthesis, Inc. Concentrations were determined using the method of
Edelhoch (52).
Circular Dichroism Spectroscopy
Circular dichroism (CD) spectra from 300 to 200 nm were collected at 25 °C in triplicate
on an Aviv circular dichroism spectrometer Model 202 using strain-free quartz cells with a path
length of 0.1 cm and an averaging time of 5 seconds. Disulfide-linked peptides were dissolved
in degassed buffer (50 mM sodium phosphate, 150 mM NaCl, pH 7.2) in an anaerobic chamber.
Thermal unfolding experiments involved monitoring 0222 using a 30 second averaging time, 90
second equilibration time, and temperature increments of 2 °C from 5 to 85 C. Melts were done
in the presence of 2M GdnHCl. Several consecutive melts were done on the same sample and
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compared. The Tm, the midpoint of the thermal unfolding curve, was estimated by extrapolating
the pre- and post-transition baselines and then determining the temperature for which the CD
signal was half of the difference. The Tm for each peptide was reproducible within 1 to 2 °C.
Analytical ultracentrifugation
Alkylated and disulfide-linked peptides, dialyzed against reference buffer (50 mM
sodium phosphate, 150 mM NaCl, pH 7.2) in an anaerobic chamber, were spun at 25 °C in a
Beckman XL-I analytical ultracentrifuge at 17,000, 20,000, and 23,000 rpm for BCRA38LAP,
BCRA38L-C-cap, and cap-C-BCRE52L and 28,000, 31,000, and 34,000 rpm for BCRAP and
BCR-CP for approximately 24 hours at each speed. The following concentrations were used:
BCRAP and BCR-CP (5 gM, 25 FM, and 50 pM), BCRA38LAP (25 gM and 50 laM),
BCRA38L-C-cap (30 gM, 50 gM, and 100 AM), cap-C-BCRE52L (30 gM, 50 JIM, and 100
aM). The contents of each cell were confirmed to be at equilibrium prior to increasing the
speed. Data were analyzed using the programs NONLIN (53) and SEDPHAT (54, 55). Various
association models were fit, including a single, ideal species and monomer-oligomer equilibria.
The results reported are from single-species fits. Partial specific volumes were calculated from
the amino-acid sequence (56). Solvent density was calculated by SEDNTERP from its composition
(56).
Disulfide-Exchange Experiment
Helix orientation was determined using an equilibrium disulfide-exchange assay (22, 34,
57), shown in Figure 5A. Different starting reactants were used to ensure that the products were
not kinetically trapped. Peptides were allowed to equilibrate in an anaerobic chamber at room
temperature in 50 mM sodium phosphate, 150 mM NaCl, 1 mM EDTA, pH 7.2. The total
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monomer peptide concentration was 50 tM. Samples were quenched by adding acetic acid to a
final concentration of 5% after the reaction reached equilibrium. Samples were considered to be
at equilibrium when consecutive HPLC traces showed no change. C-BCRA38LP was sparingly
soluble in phosphate buffer, so the assay was performed in the presence of 0.25 M urea and 5%
acetonitrile. For the BCRA38L disulfide-exchange experiment, acetonitrile was added to a final
concentration of 20% immediately before acetic acid was used to quench the reaction. The
products were run on an analytical HPLC, monitored at 229 nm, and the identities of the peaks
were confirmed by liquid chromatography-mass spectrometry. Adjustments to the absorbance
were made for the difference in the number of amide bonds in the peptides, and an equilibrium
constant was calculated.
RESULTS
Biophysical Characterization of the Bcr coiled coil
To probe determinants of helix-orientation specificity in the Bcr oligomerization domain,
peptides corresponding to Bcr residues 30-65 were constructed with either GGC on the C-
terminus (BCR-C) or KWCGG on the N-terminus (C-BCR) (57), as shown in Figure 1C. The
glycine residues on the peptides provide flexibility in disulfide bond formation, while the
trptophan and lysine residues provide a means to separate and identify the various peptides by
HPLC. These constructs contain only the coiled-coil portion of the oligomerization domain,
lacking the linker and short "swap domain" helix. The cysteine residues on the termini allow the
peptides to be constrained in a parallel or antiparallel orientation via a disulfide bond.
Both the parallel and antiparallel disulfide-constrained peptides are highly helical in
phosphate buffer, as shown in Figure 3A. The ratio of the minima at 208 and 222 nm indicates
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that the helices are associating and is typical of spectra observed for coiled coils (58). The
antiparallel orientation is slightly more helical than the parallel orientation and is much more
stable to thermal denaturation (Figure 3B). The Tm of the antiparallel construct is -53 °C,
whereas that of the parallel construct is -37 °C. Equilibrium sedimentation experiments run at
and around concentrations used for other characterization studies indicated that both the
disulfide-constrained parallel and antiparallel peptides had the molecular weight expected for a
two-stranded coiled coil (Figure 4A, 4B, and Table 1).
To confirm that the Bcr coiled-coil peptide prefers an antiparallel orientation, oxidized
and reduced peptides were mixed together and allowed to equilibrate in an anaerobic
atmosphere. A clear antiparallel preference was evident from two experiments with different
starting conditions. The first experiment was performed by mixing BCRA P (12.5 AM), C-BCR
(12.5 gM), and BCR-C (12.5 tM) at pH 7.2 (Figure 5B). Exchange took place within a few
minutes and showed a preference for an antiparallel orientation with Keq - 1.3x10-3. To ensure
that the reactants were not kinetically trapped, the disulfide-exchange experiment was repeated
by mixing BCR-C P (12.5 gM) with C-BCR (25 ,tM) (Figure SC). This experiment gave Keq 
1.6x10-3 . These experiments establish that although the Bcr peptides can, in fact, fold as both
parallel and antiparallel two-stranded coiled coils, the antiparallel orientation is preferred and
helix-orientation preference in full-length Bcr is not determined by the swap domain.
Sequence-based and structural analysis of Bcr
The role of charged residues at e and g positions has been extensively studied as a source
of interaction specificity for coiled coils. In Bcr, however, inspection of the e and g position
residues does not suggest any strongly preferred helix orientation. A helical-wheel diagram
(Figure A and B) can be used to assess potential interactions in each state. In the parallel
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orientation, salt bridges typically occur between the g position of one helix and the next e
position of a partner helix (e'+). Four such interhelical salt bridges are possible in a parallel Bcr
structure, and there are no putative g to e'+ electrostatic repulsions in the parallel state (Figure
IB). The antiparallel x-ray structure of Bcr also contains four interhelical salt bridges and no
potentially repulsive g to g' or e to e '+ interactions (Figure 1A). Thus, a simple sequence-based
analysis of charged surface residues does not strongly favor either orientation.
Coiled-coil orientation specificity is determined by the relative stability of the parallel
and antiparallel states. Several d-position residues in the Bcr crystal structure, Ile 31, Ala 38,
and Glu 52, are unusual for parallel, dimeric coiled coils, suggesting that these residues may
specify an antiparallel state by destabilizing the parallel one. We analyzed the unusual d-
position residues by constructing computational models of the native and mutant Bcr sequences
on both parallel and antiparallel backbones and by examining the SOCKET database of coiled
coils with greater than 15 amino acids. SOCKET identifies coiled coils in the PDB
automatically by detecting packing interactions and can be used to derive the frequency with
which different amino acids occur in certain heptad positions (28).
The Bcr crystal structure contains an isoleucine (Ile 31) at a d position near both ends of
the coiled coil. Harbury et al. have demonstrated that 3-branched residues, such as isoleucine,
do not pack well at the d position in a dimeric parallel orientation and typically lead to the
formation of higher-order oligomers (22). Thus, Ile 31 could be an element of negative design,
favoring an antiparallel orientation of Bcr by destabilizing the parallel state. On the other hand,
the effect of Ile 31 may be mitigated by its location at the end of a helix, where it is relatively
solvent exposed and not restricted to as stringent packing requirements as it would be in the
middle of the coiled coil. To test its role in determining the orientation specificity of Bcr,
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position 31 was mutated to a leucine in all mutants made. Leucine was chosen because it is
found more frequently than any other residue in the d positions of dimeric parallel coiled coils
(28, 59). Modeling on parallel and antiparallel backbones showed that leucine is easily
accommodated in the core of both parallel and antiparallel Bcr dimers.
Ala 38 is another unusual residue at a d position in Bcr that may provide a natural
negative design element disfavoring the parallel orientation. In the parallel orientation, two
alanines would be directly across from one another, creating a large cavity in the core. The
residues above and below the pair of alanines, Ile 31 and Leu 45, are not large enough to reach
into the cavity and fill the void space. Analysis of coiled coils in the PDB supports the idea that
Ala is highly unfavorable at the d position of parallel coiled coils and may be better
accommodated in antiparallel structures. In dimeric coiled coils with greater than 15 amino
acids, there are five times more alanines at d positions in antiparallel coiled coils compared to
parallel in the SOCKET database (28). Further, our molecular mechanics calculations suggest
that although an Ala to Leu mutation at position 38 stabilizes both orientations, it stabilizes the
parallel orientation more. Thus, we chose to mutate Ala 38 to Leu to test whether this would
stabilize the parallel orientation preferentially to the antiparallel. Leu was again chosen because
it is so common in the d position of parallel dimers; it is found five times more frequently at the
d position in parallel dimeric coiled coils than antiparallel (28).
Glu 52 is a third d-position residue that may provide an element of negative design
disfavoring the parallel orientation. In the crystal structure of Bcr, the glutamates at position 52
reach into solvent, leaving very little hydrophobic side-chain packing in the core. In a model
parallel structure, the glutamates behave similarly, but leave a larger cavity in the core because
they are positioned directly across from each other. Interestingly, there are no glutamates in d
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positions in parallel coiled coils within the SOCKET database, but glutamates are found nearly
as often as hydrophobic residues such as Ile, Ala, Met, and Tyr at d positions in antiparallel
coiled coils. In our models, changing Glu 52 to Leu improved core packing in the parallel
orientation, but was not as easily accommodated in an antiparallel orientation. Using idealized
backbones, a leucine at position 52 can be modeled in parallel structures with rotamer
conformations that are common in the PDB (60). However, the most energetically favorable
packing of leucine in antiparallel structures forces at least one side chain to adopt a statistically
uncommon rotamer conformation, indicating that leucine cannot be accommodated without some
strain. Therefore, Glu 52 may favor the antiparallel orientation of Bcr via greater destabilization,
relative to Leu, of the parallel vs. the antiparallel state.
Helix-orientation specificity and characterization of the mutants
To investigate the role of d-position residues Ile 31, Ala 38, and Glu 52, two variants of
C-BCR and BCR-C were synthesized. All the mutants replaced Ile 31 with Leu. C-BCRA38L
and BCRA38L-C additionally contained Leu at position 38, and C-BCRE52L and BCRE52L-C
contained Leu at position 52. Sequences are given in Figure 1C.
BCRA38L remained antiparallel, with an equilibrium constant of (7.8x10-5+3.2x10-5 )
(Figure 6A) in a disulfide-exchange assay. Because BCRA38L exhibited such a strong
antiparallel preference, we characterized the disulfide-linked peptide BCRA38LAP and compared
it with BCRAP. Figure 7A shows that BCRA38LAP is slightly more helical than BCRAP at 25°C,
and the ratio of mean residue ellipticities at 208 and 222 nm is typical of coiled coils (58).
BCRA38LAP is more stable than BCRAP to thermal denaturation (Figure 7B). The Tm for
BCRA38LAP is about 17 C higher than that for BCRAP.
The A38L mutation caused oligomerization specificity to be lost. AUC data for
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BCRA38LAP did not fit a single-species or two-state model well and gave a weight average close
to that of a six-helix species (Table 1). BCRA38L-C-cap still did not fit a single-species model
or two-state equilibrium model and had a single-species weight close to BCRA38LAP (Table 1).
BCRA38L-C-cap was less helical than BCRA38LAP, shown in Figure 7A, and was much less
stable than either disulfide-bonded BCRA38LAP or BCRAP to thermal denaturation.
In disulfide-exchange experiments, BCRE52L showed a loss of orientation specificity
(Figure 6B). The equilibrium constant was determined to be 2.2, favoring the parallel orientation
slightly. Because there was no clear orientation specificity, the cysteine group was capped for
biophysical analysis to preclude the formation of a disulfide bond. Cap-C-BCRE52L was as
helical as BCRAP, shown in Figure 7A, and the Tm was -64 °C in the presence of 2M GdnHCl,
indicating this complex was much more stable than BCRAP (Figure 7B). The Glu to Leu
mutation also caused a change in oligomerization state; AUC data for cap-C-BCRE52L fit well
to a single-species trimer with random residuals (Figure 4C).
DISCUSSION
In this study, the Bcr oligomerization domain was used to study coiled-coil orientation
specificity. Analysis of the Bcr sequence using general principles of coiled-coil structure does
not reveal why the coiled-coil domain adopts an antiparallel orientation. The short swap helix in
the Bcr oligomerization domain could potentially play a role, or the helix orientation could be
encoded in the coiled-coil sequence in a way that we do not yet know how to read. To explore
how orientation is encoded in this fold, we characterized several model peptides. We established
that even in the absence of the N-terminal swap domain, Bcr constructs retain a coiled-coil
structure and adopt an antiparallel orientation, indicating that orientation preference is encoded
directly in the coiled-coil part of the sequence.
101
Given that the orientation specificity of Bcr is encoded directly in its sequence, we
considered several features that might favor an antiparallel over parallel orientation. First, we
examined charged residues at e and g positions. Surface electrostatics alone have been used
successfully to impart orientation specificity (36, 37), and charge complementarity is now a
reliable technique for designing an antiparallel coiled coil (31, 32, 38, 39). According to general
principles elucidated in the coiled-coil studies mentioned above, however, the antiparallel and
parallel orientations appear roughly equivalent from an electrostatic perspective. Therefore, a
role for the e and g positions in establishing orientation specificity in Bcr is not obvious.
Residues in the a and d positions of the Bcr core could also be important for encoding an
antiparallel orientation preference, and much less is known about the roles of residues at these
sites. Some of the d-position residues in Bcr do not appear to be optimal for stability, raising the
possibility that they instead provide a negative-design element disfavoring the parallel state (17,
39, 61-64). Elements of negative design have been used to both manually and computationally
design coiled coils and helical bundles that adopt different orientations and oligomerization
states (17, 31, 38, 39, 61, 64, 65). In this study, the unusual d-position residues in Bcr were
mutated to determine their role in defining coiled-coil orientation. Based on previous studies and
current modeling, isoleucine (or any 3-branched amino acid) at d cannot be easily
accommodated in parallel dimers due to geometric packing restraints (22), so Ie 31 was mutated
to leucine in all mutants tested.
The alanine at position 38 in the crystal structure, located in the middle of the coiled coil,
may also prevent Bcr from adopting a parallel orientation. When electrostatics are equal in both
the parallel and antiparallel orientations, placement of large and small core residues in the helix
can cause a switch from antiparallel to parallel or vice versa (33). An antiparallel coiled-coil
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trimer has been designed using steric matching (pairing alanine with a large non-natural residue)
to give the desired orientation (30). In addition, the SOCKET database (28) shows a definite
preference for alanines at d positions in antiparallel versus parallel dimeric coiled coils. Due to
the axial stagger between interacting a and d-position residues in some antiparallel coiled coils,
more interdigitated core packing is possible than in parallel coiled coils. Interdigitation may be a
strategy for compensating for holes in the hydrophobic core (29).
Mutation of Ala 38 to Leu did not cause a change in helix orientation, but did lead to a
change in oligomerization specificity. BCRA38LAP was more helical and stable than BCRAP.
Increasing hydrophobic content in proteins is frequently stabilizing (66), and indeed, changing an
al]anine to a leucine at a d position in a model coiled-coil homodimer designed by Moitra et al.
stabilized the complex by 9.2 kcal/mol and increased the Tm by - 30 °C (67). In Bcr, an Ala to
Leu substitution stabilized antiparallel conformations over parallel ones, as reflected by the
increased antiparallel preference measured in the disulfide exchange reactions.
Ala 38 seems to be more important for oligomerization specificity than for helix
orientation specificity, as equilibrium centrifugation data for both BCRA38LAP and BCRA38L-
C-cap do not fit a single-species or a two-component equilibrium model. BCRA38LAP and
BCRA38L-C-cap have a single-species weight average around that of a hexamer. This type of
change is not unprecedented. Subtle changes in core packing can cause a change in
oligomerization state (22, 68). In a study by Monera et al., the relative placement of Ala and Leu
residues was important for oligomerization specificity. Two alanine residues on the same layer
in an antiparallel coiled coil formed a dimer, but when the positions of the alanines were
staggered such that one layer contained Ala-Leu and the other Leu-Ala, a tetramer formed (68).
This suggests it can be more favorable to form two smaller cavities than one large one. In a
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similar manner, Ala at position 38 of Bcr may preclude high-order oligomerization due to an
especially large energetic penalty for large cavities in the core. This is consistent with the
formation of higher-order oligomers upon mutation of Ala 38 to Leu.
Along with constraints on hydrophobic packing, polar residues in the core can be critical
for disfavoring an undesired state. For example, Oakley and Kim showed that if the location of
an a-position Asn is moved such that a buried Asn-Asn hydrogen bond can form only in the
antiparallel orientation, this state is strongly preferred (34). However, asparagines are not found
in the core of antiparallel dimeric coiled coils often (28), and Asn-Asn interactions at the a
position have not been observed in any antiparallel coiled-coil crystal structures thus far (27).
Asn-Asn hydrogen bonds are seen very frequently in parallel coiled coils and probably play a
large role in giving some coiled coils a parallel orientation.
Polar or charged residues other than Asn could also provide a mechanism for negative
design against a particular orientation and, therefore, be important for establishing helix
orientation. For example, this idea has been explored by Campbell and Lumb in a model dimeric
coiled coil. In their study, a Lys in an a position interacting with a charged residue at g' gave
oligomerization specificity. However, this combination of residues did not impart a specific
helix orientation, due to the favorable interactions lysine could make in both the parallel and
antiparallel states (69). In the context of a different model heterodimer, a buried Arg at a d
position, with the potential to interact with a Glu at g', was not sufficient to specify helix
orientation, but did give a specific dimer (70). Another study took an antiparallel coiled-coil
mitochondrial fusion protein with two glutamates in d positions and mutated one at a time to
leucine. Membrane fusion was adversely affected by these mutations. The cause of the loss of
function was not apparent, however, as no structural analysis of the mutants was done (10).
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Glutamate is common at the d position in antiparallel coiled coils, but is rarely found in
parallel dimers; thus, it may be playing a special structural role. Bcr contains a glutamate in a d
position, and examination of modeled structures suggested that this residue may disfavor the
parallel orientation by blocking interhelical salt-bridge interactions between residues Glu 48 and
Arg 53, as well as by packing poorly in the core. In C-BCRE52L, Glu 52 was replaced by Leu,
and orientation specificity was lost. Although Ile 31 was also changed to Leu in this mutant, the
31 L mutation did not alter orientation preference in the context of BCRA38L. Therefore, the
loss of orientation specificity seen in BCRE52L is likely due to removal of the core glutamate.
The E52L mutant also changed oligomerization state. Cap-C-BCRE52L is a single-species
trimer by analytical ultracentrifugation. An up-up-down trimer, in which one c-helix is oriented
antiparallel relative to two adjacent parallel helices, is consistent with all of the biophysical data.
With a helical bundle in this topology, it would be possible to get nearly equal amounts of
parallel and antiparallel helix pairs in the disulfide-exchange experiments.
Thus, Glu 52 plays at least two roles in the Bcr oligomerization domain; it disfavors the
formation of higher-order oligomers and simultaneously imparts helix orientation specificity. It
is easy to understand why Glu residues at d positions might prevent the formation of higher-
order complexes. In the dimer, the glutamate carboxyl groups can reach out of the core and
interact with water. However, these charged atoms would be almost completely buried in a
coiled-coil trimer or tetramer, at a significant cost in solvation energy. Whether or how Glu 52
plays a negative design role in disfavoring a parallel dimer state is less clear. In the x-ray
structure of Bcr, Glu 52 interacts with Arg 55 on the same helix. In models of parallel dimeric
versions of Bcr, this residue interacts with Arg 53 on the opposite helix. Neither set of
interactions is obviously superior, and it is possible that Glu 52 could in fact be accommodated
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in a parallel Bcr dimer. Nevertheless, a role for this residue in influencing helix orientation is
suggested by the loss of orientational specificity in the disulfide-exchange experiment.
Numerous studies have used protein design as a way to explore determinants of coiled-
coil structural specificity, and this has been a powerful and effective approach (15, 22, 27, 33,
34, 61, 68-70). However, general principles uncovered in model systems do not explain the
specificity observed in many native coiled-coil proteins. Some interactions that are effective in
designed proteins are rare or even unprecedented in naturally occurring ones (34, 61). In this
work, we examined determinants of structural specificity in the Bcr oligomerization domain and
found them to be subtle, with some residues playing multiple roles. The influence of charged
residues, such as Glu 52, is likely to be highly context dependent, varying according to the
precise interactions that can be formed in multiple competing states. Methods for predicting
helix-orientation specificity may need to address this complexity explicitly.
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TABLES
Table 1: Analytical Ultracentrifugation Data Fit to a Single Species Model for Bcr peptides
BCRAP BCR-C P BCRA38LAP BCRA38L-C-cap cap-C-BCRE52L
1 (cm3 /g)a 0.73055 0.72908 0.734 0.73055 0.73780
MWcalc 4731.38 4573.19 4773.46 4733.27 4930.61
WinNONLIN
MWobs 10042 10395 25608c 26031c 14093.97
Stoichiometry 2.12 2.27 5.36 5.50 2.86
SEDPHAT
MWobs 9995 10245 28029 25698.2 14111
Stoichiometryc 2.11 2.24 5.87 5.43 2.86
apartial specific volumes were calculated as previously described (71). Partial specific volumes
of disulfide bonded mixtures are averages of the components.
bStoichiometry is calculated as (MWobs/[MWcalc for a single helix]).
CFit with non-random residuals
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Figure 1: Helical-wheel diagram of Bcr in an antiparallel (A) and parallel (B) orientation. (A)
Solid lines represent interhelical salt bridges that always form in the crystal structure. Dashed
lines represent potential interhelical salt bridges that form in half of the copies in the asymmetric
unit. (B) Dashed lines represent potential g to e' salt bridges that could form in a parallel dimer.
(C) Peptides used in this study. C-BCR and BCR-C have the same sequence for residues 30-65
as was used in the crystal structure.
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Figure 2: The Ber oligomerization domain dimer, PDB ID 1K1F (43). In the crystal
structure, two such dimers associate to form a tetramer.
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(B) Thermal denaturation of BCR" (antiparallel, *) and BCRP (parallel, e) monitored at 222 nm
in 33 mM sodium phosphate, 100 mM NaCI, 2 M GdnHCI, pH 7.2. Melting temperatures
indicate that the antiparallel conformation is more stable than the parallel by -16°C.
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Figure 4: Analytical ultracentrifugation data for Bcr coiled coils. Global fits to data
collected at three speeds and three concentrations are shown with representative experimental
traces and residuals to the fit. Data shown were collected at 17,000 rpm with 50 $M total
monomer concentration. (A) BCRAP and (B) BCRP are both two-stranded coiled coils at 25 pM,
in 50 mM sodium phosphate, 150 mM NaCl, pH 7.2; (C) cap-C-BCRE52L is a single-species
three-stranded coiled coil at 50 ALM in 50 mM sodium phosphate, 150 mM NaCl, pH 7.2. All
data were fit with WinNonLin.
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Figure 5: Disulfide-equilibrium exchange experiment used to determine the helix
orientation of the Bcr coiled coil. (A) N-terminal cysteine peptides (C-BCR) are in gray, and
C-terminal cysteine peptides (BCR-C) are in white. Combinations of disulfide bonded and
reduced peptides were mixed together and allowed to equilibrate at 25°C, then the reaction was
quenched with acetic acid and run on reverse phase HPLC. (B) & (C) Disulfide exchange
reactions were initiated from two conditions. The concentration of different species was
monitored as a function of time by HPLC. Both experiments gave similar Keq values, 1.3x10-3 in
(B) and 1.6x 10-3 in (C), confirming that the reaction had reached an equilibrium strongly
favoring the anti parallel species.
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Figure 6: Helix orientation of Ber mutants determined as in Figure 5. Representative
disulfideexchange data in 50 mM sodium phosphate, 150 mM NaCI, 1 mM EDTA pH 7.2,
25°C. (A) BCRA38L-CP (12.5 JlM) and C-BCRA38L (25 JlM); Keq = 7.8x 10-5:t3.2x10-5. (B)
C-BCRE52LP (12.5 JlM) and BCRE52L-C (25 JlM); Keq=2.2.
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Figure 7: Circular dichroism spectra and thermal melt of Bcr mutants. (A) Circular
dichroism spectra of BCRA38L' ([), BCRA38L-C-cap (+), cap-C-BCRE52L (o), compared to
BCRAP (.). The peptide concentration was 50 iM for alkylated peptides and 25 gM for disulfide
bonded peptides in 50 mM sodium phosphate, 150 mM NaCl, pH 7.2 at 25 °C. (B) Thermal
melt of BCRA38LAP (C), BCRA38L-C-cap (+), cap-C-BCRE52L (o), compared to BCRAP (.)
monitored at 222 nm. BCRAP was in 33 mM sodium phosphate, 100 mM NaCI, 2 M GdnHCl,
pH 7.2. All other peptides were in 50 mM sodium phosphate, 150 mM NaCl, pH 7.2 at 25 °C.
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CHAPTER FOUR
Computational Design of a Bcr Inhibitor
Collaborators: Devdoot Majumdar helped with the initial stages of design and helped develop
the BCR-C and C-BCR expression and purification protocols, and Nora Zizlsperger developed
purification strategies for Bcr with the swap domain and the Bcr inhibitor peptides. Nora and
Jeremy Fisher developed and performed the pull-down assay.
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ABSTRACT
A defining feature of 95% of Chronic Myeloid Leukemias (CML) and 20% of Acute
Lymphoblastic Leukemias (ALL) is a reciprocal translocation event between chromosome 9 and
chromosome 22. The reciprocal translocation joins the c-abl and bcr genes that code for a fusion
protein, Bcr-Abl. Homo-oligomerization of Bcr through the coiled-coil region is the critical
event that causes Abl kinase to be constitutively active, triggering numerous cytoplasmic and
nuclear signal transduction pathways that lead to the eventual onset of leukemia. Although
existing drugs used successfully to treat leukemia, such as Gleevec, target the Abl kinase protein,
the Bcr oligomerization domain may be a good alternative or complementary target when people
become resistant to current drugs. Using the Bcr oligomerization domain crystal structure, four
antiparallel coiled-coil inhibitors were designed using computational methods. The goal was to
design a dominant negative inhibitor to the Bcr oligomerization domain. Peptides were
expressed in E. coli, purified, and tested using a pull-down assay. The inhibitors failed to bind to
the Bcr oligomerization domain, but did bind to the Bcr coiled-coil region in a less stringent
assay. Possible reasons as to why the designed inhibitors failed to bind in the stringent assay are
discussed, and improvements for future designs are suggested.
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INTRODUCTION
Approximately 34,810 new cases of leukemia will occur in the United States this year,
according to the American Cancer Society. Of these, an estimated 4,600 new cases of Chronic
Myeloid Leukemia (CML) and 3,970 new cases of Acute Lymphoblastic Leukemia (ALL) will
be diagnosed (1). A defining feature of 95% of CML (2) and 25% of ALL in adults (3) is a
reciprocal translocation event between c-abl on chromosome 9 and bcr on chromosome 22,
shown in Figure 1A. The shortened chromosome 22, known as the Philadelphia Chromosome
(Ph+), codes for the Bcr-Abl fusion protein (2), which is localized to the cytoplasm (4).
The role of Abl in wild-type cells is established, but Bcr's role in the cell is not entirely
clear; however, both play significant roles in causing leukemia when fused together. In wild-
type Abl, tyrosine kinase domains carry signals between the cytoplasm and nucleus, playing a
key apoptotic-regulation role in response to DNA damage (5). Abl kinase is activated by
phosphorylating Tyr1294 and TyrI 127 (6). Found in both the cytoplasm and nucleus, Bcr
(breakpoint cluster region) has many different domains, including oligomerization, serine and
threonine, SH2 binding, guanine exchange factor (GEF), and guanosine triphosphatase-activating
protein (GAP) domains (4). Bcr self-association is mediated by a coiled-coil region within its
oligomerization domain and is the critical event that causes Abl kinase to be constitutively active
(Figure 1C) (6, 7). Constitutive activity of Abl kinase triggers numerous cytoplasmic and
nuclear signal transduction pathways that disrupt cell-cycle regulation and eventually lead to
leukemia (2). However, in the absence of the Bcr coiled-coil region, kinase activity can be
restored with point mutations (P1013 or P1124) to the Abl kinase SH3 domain (6).
The x-ray crystal structures of the Bcr oligomerization domain (8) and different domains
of Abl (9, 10) have been solved. The crystal structure of the Bcr oligomerization domain (PDB
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accession no. KIF, Figure 2A & B) reveals an antiparallel coiled coil. The monomer consists
of a long o-helix that participates in the coiled coil, preceded by a loop and another short helix.
The short helix associates with the long o-helix of the other monomer in the homodimer,
forming a swap domain (11). Without the swap domains present, the long antiparallel coiled coil
maintains an antiparallel orientation (12). The x-ray crystal structure of Abl kinase is typical for
kinases, consisting of two different lobes, both containing of a mixture of n-sheets and oc-helices,
with an ATP binding site located in between the two lobes (13). Upon binding to ATP, Abl
kinase undergoes a conformational change in a loop region, transforming the structure from an
inactive to active state (9).
Existing drugs used to treat leukemia, such as Gleevec (9, 14), target the Abl kinase ATP
binding region. Gleevec, an extremely successful drug made by Novartis, binds an inactive
conformation of Abl kinase, shown in Figure B. When Gleevec binds the Abl ATP-binding
site, intracellular signaling is abrogated, preventing proliferation and inducing apoptosis in Ph+
cell lines. As a result of Gleevec therapy, 94% of patients have normal blood counts and 69%
show no sign of the Ph+ chromosome in their bone marrow (4). However, upon progression to
advanced CML stages, only 15-34% of patients taking Gleevec have white blood cell counts
within the normal range, and only 16-24% of patients have less than 35% of cells containing the
Ph+ chromosome (15). The effect of the drug lasts from 3 to 6 months for patients with
advanced CML (15), and some people are resistant or become resistant (14, 15) to Gleevec due
to mutations that affect the ATP binding site or shift the equilibrium to the active conformation
where Gleevec is unable to bind (15). Therefore, it is important to explore other potential drugs
and targets. In much the same way HIV is treated with combination therapies, a potential
therapy combining Gleevec with a drug that targets another region may be effective (14).
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Developing other leukemia therapies that could be used with Gleevec or on their own is
an active area of research. For instance, two molecules made by Parke-Davis, PD173955 (9) and
PD166326 (16), can bind to both the active and inactive conformations of Abl. Other potential
combination therapies include: targeting Bcr-Abl RNA with antisense oligonucleotides, utilizing
molecules designed to inhibit other signaling proteins, or trapping Bcr-Abl in the nucleus by
suppressing nuclear export (4). Gleevec could also be combined with therapies proven to work
clinically to treat CML, such as interferon-a therapy (14).
Because the coiled-coil region of the Bcr oligomerization domain is essential in Bcr-Abl
transformation (17-19), a drug targeting this domain may offer a viable approach for
combination therapy with Gleevec. Interestingly, the Bcr oligomerization domain, which
associates as a tetramer in solution and in the crystal structure, can be replaced with a parallel
dimeric coiled-coil domain, GCN4, and still cause Bcr-Abl transformation (17). Because GCN4
has the same transformation effect as the Bcr coiled-coil region, dimerization, not
tetramerization, is required for Abl kinase constitutive activity. Adding a stoichiometric excess
of the isolated Bcr coiled-coil region suppresses the Bcr-Abl transformed phenotype (20-22) and
has been found to increase sensitivity to Gleevec (22). In addition, targeting Bcr may result in
fewer side effects. Within the first few weeks of life, mice homozygous for c-abl disruption
become runted and die (23), whereas bcr-null mutant mice are normal except for an increase in
neutrophil reactive oxygen metabolism (24).
Although most drugs are small molecules, inhibiting protein-protein interactions with
peptides has precedence in the literature and in the clinic. Peptide vaccines, targeting proteins
other than Bcr, are currently being considered to treat CML (14), and some current CML
treatments, such as IFN-a, are administered intravenously (14, 25). Miniproteins can serve as
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effective inhibitor scaffolds onto which critical binding residues can be grafted. For example,
the avian pancreatic polypeptide (aPP) has been used as a scaffold to design several inhibitor
peptides to bind a variety of molecular targets (26-32). Highly specific inhibitors for Bcl-2 and
Bcl-XL, two critical proteins involved in apoptosis, were designed with this method and have
nanomolar dissociation constants (27, 30). Utilizing a coiled-coil scaffold, several successful
inhibitors that target coiled-coil structures have been made and tested. Using standard coiled-
coil pairing rules, the Alber group designed a coiled-coil inhibitor that would heterodimerize
with the APC tumor suppressor coiled-coil domain with greater affinity than the self-association
of APC tumor suppressor or the inhibitor (33).
Many peptide inhibitors for HIV viral fusion, also a coiled-coil mediated process, have
been designed by structural examination and modeling. One particularly exciting example is
Fuzeon, made by Trimeris, which is currently on the market to treat HIV (34). This drug is a 36-
amino acid peptide that must be taken intravenously. Many more peptide inhibitors for HIV
viral fusion have been developed using protein engineering (35-37), and some inhibit HIV entry
into cells at nanomolar concentrations in vitro (38). Solution and structural characterization of
HIV glycoprotein peptide inhibitors have led to small molecule inhibitors that target viral
membrane fusion in the same manner as the inhibitory peptides (35, 39, 40). Further, small
molecule inhibitors that block other protein-protein interactions have been found (41, 42).
Many exciting advances in protein design have been made by the pharmaceutical industry
and academic groups. In the pharmaceutical industry, computational protein design techniques
have been very successful at stabilizing molecules, such as granulocyte-colony stimulating factor
(G-CSF) (34) and human growth hormone (43). Enzymes with specificity for an entirely
different molecule (44) and proteins with completely new folds (45) have been designed. In
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addition, we have used protein design to create a heterotetramer from a homotetramer on a
minimal scaffold (46), and very similar methodology can potentially be applied to design
inhibitors for protein-protein interactions implicated in disease.
Despite successes in protein design, there are limitations to modeling large complex
molecules, and a balance between computational speed and accuracy must be attained through
the use of approximations in the design process. Modeling electrostatics and solvation effects is
difficult due to the current inability to model solvent explicitly. Computational protein design
uses many different approximations for electrostatics and solvation energy. Further, side chains
are modeled in discrete conformations (rotamers), so side-chain conformations with the lowest
energy for a particular site may not be present in the rotamer library and a less than optimal
solution may be used. Although computational techniques are very effective, an iterative
approach that combines computational design with experimental testing of the designs is needed,
due to the many approximations that must be made.
The goal of this project was to computationally design oc-helical inhibitor peptides to
block Bcr oligomerization by forming a coiled-coil heterodimer with native Bcr. The inhibitors
were designed to be dominant negative inhibitors of Bcr oligomerization. Although the Bcr
oligomerization domain forms a tetramer (11), dimerization of the domain is the critical event
that leads to the dysregulation of Abl kinase in the Bcr-Abl oncoprotein (6, 17). Therefore, if
Bcr dimerization could be blocked by an inhibitor protein, the efficacy of a leukemia therapy
based on such an inhibitor could be explored, and specific interactions between the peptide
inhibitor and Bcr could aid in the design of future small molecule therapeutics. To overcome
difficulties with computational protein design, several different computational techniques were
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utilized to design oa-helical inhibitors that potentially disrupt Bcr oligomerization. The inhibitors
were expressed in E. coli, purified, and experimentally characterized.
METHODS
Computational design overview
For all design calculations, chains A and B or G and H from the Bcr oligomerization
domain crystal structure (8) (lK F) were used. The backbone of Bcr bound to its inhibitor was
created using the backbone from the Bcr oligomerization domain (lKlF) structure. Chains G
and H from the crystal structure were used for the stability calculation, as those chains had the
lowest B values when compared to all other dimers in the crystallographic asymmetric unit.
Chain G was used to model native Bcr monomer, whereas Asp 30 to Glu 66 from chain H
(renumbered Asp 1 to Glu 37 for the calculations) were used to model the inhibitor.
A flow chart of the design process is shown in Figure 3. The design problem was divided
into four different regions (Figure 3, Step A & Figure 4) to aid in faster computation and to make
picking target sites and deconvoluting results easier. First, the analysis was broken down into
swap domain vs. coiled coil. The following sites that interact with the swap domain, or have
potential to do so, were designed: Q18, N21, Q22, E23, R24, R25, 128, Y29, L30, T32, L33,
K36, E37. A designed site is a position where multiple amino acids are considered during Monte
Carlo sampling. The coiled-coil region was divided into three sections, shown in Figure 4.
Coiled coils contain a heptad repeat (a,b,c,d,e,f,g), where a and d are typically hydrophobic and
e and g are hydrophilic residues. The following positions (denoted by position in Bcr followed
by heptad position) at the Bcr-inhibitor interface were designed in separate sections: Region 1 -
I2(d), E3(e), G5(g), L6(a), R8(c), A9(d), K10(e), S12(g), I13(a), R15(c), L16(d), and E17(e);
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Region 2 - K10(e), S12(g), I13(a), R15(c), L16(d), E17(e), E19(g), V20(a), N21(b), E23(d),
R24(e), and R26(g); Region 3: E19(g), V20(a), N21(b), E23(d), R24(e), R26(g), M27(a),
L30(d), Q31(e), L33(a), L34(a), and K37(d). For each region, the sites were designed
simultaneously in a large-scale selection, and 17 (Cys, Gly, Pro were excluded) and 14 (Cys,
Gly, Pro, Phe, Tyr, and Trp were excluded) out of the twenty amino acids were allowed at each
e,g and a,d design position, respectively. The basic energy function, discussed in the next
section, was used to calculate energies of the sequences (Figure 3, Step B). Sequences were
optimized and ranked for stability (Figure 5A).
Basic energy function
Energies were calculated using the following equation:
i- ,1- nI
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The total energy used in the design calculation was defined as the sum of energy over self
energies added to the sum over all residue-residue energies, or pair-wise interactions. The self
energies of a residue are defined as interactions within a particular side chain, with the backbone,
and with positions not included in the design calculation, whereas the pair-wise energies include
inter side-chain interactions. Using a 12-6 Leonard-Jones potential, van der Waals interactions
were calculated using van der Waals radii from CHARMM paraml9 scaled to 90% (47) for both
the self and pair-wise terms. The van der Waals radii and total energy were scaled to 90% to
overcome some of the small steric clashes that result from discrete rotamer approximation.
Torsion energies for the self-energy terms were also computed using CHARMM paraml9. A
distance-dependant dielectric function, which is essentially a Coulombic term with epsilon varied
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as a function of atomic distance, was used to describe the electrostatics of both the self-energy
and pair-wise energy terms. A dielectric constant of 4r was used for the self-energy calculations,
and pair-wise electrostatic energy was calculated with E = 4r for polar-polar interactions, 8r for
polar-charged interactions, and 16r for charged-charged interactions. The distance-dependant
dielectric function was parameterized to agree with Poisson-Boltzman calculations for coiled
coils by Nick Levenson and Jiangang Chen. The Effective Energy Function (EEF1) (48) from
CHARMM was used to describe solvation energies for both the self and the pair-wise energy
terms.
A pentapeptide model, in which each residue was modeled as the middle residue (X) in a
Gly-Gly-X-Gly-Gly sequence, was used to approximate the unfolded state. The local x-ray
crystal structure backbone of X and two flanking residues on either side was used. An ensemble
average of all possible rotamer states was used to describe X, and the energy function mentioned
above was used to describe the unfolded state.
Sequence search and side-chain repacking
Sequence space was sampled using a Metropolis Monte Carlo search algorithm with 20
cycles of 1500 steps using a linear temperature gradient from 300 to 200K or 280K. If there was
very little improvement in energy, the calculation was stopped at 280K. The designs involving
the swap domain were done with the Dunbrack 1999 backbone-dependent rotamer library (49).
The Dunbrack 2002 backbone-dependent rotamer library (50) was implemented in the design
algorithm following the swap domain study and was used to the design the coiled-coil regions.
The 2002 library was thought to be more accurate and have better statistics because it contained
more rotamers from a larger and more up-to-date PDB. Based on the basic energy function
energies, side chains at and around design positions were placed in optimal configurations, using
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the dead-end elimination algorithm (DEE) followed by the A* algorithm (51, 52) (Figure 3, Step
B).
ICTJ design
ICT1 used computation as a guide to manually design an inhibitor. Visual evaluation of
the inhibitor structures was used to assess the quality of the model and make final design
decisions. Several positions found to be promising were investigated further by independently
selecting residues at each site (Figure 3, Step H). Because the basic energy function used 90%
van der Waals radii to decrease small steric clashes caused by rotamer approximation, each
promising site was enumerated (Figure 3, Step I) and the top 5 solutions at each single-site
position were minimized with 100% van der Waals radii using 500 cycles of steepest decent,
followed by 500 cycles of Adapted Basis Newton Raphson (ABNR). The backbone was fixed
during minimization. The van der Waals energies were recalculated with 100% van der Waals
radii (Figure 3, Step J). Following minimization, residues with the most van der Waals
improvement compared to wildtype and best packing, based on visual inspection, were combined
to design ICT1.
Better energy functions (Design of ICT2, ICT3, ICT4)
All solutions from the large-scale selections were minimized with 100% van der Waals
radii and 10 rounds of steepest decent followed by 10 rounds of ABNR (Figure 3, Step C).
Following minimization, three energy function models (GB, EEF/GB, and Combo models) that
calculate solvation differently were used to evaluate the structures (Figure 3, Step D). These
more realistic energies were calculated using CHARMM paraml9 van der Waals energy (100%
radii), Coulombic energy with a dielectric constant of 4, and a surface tension term computed as
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the solvent accessible surface area (ASA) multiplied by 7 cal/mol.A 2 (53). For the GB model,
the polarization energy for the transfer of a protein from environment dielectric of £in=4/cout=4 to
Ein=4/Fout=80 was computed (54). PEP was used to calculate Born radii (55). For the EEF/GB
model, GB reaction field energies were substituted with EEF desolvation energies.
ICT2 was designed using the GB model. ICT3 was designed using the EEF/GB energy
function model (Figure 3, Step D). In both designs, the top 10 most energetically favorable
solutions were ranked according to helix propensity, and the solution with the largest helix
propensity was chosen. Helix propensity was chosen as a method of evaluation because it was
not directly taken into account in our energy function model. Helix propensity of a structure was
calculated by summing the helix propensities of each residue in the protein (56). The sequences
from each region were merged together to create one top solution (Figure 3, Step E).
The intersection of top-ranked solutions in GB and EEF/GB models (the Combo Model)
was used to design ICT4 (Figure 3, Step D). The GB calculation used in the Combo model did
not contain the energy of the backbone with itself or the energy of the side chains with
themselves for the polarization term. Energetic cut-offs for both the EEF/GB and GB Model
energies were adjusted such that only the top -100 solutions that scored well with both models
were considered. The solution with the top helix propensity was chosen from -100 solutions for
each region, and the regional sequences were merged into one solution (Figure 3, Step E).
Refining inhibitor sequences
The final ICT2, ICT3, and ICT4 inhibitor solutions were repacked, and side-chains were
minimized with 10 rounds of steepest decent followed by 10 rounds of ABNR while holding the
backbone fixed (Figure 3, Step F). The minimized solutions were evaluated with the better
energy functions. To ensure all the mutations were contributing to a Bcr-inhibitor structure more
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stable than Bcr, wild-type residues were individually substituted at each of the mutated positions
(Figure 3, Step G). The residues were placed in their optimal conformation by repacking a
combination of residues at the Bcr interface. The solution was minimized, and the energy was
evaluated with the better energy functions. If the energy improved upon substituting a wild-type
residue for a designed residue, the wild-type residue was retained in the design. Solubility of the
inhibitors was also considered; sequences chosen do not have large numbers of hydrophobic
residues that might lead to insolubility. Each designed inhibitor was run through Paircoil2 (57)
to ensure the designed inhibitor retained a high coiled-coil propensity.
Specificity Calculation
ICT1-4 were computationally checked to ensure that they would have specificity for Bcr
in preference to homodimerization (Figure 3, Step K & Figure 5B). To perform the specificity
calculation, the desired state (Bcr-inhibitor) and undesired states (inhibitor-inhibitor and Bcr-
Bcr) had to be modeled. Ideally, the same set of chains from the crystal structure would be used
to model desired and undesired states in stability and specificity calculations. Copies of Bcr in
the asymmetric unit varied in the number of residues resolved at the N- and C-termini. To
maximize the number of residues modeled in desired and undesired states, the A and B chains
were used in the specificity calculation, as these chains had the most residues resolved.
However, the A and B chains had higher B factors than the G and H chains used in the stability
design. Residues from Asp 30 to Lys 68 (renumbered Asp 1 to Lys 39) were used to model the
inhibitor in both the inhibitor-inhibitor and Bcr-inhibitor complexes. Bcr, in the Bcr-Bcr and
Bcr-inhibitor complexes, was modeled using residues Met 1-Lys 67. To mimic backbone
flexibility, both the A/B and G/H backbones were used to check designed inhibitors for rotamers
that had a low probability of being found in the PDB, based on statistics in the rotamer library.
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If a low-probability rotamer was found on both backbones, the rotamer conformation was
considered unfavorable. However, if a low-probability rotamer occurred on one of the two
backbones, the rotamer conformation was considered favorable because the rotamer could pack
in a high-probability rotamer with a small amount of backbone flexibility.
Purification of Bcr and inhibitor
To construct BCR-C, residues 30-65 were removed from pMAL/BCRI 74 (11) via PCR.
For BCR-C, GSKGG was added on the N-terminus, and GGC was added on the C-terminus. C-
BCRFL, which contained residues 1-74, was produced by PCR from pMAL/BCRI 74 (11). Using
DNA Works (58) to design oligos, the BCR inhibitors, shown in Figure 6, were constructed with
an N-terminal GSCGG using gene synthesis techniques. The genes were cloned into pSV282
using BamHI and XhoI restriction sites. The pSV282 plasmid contains a six-residue histidine
tag, E. coli maltose binding protein (MBP), and a tobacco etch virus (TEV) protease cleavage
site upstream of the BCR gene.
BCR-C, C-BCRFL, and BCR inhibitors were grown at 37 °C and induced with 0.1 mM
IPTG at 0.4 O.D. for 2 hours. Cells were pelleted, then resuspended in 50 mM Tris pH 8, 500
tM EDTA, 100 mM NaCl, with two Roche Complete protease inhibitors. The cells were
sonicated, pelleted again, then the supernatant was added to an appropriate amount of amylose
resin. The column was washed with 5 column volumes of 50 mM Tris pH 8, 500 gM EDTA,
100 mM NaCl in batch. About 1 mg of TEV protease per liter of culture was added to the beads,
and the reaction was allowed to proceed for 2 hours at room temperature. TEV-cleaved Bcr was
HPLC purified before use.
BL21-RIL cells containing pRK793 were obtained from Science Reagents to make the
TEV protease. Cells were grown at 37 °C in 100 g/mL ampicillin and 35 tg chloramphenicol.
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Upon induction of expression at 0.5 O.D. with 1 mM IPTG, the temperature was reduced to 30
°C. Cells were pelleted and resuspended in 20 mM Tris (pH 8), 0.5 M NaCl. Cells were
sonicated, then polytheleneimine (pH 7.9) was added to a final concentration of 0.1%. Cells
were pelleted, mand the supernatant was run on a NiNTA column using 20 mM Tris, 0.5 M NaCl
to wash the column. The sample was eluted with 4 column volumes of 20 mM Tris (pH 8), 0.5
M NaCl, 120 mM imidazole, followed by 20 mM Tris (pH 8), 0.5 M NaCl, 300 mM imidazole.
Before running on an S-200 size-exclusion column, 1 mM EDTA and 1 mM DTT were added to
all fractions. The centricon system was used to concentrate fractions containing TEV.
Pull-down assay
Concentrations of proteins were measured using the Edelhoch method (59). C-BCRFL
was biotinylated by rocking 1 mg/mL C-BCRFL, 1 mM maleimide-PEO2-biotin in PBS, pH 7.4
(137 mM NaCl, 2.7 mM KC1, 10 mM Na2HPO4, 2 mM KH 2PO 4) at room temperature.
Following biotinylation, C-BCRFL was HPLC purified again. Appropriate amounts of
monomeric avidin beads (assuming binding capacity was 1 mg/mL) were mixed with
biotinylated protein and rinsed with 4 column volumes of PBS. Monomeric avidin beads were
prepared by standard protocol from Pierce (Cat #20228). Stoichiometric amounts of inhibitor
BCR and biotinylated C-BCRFL were added and allowed to equilibrate for 1 hour, then the
mixture was added to the avidin beads. The samples were spun down, and the supernatant was
removed. The samples were eluted with 4 volumes of 2 mM biotin in PBS and run on a tris-
tricine gel.
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RESULTS
Four oc-helical inhibitors were computationally designed to bind the Bcr oligomerization
domain and adopt an antiparallel coiled-coiled structure, similar to the antiparallel coiled-coil
structure in the native protein. First, the results section compares the performance of the energy
function in placing side chains in conformations similar to the x-ray crystal structure. Second,
the selected inhibitor sequences and important interactions that are predicted to provide stability
and specificity for the Bcr-inhibitor complex are presented.
Comparison of repacked Bcr with the crystal structure
Before designing the inhibitor, the side chains on the Bcr oligomerization domain crystal
structure (chain G and H) were repacked using the Dunbrack 2002 backbone-dependent rotamer
library to determine how accurately the rotamer library approximated the native structure. The
swap domain on the H chain was truncated to simulate the Bcr inhibitor. A rotamer within +/-
40 degrees from the native rotamer was considered correct. On the H chain, Arg 24 was found in
a conformation not represented in the rotamer library, most likely due to its role in tetrameric
packing. The conformation of Asn 50, on the G chain, was found to be in a low-probability
rotamer (probability 0.0072). Leu 16 on the H chain was also in an unfavorable conformation in
the crystal structure. Overall, the limitations of the rotamer library did not affect other residues.
Design of a potential inhibitor swap domain region
The swap domain has potential to yield additional stability and specificity to the inhibitor
we design. From the large-scale selection, selected residues at Gln 18 and Gln 22 deviated from
the native sequence, with some consensus among the top solutions. These positions were
evaluated further by enumerating (testing all combinations of) 17 amino acids at each position
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individually. However, neither position yielded a large amount of stabilization, and packing was
not improved based on structural examination. Therefore, using residues in the swap domain to
further stabilize and add specificity to the designed inhibitor was not considered a viable
strategy.
Using the basic energy function /visual design (ICTI)
Our first approach used computation to guide the manual design of an inhibitor.
Obtained from top solutions in regions 1-3, the following positions were promising because a
consensus of residues at these sites deviated from the native sequence: L6, A9, L16, E17, V20,
E23, and M27. These positions are far enough apart in structure space that their individual
energy contributions should be unaffected by other designed positions and thus be additive.
Therefore, the sites were considered independently in separate calculations. The energies of the
top 5 solutions at each site are shown in Table a.
The residues of ICT1, L6V, L16K, E17L, V20I, (Figure 7) were chosen based on
introducing stabilizing van der Waals interactions at individual sites (Table lb) and visual
inspection of packing in the model structure. Mutations to A9 and E23 did not improve van der
Waals interactions and were not included in ICT1. Based on visual inspection of the solution,
L6V(a) and V20I(a) enhance hydrophobic packing in the core (Figure 7B and C). L16K forms a
d-g' salt bridge with Glu 48 on Bcr, and the aliphatic portion contributes to core packing (Figure
7I)). Lys 16 also acts as a negative design element against the inhibitor-inhibitor complex due to
charge repulsion, as the two lysines are in close proximity on adjacent layers (Figure 7E).
Further, the close proximity also leads to poor core packing in the inhibitor-inhibitor structure,
leaving a large void space in the core. As a result, Ile 20 is placed in a poor rotamer
conformation to fill the void space. Leu 17(e) shows significant van der Waals stabilization
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(Figure 7F). The stabilization energy of the ICT 1 sequence over wildtype (Table 2a) was
calculated with the better energy functions after having been minimization. Despite an
improvement in van der Waals energy at individual sites, van der Waals energies improved much
less than was anticipated when all the mutations were considered together. However, given
improvements seen at individual sites, this inhibitor was still made and tested.
Effect of minimization
Minimization was found to be a critical element after running a small-scale test set where
positions 16, 17, and 18 were designed with four possible amino acids enumerated at each site.
Structural stability before and after minimization was vastly different, yielding a very large
difference in solution ranking (Figure 8). The energies before and after minimization were
evaluated with the better energy function models, allowing the energies to be broken into energy
terms (van der Waals, Coulumbic + solvation, and total energy). After minimization, solutions
that ranked poorly before minimization had some of the lowest overall energies in the data set.
Based on the small selection, the re-ranking after minimization can be attributed to relieving
small steric van der Waals clashes.
Better energy functions (ICT2, ICT3, ICT4)
The initial selection, which used the basic energy function, yielded 11,208 solutions for
Region 1, 7231 solutions for Region 2, and 5093 solutions for Region 3. Model structures were
constructed for each solution by placing side chains in their lowest energy rotamer conformation
within the structure. The top solutions in each region were combined to create one or two
inhibitor sequences. The top sequences were modeled, minimized, and evaluated with the better
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energy functions. The sequences scored well with Paircoil2, indicating they were likely to form
coiled coils.
ICT2 (Figure 9) was designed using the GB energy function model (GB model). An
interesting trend, seen in many of the top GB model solutions, involved mutating most of the g
positions to arginine. Rather than choosing the top design, this trend was isolated and tested as
ICT2. At several g positions, ICT2 contained E5R, S 12R, R26I, and L33R mutations (Figure
9B-E). E5R introduces an intrahelical salt bridge with Asp 1, and S12R forms a salt bridge with
Glu 48. Further, the arginines at g also provide a negative design element against the inhibitor-
inhibitor complex (Figure 9F). In addition, Met 27 was changed to leucine to avoid oxidation
problems. Other than Met 27, leucine had the lowest energy of all hydrophobic residues at this
site. In this particular inhibitor, Leu 27 assumes a poor rotamer conformation in the inhibitor-
inhibitor complex, disfavoring the complex (Figure 9G). The stability of ICT2 relative to the
native Bcr sequence is shown in Table 2.
ICT3 was designed using the EEF/GB energy function model. The top solution for ICT3
is shown in Figure 10. Again, an arginine motif at the inhibitor g position occurred as in ICT2,
providing the same favorable interactions in the Bcr-inhibitor complex and a negative design
element against the inhibitor-inhibitor complex. The calculations suggested a M27E mutation in
the core. The glutamate packs in much the same way the methionine did. Unlike methionine,
the glutamate carboxyl groups are able to form an intrahelical salt bridge with Arg 31 (Figure
10B), another selected residue. M27E also has potential to form an interhelical salt bridge with
Lys 39. Glu 21 (b) makes an intrahelical salt bridge with Arg 24, and it may interact with the
swap domain (Figure 10C). Position 33 (g), at the end of the helix, is very solvent exposed, and
replacing Leu 33 with Arg adds some hydrophobic packing, but allows the charged group to be
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solvent exposed (Figure lOD). L33R also interacts with the hydroxyl group on Tyr 29. R34
forms an interhelical salt bridge with E32. The g-position arginines can then provide some
specificity for the Bcr-inhibitor complex, as in ICT2. However, some salt-bridge interactions
form in the inhibitor-inhibitor complex, which are somewhat troubling. ICT3 was designed
before a bug was found in the better energy function. The problem involved incorrect
assignment of Born radii on different chains. The calculations were re-run after the bug was
fixed, and ICT3 was no longer the top solution. However, the same general trends were found.
To design ICT4, the intersection of the top-ranking solutions from both the EEF/GB
Model and GB Model was used (Figure 11). The g-position arginine motif was also seen in this
inhibitor. Because this motif was already tested in ICT2, these residues were not mutated in the
ICT4 inhibitor design. Instead, we decided to focus on some interesting core mutations that
arose in this calculation. Most likely, the V20L mutation causes the inhibitor to gain more
stability due to better core packing (Figure 1 B). The Q3 lE mutation yields a possible
interhelical salt bridge with Lys 39 (Figure 11C), but this interaction does not form in the
repacked structure due to a competing intrahelical salt bridge. 30L packs better in the pocket
formed by Bcr and the swap domain (Figure 1 ID). The L16A mutation could increase
specificity for the Bcr-inhibitor complex. The two residues at position 16, located in the middle
of the helix, are on adjacent layers in the inhibitor-inhibitor complex (Figure IE). The
proximity of the alanines yields a large void space in the inhibitor-inhibitor complex, disfavoring
the complex (46). Leu, in the M27L mutation, (Figure 1 F) assumes a low-probability rotamer
in the inhibitor-inhibitor complex, also disfavoring the complex.
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Results of pull-down assay
Both the negative and positive controls worked properly in the assay. For the negative
controls, BCR-C or the inhibitors were added to monomeric avidin beads to determine if they
bound in the absence of C-BCRFL. A band was not seen in this control (Figure 12A). For the
positive control, BCR-C was added to biotinylated C-BCRFL, equilibrated, then immobilized on
the streptavidin beads. Eluted BCR-C is circled in Figure 12A. ICT1-ICT4 did not bind in the
pull-down assay (Figure 12A-D), but preliminary results indicate ICT2 and ICT3 bound to BCR-
C in a less stringent assay.
DISCUSSION
In this study, we used computational approaches and manual intervention to design
several oc-helical inhibitors to the Bcr oligomerization domain, part of the Bcr-Abl oncoprotein.
Although the Bcr oligomerization domain tetramerizes, the inhibitors were designed to block
dimerization of the Bcr oligomerization domain, as Bcr dimerization is the critical event that
leads to uncontrolled Abl kinase signaling (6, 17). The Bcr-inhibitor complex was designed to
adopt the native Bcr coiled-coil architecture. Inhibitor sequences were computationally
designed. Regions of the c-helical inhibitor interacting with the swap domain were kept native,
as computational studies showed little improvement in stability upon substitution with other
amino acids. In this chapter, the inhibitor designs focus on stabilizing interactions in the long
coiled-coil region. In most cases, the final sequences were tweaked by manual intervention to
obtain soluble sequences that tested overall trends uncovered in the computational analysis. The
inhibitors were made and experimentally tested, but failed to bind BCR in pull-down assays with
C-BCRFL. ICT2 and ICT3 bound in less stringent assays with BCR-C. Challenges with
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computational design and potential reasons why the designed inhibitors failed to bind with high
affinity are discussed.
Challenges with computational protein design
Despite successes in protein design, necessary assumptions needed to make protein
design tractable create limitations on the accuracy of methods and the size of the design problem.
Some difficulties include modeling aqueous protein solvation, the rotamer approximation,
approximate models of the unfolded state, and lack of backbone flexibility. Techniques to
overcome some of these limitations were used to design the Bcr inhibitor peptides.
Challenges modeling solvation
Modeling solvation in proteins is a major problem in computational protein design.
Solvation energies have many components, including van der Waals forces, hydrogen bonding,
electrostatic interactions, and many solvent molecule configurations (60). Solvent and
electrostatic models are tightly coupled, as water competes with other side chains for interactions
with polar residues. Explicit solvent models are intractable for computational protein design
(60), but continuum solvation approaches are used frequently (61, 62). The finite difference
Poisson Boltzman (PB) continuum solvation model is considered among the most accurate, but
many other continuum solvation models used in protein design approximate PB well and use
fewer computational resources (63).
We used three continuum electrostatics models, the Effective Energy Function (EEF), the
Generalized Born solvation model (GB), and a modified GB solvation model. In the basic
energy function, we used a combination of a distance-dependant dielectric function and EEF to
model electrostatics and solvation. The distance-dependant dielectric function, parameterized for
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coiled coils, contained a dielectric constant based on the type of interaction (charge-charge,
polar-polar, etc). EEF is based on reference states taken from vacuum-to-water solvation
energies for atom groups in small molecules. The solvation energy is calculated by subtracting
the volume-based loss of solvent surrounding an atom from the reference-state solvation energy
(48, 62). The EEF model, itself, did not account for charge screening due to solvent; however,
by adding in the distance-dielectric model, we crudely accounted for screening.
The better energy functions, which model solvation more accurately than the basic
energy function, were used to evaluate and choose ICT2-4 designs. Electrostatic screening, a
vital part of solvation energy, is particularly important for designing proteins that have high
specificity, as polar interactions are affected by solvent screening and play a significant role in
providing specificity. A solvated charge induces ordering of polar solvent molecules around it,
forming a field opposite to its own. Interaction of a charge with its own induced field is called
the "reaction field" energy. The effect on interactions with other charges is called screening and
this decreases the effect of the charge on other charges nearby. In both of our better energy
functions, we used Generalized Born (GB) solvation energy (53, 61, 64) to model solvation
effects. The solvation energy contains electrostatic terms and a solvent accessibility term that
captures cavitation and non-electrostatic interactions with water. The solvent accessibility term
helps model the hydrophobic effect, whereas the polarization term models the effects of solvent
screening on side-chain interactions and contains a reaction field term (53, 64). The solvent
screening term can be broken into the interaction of a side chain with itself, with another side
chain, and with the backbone, as well as backbone with itself (53, 63, 64). The reaction field
term is also part of the polarization energy.
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One of our better energy functions, the GB Model, used all of the GB terms mentioned.
In another model, elements of GB and EEF were combined. EEF models the loss of interaction
with waters around an atom as a function of volume of solvent effectively displaced by
neighboring atoms. As such, EEF is very similar, in theory, to the reaction field term, so the GB
reaction field was substituted with EEF in the EEF/GB better energy function model. The GB
reaction field is very sensitive to the unfolded-state model, which assumes that the side chain is
completely solvated and not making any interactions with other side chains in the unfolded state.
We know this assumption is untrue, but it is impossible to know exactly what to model for the
unfolded state. As a result, the Born radii of the side-chain atoms in the unfolded state are much
smaller than if inter side-chain interactions were present, as the Born radii are directly dependent
on the volume proximity of surrounding atoms. EEF energies are smaller than GB reaction field
energies because they use an aqueous reference state and may give less error. EEF may be better
because its effects can be broken down into interaction terms, whereas GB reaction field is a
single term that is not decomposable. Because both better energy functions have caveats, both
energy functions were used alone and together to design three other inhibitors. In all subsequent
inhibitor designs, the solutions were minimized and one of the better energy functions was used
to evaluate the structure.
Rotamer approximation
Known as the rotamer approximation problem, modeling side chains with discrete
conformations may have led to less optimal solutions for ICT 1. The rotamer library contains a
discrete number of rotamers for each residue, and rotamers are unlikely to fit exactly into the
designed protein structure. Most rotamers will be close to, but not in their optimal conformation
within the protein structure.
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Several methods to overcome the limitations of the rotamer approximation have been
employed by other groups. For instance, the van der Waals term, modeled using a 12-6 Lennard-
Jones potential, has a small attractive term and a large repulsive term. The repulsive term may
be softened by scaling the van der Waals radii by 5 to 10% (46, 65-67) when discrete rotamers
are used. However, the scaling adversely effects the van der Waals energy attractive component
and can lead to overpacking (68). Secondly, more rotamers can be added to the rotamer library
to reduce the rotamer approximation problem (69, 70). However, extremely large rotamer
libraries increase conformational search space dramatically and are mainly used for small
proteins (61). lexible or multiple backbone models have been used to overcome the rotamer
approximation (45, 71-73). To accommodate discrete rotamers without a large steric clash, we
use 90% van der Waals radii and 90% of the total van der Waals energy term for the initial
energy calculation and repacking. Final energies are calculated after minimization with 100%
van der Waals radii to prevent overpacked cores.
Minimization is another way the rotamer approximation problem can be overcome.
Although minimization can help selected rotamers reach their minima within the protein
structure, minimization should be done with caveats in mind. For instance, over-minimization
with an unrealistic energy function or solvation model can lead to structural distortion, so a small
number of minimization rounds were used. Further, minimization was done using a very crude
electrostatics model present in CHARMM, which could minimize side chains, particularly
charged side chains, into unrealistic conformations. Given the relatively small number of
solutions sampled in this study, minimization was feasible. For a very large number of
structures, minimization would be infeasible, due to the computational time needed to minimize
each structure.
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Based on the ICT1 inhibitor and other solutions attained with the basic energy function,
we decided to minimize all structures slightly, then recalculate the energy with better energy
functions. Some good solutions might appear bad due to small steric clashes, causing their
energies to be high when evaluated with the basic energy function. The small clashes could be
relieved with a small amount of minimization. Minimization caused many of the solutions to re-
rank significantly. Interestingly, the basic energy function calculation, utilized 90% van der
Waals radii to reduce steric clashes caused by the rotamer approximation. However, the
signifant re-ranking of solutions showed scaling the van der Waals radii and term was
insufficient in eliminating small steric clashes. In the design of ICT2, ICT3, and ICT4, a small
amount of minimization removed steric clashes caused by discrete rotamers.
Toward overcoming challenges modeling the unfolded state
Using helix propensity for final solution evaluation helps compensate for our poor
unfolded-state model. For each amino acid, the unfolded-state model consisted of the local
pentapeptide backbone from the x-ray crystal structure, containing two glycine residues on either
side. Helix propensity captures several elements, dependant on amino acid, that are not present
in our unfolded state model, including loss of conformational entropy. The top solutions for
ICT2-4 from each selection were further evaluated using helix propensity as a guide.
Challenges designing an inhibitor
One of the main challenges in designing a dominant negative inhibitor is the trade-off
between using positive and negative design. There are many technical difficulties in including
negative design, and many successful protein designs have not included negative design, only
considering positive design in calculations (see Chapter 1). In this study, stability was
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optimized, and specificity was checked after the sequence was designed. Using negative design
in calculations often results in reduced stability (see Chapter 1), and compromising stability was
not considered viable for the first round of the Bcr inhibitor design. If inhibitor-inhibitor
complexes form, specificity could be optimized in a second-round design after binding to the
target protein is established. Although the concepts are similar, optimizing for Bcr-inhibitor
specificity is much more difficult than designing a completely de novo heterooligomer, as in
Chapter 2. For example, when designing both partners of a heterodimer, negative design
elements that disfavor both homooligomeric states can be introduced. However, negative design
elements cannot be introduced into the target protein to prevent homodimerization when
designing an inhibitor. The inhibitor and target protein must heterodimerize with higher affinity
than the target self-associates. Further, specificity must be considered to prevent inhibitor-
inhibitor complexes. In addition, the Bcr inhibitor may form a higher-order oligomer or a
completely different structure. Modeling all undesired states is impossible because all undesired
states cannot be predicted. Further, modeling many undesired states dramatically increases
computation time, so only the undesired states most likely to form (Bcr-Bcr and inhibitor-
inhibitor antiparallel dimers) were modeled.
Performance of Inhibitors
Protein design is an iterative process and insights from both positive and negative results
can be incorporated into future designs. Selecting a high frequency of lysine residues and large
hydrophobics on the surface are common problems with computational protein design and
various remedies have been tested by other groups (62, 66, 68). Designed using the basic energy
function, ICT1 manifests some common problems seen with computational protein design.
Some selected salt-bridge interactions were not used, due to the large number of lysine residues
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frequently seen in solutions. It is unclear whether this preference for lysines is realistic or a
function of the energy calculations. Lysine was selected very frequently in e and g positions and
with much more frequency than other charged residues in core positions. Although selected
lysine and arginine residues at a and d are not completely buried in the dimer core and can make
important interactions with e' and g' positions, the heptad may be disrupted and the structure
destabilized if charge is placed too frequently in the core by the design calculations. The large
number of rotamers that lysine and arginine have in the rotamer library may enable the
hydrophobic regions of these residues to pack well in many places. On the other hand, the
desolvation penalty may be modeled poorly, allowing these charged residues to be selected for
core coiled-coil positions. Large hydrophobic residues were selected to be on the surface at a
higher frequency than expected based on natural proteins. The basic energy function does not
have a penalty for putting hydrophobic residues on the surface. For the remainder of the
inhibitors, we used side-chain minimization and better energy functions to overcome problems
seen in the ICT1 design.
The ICT design focused on hydrophobic packing, selecting residues based on
individual-site top solutions, visual inspection of the model structure, and improvement in van
der Waals energy over native residues at a design position. Following individual-site selections
at promising positions, inhibitor sequences were modeled on the Bcr structure and evaluated.
Based on visual inspection, some inhibitor structures appeared to pack better than their energy
reflected, as side chains assumed good rotamer conformations and placed more hydrophobic
bulk in the core.
ICT1 did not bind in the pull-down assay for several possible reasons. The Lys 16
introduced in a core d position may adversely affect interhelical interactions and hydrophobic
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bulk in the core. Lys 16(d) is one heptad from Glu 23(d), another charged core residue. Further,
E1 7L at e removed an interhelical salt-bridge interaction present in the crystal structure,
potentially interfering with interhelical association. The a-position core mutations for this
structure, which were purely hydrophobic, could be tested without Lys 16(d) and Glu 17(e) to
determine if an inhibitor with a position mutations will bind Bcr. Further, the overall van der
Waals stabilization was not nearly what was predicted based on contributions from individual
sites. Some of the sites may have been too close to assume they were independent, whereas the
difference may be due to small differences in side-chain repacking at sites further away from the
mutated site.
Despite two potential g-g' interactions not forming in the crystal structure, these
interactions may be important interactions in solution. ICT2 was designed using the GB model,
and many solutions showed an Arg motif at the g position on the surface. Given the inhibitor did
not bind C-BCRFL in the pull-down assay, the native g-g' interactions may be important, as the
two potential salt bridges may form in solution or the g position interactions may provide
additional stability to the molecule. However, preliminary results indicate ICT2 bound BCR-C
in a less stringent assay. The inhibitor replaced the two potential interhelical salt bridges with
one intra- and one interhelical salt bridge.
Given ICT2 did not bind C-BCRFL in the pull-down assay, it is not surprising that ICT3
did not bind C-BCRFL either. However, preliminary results indicate ICT3 bound BCR-C in a
less stringent assay. ICT3 was designed with the EEF/GB model and contained the same Arg
motif at g, as was used in ICT2. As in ICT2, two potential interhelical salt bridges from the
crystal structure were replaced with one intra- and one interhelical salt bridge. Further, two
additional interhelical salt bridges involving residues E27/K39 and R34/E32 have potential to
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form between the long helices. Although M27E mutation yielded a potential interhelical salt
bridge, having a charged residue in the core probably destabilized the interaction. Unfortunately,
a bug in the better energy function was discovered after ICT3 was designed. The bug affected
how Born radii were calculated between different chains. Although ICT3 was no longer the top
solution, some of the same trends were seen in the solutions once the bug was fixed.
ICT4 consisted of predominantly core mutations and may have changed the
oligomerization state of the inhibitors. Because both of the better energy functions are
approximations, ICT4 sought to find the intersection of low-energy solutions calculated with the
EEF/GB and GB energy function models. In Chapter 3 of this thesis, mutating one core residue
led to a change in oligomerization state; ICT4 had four amino acids mutated in the core. Two of
the core mutations were thought to increase stability. Two other mutations were thought to add
negative design elements through increasing cavity size in the core or rotamer strain in models of
the inhibitor-inhibitor dimer. The two mutations thought to increase stability may have caused a
higher-order oligomerization state to form.
Mutating M27 to leucine may have destabilized ICT1, ICT2, and ICT4. M27 was
changed to leucine to avoid methionine oxidation in subsequent biophysical tests. However, the
calculations predicted leucine to be slightly destabilizing relative to methionine. Before
methionine is mutated in another design round, the mutation should be tested in isolation to
determine any deleterious effects.
Biophysical characterization of the oligomerization state and structure of the inhibitor
may prove useful for a subsequent design round. BCR-C cannot bind if C-BCRFL is dimerized.
Determining the molecular weight of the inhibitors via AUC would be easy and potentially
useful to determine if the inhibitor was forming a distinct alternative state. The alternative state
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could be explicitly designed against in the next round. Evaluating the Arg motif at g may give
insight into the possible inhibitor complex. Because the Arg motif at g emerged when using the
three better energy functions, evaluating the motif further may prove useful. ICT2 could be
used, with the caveat that M27 is mutated, to further test this motif for higher-order oligomers
and as a negative design technique against the inhibitor complex. The role the g-g' interactions
play in stabilizing and directing orientation in Bcr could be probed by doing a small amount of
AUC and CD.
Although the Bcr inhibitors should be able to inhibit C-BCRFL, the pull-down assay used
to test the inhibitors was perhaps too stringent an assay to test the first round of design. A less
stringent assay that uses only the Bcr coiled-coil region (BCR-C) could be used to test for
binding. Using SulfoLink beads from Pierce, BCR-C was covalently attached to the beads
through its cysteine group. The inhibitor was added to the beads, and the mixture was heated,
then cooled. Preliminary results indicate that ICT2 and ICT3 bind to BCR-C in this less
stringent pull-down assay, and these inhibitors could be optimized to bind tighter.
Future Directions
In retrospect, several things could have been done better in the design process, and
improvements could be added to the general computational design implementation. However,
determining better energy functions for protein design, implementing backbone flexibility, and
compensating for the rotamer approximation are computational protein design problems that will
involve much more research by many different groups.
Future designs should try mutating only one to two amino acids to determine effects on
stability and specificity. ICT1-4 mutated five to nine out of 37 sites. In ICT3, about 25% of the
residues were changed. By making fewer mutations, it would be easier to deconvolute the
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mutational effects, and the structure's stoichiometry and topology are less likely to deviate from
native.
It is unclear if sampling more sequence space would have led to a large improvement in
the stability of the Bcr-inhibitor complex. In current Bcr inhibitor designs, the initial calculation
with the basic energy function could have sampled more sequence space. With the number of
sites and residues considered in the initial calculations, there were 2.21x1014 , 2.68x1014, and
1.82x1014 solutions possible for Region 1, 2, and 3, respectively, and only 11,208, 7231, and
5093 solutions for Region 1, 2, and 3, respectively, were considered from the calculation. The
number of sequences actually sampled was about 5 billionith of a percent of possible solutions.
Interestingly, the top energies had extremely incremental improvement over the wild-type. The
overlapping positions within Region 1, 2, and 3 yielded nearly identical top solutions. However,
oftentimes energy was improved in the final sequence by substitution of a wild-type residue,
indicating undersampling.
Time spent on minimization places a cap on the number of sequences that can be
searched in a reasonable amount of time. Evaluating more sequences with our better energy
function would have been computationally prohibitive, as the better energy function is much
more computationally intense. Building and minimizing each solution also takes a great deal of
computational time and is impractical for 1014 solutions. Merely taking the top solutions from
1014 possible solutions from the basic energy function calculation is not reasonable, due to the
large amount of solution re-ranking after minimizing structures. However, from the design of
Bcr inhibitors, we find that minimization improves the design process and better approximate
van der Waals functions may improve performance in future designs.
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Many solutions from the basic energy function had large hydrophobics on the surface and
had intrahelical interactions, and the better energy functions seemed to mitigate the large
hydrophobics on the surface, somewhat. However, incorporating an aggregated state may be
helpful to design against large hydrophobic residues on the surface. Harbury and Havranek
modeled the aggregated state by placing their target structure in a medium with a lower dielectric
than water (74). This alternative state could be easily incorporated into the current design
implementation. Binary patterning, as discussed in the introduction to this thesis, could also be
done to limit hydrophobic residues on the surface. Another problem seen frequently was
intramolecular, rather than intermolecular salt-bridge formation. Some studies have found that
increasing the intermolecular component weights yield more interhelical interactions (75, 76).
The interhelical interactions help to favor the Bcr inhibitor complex over the inhibitor-inhibitor
and Bcr-Bcr complexes.
Thousands of solutions are output from a design calculation and determining useful
patterns or families of solutions from the output is very difficult. Solutions from protein design
could be clustered into groups and families using clustering software, similar to that used to
study DNA arrays. Difficulties in finding patterns increases with the complexity of the design.
When just a few residues are selected, as in the BBA heterotetramer design in chapter 2,
discerning patterns was not a problem. However, the Bcr inhibitor design involved targeting
many more sites in each design. Havernek et al. utilized clustering to determine families of
sequences that yielded specificity for hetero versus homodimeric coiled coils. Several families,
including one not found in natural coiled coils, emerged from clustering analysis and were found
to be heterospecific (74). Clustering could be done on many crude solutions, then the top
solution from each cluster could be minimized and evaluated. Not only does clustering aid in
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determining patterns, it also would make our design process more automated. Any future student
doing design should investigate more bioinformatic approaches, as they may provide data
analysis techniques for handling large amounts of sequence data obtained from design.
Our design implementation could be improved by employing different metrics to restrict
sequence space. A fast, yet accurate method, is needed to eliminate much of sequence space.
Much time was spent searching parts of sequence space that were not feasible coiled coils. For
coiled-coil design, a fast sequence-based method, such as SVM (support vector machine), could
be used to parse sequence space, picking the top percentage of feasible solutions. Alternatively,
Paircoil2 (57) could be run on all sequences, and feasible coiled coils could be built, minimized,
and the energy could be evaluated with a better energy function. For more general structures, a
secondary structure prediction program could be used to parse sequence space before energies
are calculated. Another option is to use an extremely fast statistical method, such as SCADS
(77), to parse sequence space before applying a more exact energy function.
In future design calculations, paying more attention to low-probability rotamers earlier in
the design process may be useful. Obtaining solutions with common rotamers from the PDB is
important for well-folded, stable structures (78). Currently, we have a rotamer strain term
incorporated in the energy function, but all the rotamers from the PDB are weighted equally in
the design algorithm. After the design calculations are done, solutions are checked to ensure no
low-probability rotamers are present. For some protein design calculations, low-probability
rotamers have been omitted from the rotamer library and a term that favors high-probability
rotamers has been added to the energy function (65). Although this term causes a deviation from
a completely physics-based energy function, this approach may work well for stability design.
However, low-probability rotamers are important for negative design and could be useful when
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designing for specificity. An optimization between low-probability rotamers in the undesired
states and high-probability rotamers in the desired states among top solutions may yield greater
specificity and stability. However, for this to be a useful technique, side chains would have to
show the same low-probability trends on several different backbones, as a small amount of
backbone relaxation may enable a high-probability rotamer to be accommodated.
Adding backbone flexibility to the design calculation may yield more sequence diversity
in the solutions. Backbone flexibility may be particularly useful for designing antiparallel coiled
coils, as they have more varied packing in the core. The a and d positions in antiparallel coiled
coils can range from being directly across from each other to being staggered. Movement of the
backbone could make the structure more accessible to sequences that are further away from wild
type. When changing the sequence a great deal, the importance of modeling other competing
states may increase. With several of the mentioned improvements it will probably be possible to
design an effective dominant negative Bcr inhibitor.
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TABLES
Table la. Unfolded minus folded energies for point mutations.
Point mutations at positions that were promising for ICTI design. The native residue is listed in
the top row, and five of the top point mutations for each position are listed in each column.
Unfolded minus folded energies calculated with the basic energy function. A larger positive
number indicates greater stabilization. Uncertainty in energy function is at least +±1 at each site.
Table lb. ICTI unfolded minus folded van der Waals energies.
L6V IL1 6K IE17L I V201
VDW(uf-f) 0.66 2.15 3.18 3.80
Unfolded minus folded van der Waals energies for inhibitor minus Bcr. A greater positive
number indicates greater stabilization. Uncertainty in energy function is at least ±1 at each site.
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L6 A9 L16 E17 V20 E23 M27
(a) (d ) (d) (e) (a) (d) (d)
L(n) 40.53 A(n) 40.53 K 40.64 L 42.02 K 41.03 K 41.48 K 42.14
K 39.82 S 39.72 A 39.46 I 40.82 L 40.2 L 40.52 M(n) 40.99
M 38.92 V 39.19 L(n) 39.01 M 40.71 I 39.96 A 50.03 A 40.76
I 38.35 I 38.91 H 38.67 V 40.53 V (n) 39.02 S 39.25 L 40.71
V 38.31 K 38.62 S 38.01 E(n) 39.01 R 38.58 M 39.05 V 40.34
Table 2a. Stabilization of designed inhibitors over wildtype BCR.
ICT1 ICT2 ICT3 ICT4
VDW Energy -0.02 12.49 40.16 2.17
EEF/GB Model 4.52 21.10 44.21 4.74
GB Model 5.74 10.63 24.37 5.03
The numbers above represent the difference of the folded minus unfolded energies of BCR and
the inhibitor. A positive number indicates the inhibitor sequence is predicted to be more stable
than the BCR sequence. Uncertainty in energy function is at least ±+1 at each site.
Table 2b. Specificity of designed inhibitors.
ICT1 ICT2 ICT3 ICT4
VDW Energy 22.07 8.63 -2.72 1.60
EEF/GB Energy 46.44 4.58 33.04 0.15
GB Energy 21.18 28.32 4.61 20.67
Specificity of designed inhibitors where Especificity = 2 EBCR-Inhibitor+Enhibitor-Inhibitor+EBCR-BCR. A
positive number indicates the inhibitor is more specific for the BCR-inhibitor complex versus the
inhibitor-inhibitor and BCR-BCR complexes. Uncertainty in energy function is at least +1 at
each site
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Figure 1. Mechanism of Bcr-Abl fusion and model for Bcr-Abl activation. (A) Reciprocal
translocation event that leads to the Bcr-Abl fusion protein. (B) X-ray crystal structure of Abl
kinase with Gleevec bound (IIEP). (C) Possible model for Bcr-Abl activation. I) When
monomeric, Bcr-Abl is unphosphorylated. This inactive conformation of Abl binds Gleevec
well. 2) Oligomerization of the Bcr oligomerization domain leads to 3) primary phosphorylation
at Y1294, followed by 4) secondary phosphorylation at Y1127. 4) The fully active conformation
of Abl, which Gleevec cannot bind. (adapted from (6))
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Figure 2. Her dimer and tetra mer. (A) The BCR oligomerization domain dimer (lKIF,
(11)). (B) Two of the dimers in (A) associate to form a tetramer in the crystal structure.
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Step C
Step D
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Step G
Figure 3. Flow chart of computational design.
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Coiled-coil
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Figure 4. Hcr regions for computational design. The BCR oligomerization monomer (shown
in blue) with the model inhibitor (shown in yellow) was divided into four different regions to
make computation more tractable.
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Figure 5. Stability and specificity optimization. (A) When designing for a highly stable
sequence, the sequence that maximizes the energy difference between the BCR-inhibitor
complex and a model for the unfolded state is chosen (f = -Efolded + Eunfolded ). (B) When
designing for specificity, the most specific sequence has the largest difference between the BCR-
inhibitor versus the Bcr-Bcr and the inhibitor-inhibitor and maximizes the following equation:
f = - 2 EBcr inhibitor + Einhibitor inhibitor + EBcr Bcr
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Peptide Sequence
C-BCR GSCGG-DIEQELERAKASIRRLEQEVNQERFRMIYLQTLLAKE-GGWK
BCR-C GSKGG-DIEQELERAKASIRRLEQEVNQERFRMIYLQTLLAKE-GGC
ICTI1 GSCGG-DIEQEVERAKASIRRKLQEINQERFRLIYLQTLLAKE
ICT2 GSCGG-DIEQRLERAKARIRRLEQEVNQERFILIYLQTRLAKE
ICT3 GSCGG-DIEQRLERAKARIRRLEQEVEQERFQEIYLRTRRAKR
ICT4 GSCGG-DIEQELERAKASIRRAEQELNQERFRLIYIETLLAKE
Figure 6. BCR and BCR inhibitors that were designed and tested.
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Figure 7. leTl designed interactions. (A) Helical wheel diagram. (B-F) Interactions were
designed using the basic energy function. The Bcr homodimer x-ray crystal structure is shown in
blue superimposed on the designed inhibitor and repacked Bcr structure in gray. The designed
residue is shown in orange and marked with an arrow, and surrounding residues with poor
rotamer conformations are shown in green.
167
To,,"1 Energy (OB mod'l)
After Minimization
IlIolic Energy Function SoluUon Roonk
...-...
604020
............ - ........ \ ..- -... -...- :.
-150
-125
~ -130
~f -135
.. -140
So.... -145
8.
Before Minimization
Towl Ene'llY (OB model)
110 -.vc:-
l 90
f 70..
50'i
;2 30 .,.~::.~ ..... ,..
10
0 20 40 60
lloI"c Energy Funcllon Solution Roonk
A.
IloIlic Energy FuncUon Solution Roonk
...
TobIl Energy (EEF mod.1)
60
,
.. .....
40
#
.'
20........:...., .. .. . ....,:.." ;
-695
-700
-665
-670
l:-S75
f-680
.. -685
i-690....
Tollli Ene'llY (EEFmodel)
-360
20 40 60
~-380 -e -400 - ...f-420 .-
~ -440
~-460 ......,..~ ...,
-480 . ..; ".'::'-
-500
Balle EMrgy Function Solution ~nk
To"l VOW Enotrgy
-205
-90
004020
c:- -210
1-215
ro
~ -220..
;t -225
Q
> -230
-235
604020
10
i-IO
f -30
~ -50
!i! -70 ......A /I. ......- : :~.'
IlIItic Enotrgy Function Sclullon Rank IloItic Energy Function Solution ~nk
SoI_aon (EEF modttl) + E1K1n>1i11acs
c:-l -340
t-345
.. -350
~ -355
II,
::: -360
-365
SoI .. lIon (EEF modol) + E1__
-335
60
..,
40
.. .'
20 ....... ,....... . . ,....' ,
..... ~ ,....
~ -280
~ -285
~ -290
~ -295
'0 -300
~ -305
I:; -310
w -315
Il8sle EnerllY Func:tlon Solution Rank IlIolic Energy Funcllon SoluUon Roonk
SoI .. lIon (OB model) + E1__
IloItic Energy Func1Ion Solution AlInk
Sol_aon (OB ....... 1) + E1~_
220 .. .f 215 •. ..... .... ..w . . . . .8210 .. . . .
+ ...,........ .- ...-
~ 205 -- .... .. .-...
200
0 20 40 60
IlIotic Enotrgy Function Sclullon AI nk
202
200
j; 198
~ 196
... 194
~ 192
+ 190
~ 188
186
184
o 20
......
40
..."
60
Figure 8. Effect of minimization on energy. Solutions from a very small-scale selection
before and after minimization evaluated by van der Waals, solvation and electrostatics, and total
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crystal structure is shown in blue, and the designed inhibitor and repacked Bcr structure are
shown in gray. The designed residue is shown in orange and marked with an arrow.
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Figure 10. leT3 designed interactions. (A) Helical wheel diagram. (B-D) leT3 interactions
designed with the EEF/GB Model. The Bcr homodimer x-ray crystal structure is shown in blue,
and the designed inhibitor and repacked Bcr structure are shown in gray. The designed residue is
shown in orange and marked with an arrow.
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and negative control for ICT3. Pull-down for ICT4. (D) Negative control for ICT4.
Experiment run by J. Fisher.
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APPENDIX A
Insights into the Computational Design
of a Heterospecific
Iavc Protein
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Both successful and unsuccessful protein designs can yield important information which
can lead to improvements in the design process. In the first part of this appendix, attempts to
stabilize the BBA homotetramer (BBAT2) and additional details about design of the BBA
heterotetramers (BBAhetT1 and BBAhetT2) are discussed. In the second part, an analysis of
the BBAhetT1 crystal structure and designed structure is presented to suggest ways the design
process could be improved to obtain more accurate protein designs. A discussion of a third
computational design round with experimental verification follows. Finally, a fourth round of
computational design was done, and mutations are suggested for experimentation.
Attempts to Stabilize the BBA Homotetramer (BBAT2)
Early work on this project attempted to stabilize BBAT2 using computational design
techniques. BBAT2 contains five layers (Figure 1), three of which are unique. Layers A and A'
(containing residues Ile 3 and benzoylated L-cU,-diaminopropionic acid (DapBz) 20), layers B
and B' (containing residues Phe 8 and Leu 16), and layer C (containing Leu 12) all contribute to
packing in the core. Each layer was computationally redesigned separately to increase stability.
Optimizing stability using layers B, B', and C simultaneously resulted in minuscule energetic
improvement.
For layers A and A', problems modeling the DapBz molecule in CHARMM and
constructing a good rotamer library for DapBz, led to higher energies for solutions containing
DapBz than solutions containing nearly every other amino acid at position 20. Problems
modeling DapBz potentially stemmed from introducing constraints in CHARMM that dictate
planar geometry in the DapBz ring structure and carbonyl group during minimization. Optimal
DapBz rotamers were found by evaluating energies about chi angles in DapBz using CHARMM.
Chi angles that resulted in minima were used to create the DapBz rotamer library. Greater
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sampling around the low-energy chi angles may have also reduced problems with DapBz in the
design calculations. When all residues were considered at layers A and A', Lys/Tyr and Lys/Phe
combinations did well. When charged residues were excluded from the selection, Ile/Met and
Leu/Tyr scored well. These residues did not fill the core as well as DapBz, however. None of
the stabilization designs seemed promising based on structural inspection and energy score.
Additional Details Regarding the Design of the BBA Heterotetramers
Details regarding the design of the BBA heterotetramers (BBAhetT1 and BBAhetT2)
can be found in Chapter 2. The purpose of this section is to discuss the thought process and
computational details behind design rounds 1 and 2. Because both core and surface regions do
not interact strongly, rounds 1 and 2 of the design process treated the core and surface regions
separately, making computation faster and results easier to interpret. Experimental data were
also used to guide the design process. Sites modeled in alternate conformations or those mutated
to SeMet in the BBT2 crystal structures were considered to be excellent design candidates
because they were unlikely to affect the basic BBA structure. To mimic backbone flexibility,
most of the computational selections were done on both available experimental SeMet-mutated
BBAT2 structures: SNE (denoted bbl) and 1SNA (denoted bb2).
Design of the core
In the core, layers A/A', B/B', and C were individually selected for heterospecificity.
Similar steric matching patterns emerged from the designs of B/B' and C layers. Redesigning
the layer A/A' was problematic due to modeling DapBz.
Designing the B/B' layer for heterospecificity was not promising, as many core residue
pairings that emerged were polar and not paired with an appropriate hydrogen-bond donor or
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acceptor. The promising sequences and heterospecific energy scores are shown in Table a. If
hydrogen bonds had been satisfied in the core, this would have been a fine method for
introducing specificity, as has been seen in several previous coiled-coil studies (1, 2). However,
unpaired hydrogen bond donors and acceptors in the core are likely to destabilize the structure
significantly. In our calculation, hydrogen bonding was calculated as a combination of
electrostatic interactions, modeled using a distance-dependant dielectric and van der Waals
interactions. Only hydrogens on polar atoms were explicitly represented. The EEF solvation
term should have prevented unpaired hydrogen bonds in the core, as desolvating a polar atom is
unfavorable in the absence of a compensating interaction.
Obtaining an unstable result is not surprising however, given specificity was optimized,
not stability. When optimizing specificity, the energy between the stabilities of the
heterotetramer and two homotetramers was maximized. Large clashes found in homotetramer
states, combined with good van der Waals packing in the heterotetramer state, caused the energy
difference between the homo- and heterotetramer states to be large, regardless of the whether
core residues were hydrophobic, charged, or polar. The heterotetramer stability was not
optimized in the specificity calculation; however, a stability calculation would have disfavored
unsatisfied hydrogen bonds in the core.
Many of the best solutions for layer B/B' contained low-probability rotamers, which are
considered undesirable in a potential design. Rotamers seen infrequently in the PDB often cause
strain, and strained rotamer conformations can adversely affect protein stability and
conformational specificity (3, 4). Using probabilities from the Dunbrack rotamer library, the
rotamer conformations for the top-scoring layer B and B' solutions were checked. In nearly all
promising solutions, at least one rotamer conformation had low probability, shown in white in
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Table lb. The structure of BBA may accommodate a limited number of residues in the B layers;
layers A and A' reach into the core, restricting where residues in the B and B' layers can pack.
In addition, DapBz was not repacked, further restricting the accessible space. Because the best
solutions contained unfulfilled hydrogen-bonding partners in the core and low-rotamer
probabilities, introducing heterospecificity into this layer was not explored further.
The middle BBA layer (layer C), containing residue 12, was also redesigned for
heterospecificity. Although more promising, some of the same problems seen in the B/B' layers
existed in layer C. Some solutions were solely hydrophobic, eliciting no worry about
destabilization due to unsatisfied hydrogen bonds, shown in Table 2a. Some residues selected,
like Tyr and Trp, left possible hydrogen-bond donors and acceptors unsatisfied, as was seen in
layers B and B'.
Layer C was much more promising, as many solutions used only rotamer conformations
seen often in the PDB, shown in Table 2b. One high-scoring solution for heterospecificity was
also among the top solutions when heterotetramer stability was optimized. The stability
optimization results for both backbones ranked Phe/Ala as 5 th when all combinations of amino
acids (except for Cys, Gly, and Pro) were enumerated at position 12.
The specificity energies would have been more realistic had minimization been
incorporated into the selection process to relieve the large steric clashes in the homotetrameric
state. In the design of the B/B' and C layers, looking at both the specificity and stability energies
of individual components (i.e. the two homotetramer and heterotetramer states) can be helpful, as
specificity energy is sometimes very high due to bad steric clashes on one homotetramer model.
For example, in Tables 1 a and 2a, Trp and Phe are predicted to make good heterotetramers based
on specificity. Trp and Phe have steric clashes in the homotetramer state which creates a large
177
van der Waals term and unrealistically high heterospecificity energies. However, steric clash is
relieved in the heterotetramer. A small amount of minimization could reduce the steric clash in
the homotetramer state, making the specificity score more realistic.
To introduce a small degree of backbone flexibility to relieve steric clashes, the design
was done on bbl (SNE) and bb2 (SNA) backbones, which each deviate by -0.7 A from the
BBAhetT1 crystal structure. Designs based on the two SeMet-mutated BBAT2 x-ray crystal
structures showed large differences in component stabilities (AAAA, BBBB, and ABAB) and
heterospecificity energies. Further, solutions were ranked differently between the two
crystallographic backbones. This makes a compelling argument for adding a small amount of
backbone flexibility to design calculations, as one solution may give a large heterooligomeric
specificity score on one backbone and not another. The backbones giving the lowest energy
structure for each hetero- and homotetramer would be considered in the specificity score
calculation.
Surface Selection
The surface of BBAT2 has two distinct faces that were treated separately in our designs.
Residues on the surface that do not interact in BBAT2 but have potential to do so were targeted,
including position 13 on one face and positions 11 and 18 on the other. Position 13 is solvent
exposed and located near the middle of BBAT2 (See Figure 6 in Chapter 2). When position 13
was mutated to SeMet to solve the BBAT2 structure, the structure remained unperturbed,
indicating position 13 could be altered without disrupting the overall BBA fold. Position 13
residues are directly across from each other on two BBAT2 faces, making position 13 a potential
site for introducing a salt bridge.
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Based on the predicted specificity energies and structures from the calculations, Glu and
Lys were clearly the best solutions at position 13, shown in Table 3. Predicted structures showed
Glu and Lys at an ideal distance, making an interhelical salt bridge, whereas Asp and Lys were
further apart and not in positions as conducive to salt bridge formation. Asp and Arg can
interact, but structurally Glu and Lys form a salt bridge with closer contacts. Glu and Arg are
long enough to interact, but their large size precludes good salt-bridge interaction geometry at
this position. Glu and Lys were chosen for position 13 on the designed heterotetramer because
of the results of the computational selection results, evaluation of the predicted structure, and the
ACID/BASE peptide model which had been shown to yield heterospecificity in a coiled coil (5).
In a separate selection for specificity, positions 11 and 18, both surface exposed residues
on either end of the helix, were redesigned. In BBAT2, monomers associate in an antiparallel
fashion, giving position Al 1/B18 and A18/B11 potential to form interhelical interactions. Using
two different backbones (bbl and bb2) and a 17-residue amino-acid library (Gly, Cys, and Pro
were excluded), a selection was done using a Monte Carlo algorithm to sample sequence space.
Using a temperature gradient from 300 to 200 K, Monte Carlo selection was run for 128 rounds,
with 1500 steps per round. The top results are in Table 4. This selection yielded charged
residues at most of the 11 and 18 positions; however, in most cases at least one other type of
amino acid was selected. Isoleucine came up a great deal in one of the positions in many of the
top solutions.
Based on knowledge that the current energy function does not penalize surface exposed
hydrophobics and with concerns over solubility, a second selection was limited to only charged
residues. The sequences were enumerated, due to the smaller size of the selection, and evaluated
in terms of specificity. Table 5 shows the results from the smaller selection. Lys and Glu
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formed salt bridges in some predicted structures. In some cases, the rotamer that has potential to
make an interhelical salt bridge was not selected, causing the interaction to not look as favorable
in the selected structure. In the top solutions selected for the ACID peptide, Glu and Asp yielded
a slightly more specific peptide than Glu and Glu at positions 11 and 18, respectively. Based on
models, Arg and Glu are too large to make a good salt bridge between positions 11 and 18.
Further, Asp interacts with Lys on the other helix with greater ease than Glu at position 18 due to
its length.
Therefore, the selections predict an ACID/BASE chemistry on the surface to introduce
heterospecificity. This design also makes sense based on previous heterooligomer design
literature (21). Lys residues were placed at the 11, 13, and 18 positions of one helix (BASE),
and with the exception of the 18 positions, Glu was placed at the 11 and 13 positions on the other
helix (ACID). Asp was chosen for position 18 on the ACID peptide based on the predicted
structures.
A final design calculation incorporated the surface residues fixed in the ACID/BASE
motif and a very limited library consisting of Phe, Ala, Leu, and Trp at position 12. The ACID
motif was enforced on the A peptide, and the BASE motif on the B peptide. The results are
shown in Table 6. Again, Trp ranked near the top for specificity, but ranked low for stability. In
this calculation, the low stability can most likely be attributed to the unsatisfied hydrogen-bond
acceptor in Trp, leaving the polar NH buried in the hydrophobic core. The heterotetramer
specificity score was significantly less for the heterotetramer containing Phe/Ala than Trp/Ala.
However, the stabililty score for Phe/Ala was much greater than that for Trp/Ala. Thus, Trp was
eliminated as a possibility for position 12. Phe packed well in position 12 and gave a substantial
amount of heterotetramer specificity. Phe/Ala at position 12 and the ACID/BASE surface
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patterning (denoted A-Ala and B-Phe) were chosen for testing in the first round of protein
design.
Experimentally, A-Ala and B-Phe formed heterotetramers, based on fluorescence
experiments, and A-Ala and B-Phe were monomeric at 25 tM concentrations. However, B-Phe
also self-associated at concentrations of 50 tM and above. This heterotetramer will be referred
to as BBAhetT1. In addition, the crystal structure of BBAhetT1 was solved.
Steric matching in the core and charge complementarity on the surface were also
evaluated independently. A peptide containing Leu/Leu at position 12 with ACID/BASE surface
patterning (A-Leu/B-Leu) tested the heterospecificity arising from charged complementarity on
the surface. Calculations predicted these peptides would be heterospecific, as shown in Table 7,
but not to the extent of other solutions. The predicted specificity energy arising from the A-
Leu/B-Leu is likely to be closer to realistic specificity energies, because core steric clashes that
make van der Waals energies extremely high were not present. Experimentally, A-Leu and B-
Leu both self-associated in solution at low concentrations, but form a heterotetramer when
mixed together.
Optimization - Round 2
The experimental results from round 1 indicated that A-Ala/B-Phe form a heterotetramer,
but the thermal stability of this complex was much lower than for BBAT2. The predicted
packing for Phe/Ala in position 12 was not ideal, as there was empty space in the core that could
potentially be filled to stabilize the complex. All 17 amino acids (excluding Cys, Pro, and Gly)
were evaluated in design calculations at this position for their ability to stabilize the
heterotetramer and preserve specificity.
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Although polar residues in the core are typically not favorable, the Phe/Ser structures
packed well. The hydroxyl group filled the core much better and left a large hole in the Ser/Ser
homotetramer state. Rather than using Ser, a hydrophobic non-natural amino acid, L-O-
aminobutyric acid (Abu), was chosen to stabilize the heterotetramer. Met looked reasonable, but
was too large in the heterotetramer structure and had potential to be too favorable in the
homotetramer state. According to round 1 calculations, Phe/Met was heterospecific, but did not
have a heterospecificity score nearly as large as other amino-acid combinations on both
backbones. Rather than trying Met, a slightly shorter non-natural amino acid, 2-aminohexanoic
acid (norleucine or Nle), was added to the calculation. A comparison of structures is shown in
Figure 2.
Another calculation checked the heterospecificity of Phe/Abu and Phe/Nle compared to
peptides tested in round 1. The selection results are shown in Table 8. On one of the backbones,
Phe/Abu was calculated to be more stable than Phe/Ala. Phe/Abu packed well in the
heterotetramer state, leaving a large hole to destabilize the homotetramer state. When the
structure was minimized and only van der Waals and surface area-based solvation energy
contributions considered, Abu was predicted to stabilize the structure by about -4 kcals/mol on
both model backbones. Depending on the backbone used, very little, if any, specificity was
predicted to be lost by changing Ala to Abu. Phe/Nle was more stable than Phe/Abu and also
packed well, but some heterospecificity was compromised by greater stabilization from the extra
methyl group in the Nle homotetramer. Based on these results, only A-Abu was made and
tested. The experimental results from round 2 indicated that A-Abu/B-Phe on the surface was
more stable and still retained heterospecificity.
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Evaluation of the Design Process with the Crystal Structure
The crystal structure of the BBAhetT1 was solved, allowing further evaluation of the
design process and energy function performance. A brief evaluation of the designed structure
versus the crystal structure was done. Possible improvements to the design process, such as use
of wild-type rotamers and different energy functions used for repacking, were evaluated. Unless
stated otherwise, energies were re-evaluated with 100% van der Waals radii with the complete
Generalized Born (GB) solvation model.
Overall agreement of designed and experimental structure
The x-ray crystal structure and designed structure of BBAhetT1 superimpose well. For
the purpose of this section, the structure designed using the BBAT2 backbone (bbl) was used for
comparison, unless otherwise noted. The core residues superimposed extremely well. The
backbone/side-chain RMSD was 1.76 A, and the backbone RMSD was 0.71 A. Most of the
amino acids in boundary positions were designed to give interhelical salt bridges. With the
exception of Leu 15, Tyr 6, and the designed interhelical salt bridges, residues that were
repacked agreed well with the crystal structure.
Assessing computational approximations using side-chain repacking
There are differences between repacking and design calculations. When repacking, the
amino-acid sequence and backbone are known and the energy function dictates side-chain
placement. With design, both the amino-acid sequence and side-chain placement are important.
When repacking, discrete rotamers are the main approximation (beside those in the energy
function); however, both discrete rotamers and backbone are being approximated in design.
Thus, repacking accuracy does not necessarily mean better performance in design. Both
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approximations can decrease the accuracy in obtaining exact inter side-chain and side-chain /
backbone interactions, and combining the approximations in design calculations can further
diminish accuracy. Nonetheless, side chain repacking was an effective way to evaluate the
accuracy of the design methods.
Given the backbone of the designed and crystal structures were very close, the question
remains as to whether small differences in backbone can account for discrepancies in side-chain
placement in the two structures. Designing on the heterotetramer crystal structure backbone
versus the homotetramer backbone yielded a 7.4% improvement in the correct placement of
rotamers at chi 1; however, only 70.4% of chi 1 angles were correct. A dramatic improvement
in side-chain placement was seen when energies used for repacking were calculated using a
pairwise decomposable GB solvation model (6, 7) and the heterotetramer crystal structure
backbone. With the EEF (effective energy function) model (8) used in the initial design
calculations, 70.4% of chi 1 positions were correct, whereas 83.3% were correct with the GB
solvation model. Such drastic differences between EEF and GB solvation models were not seen
with the designed structure backbone, as the performance only increases from 63.0% (EEF) to
68.5% (GB). The energy functions, particularly the GB solvation model, seem to be very
sensitive to the backbone used. Further, there are significant differences between repacking
accuracy on the exact backbone versus an approximate backbone.
In predicted structures, the position of Tyr 6, located toward the end of the BBA helix on
the surface, was consistently wrong. Tyr 6 packs against the helices in the BBAhetT1 crystal
structure, but is much more solvent exposed in the BBAhetT1 designed structure. The hydroxyl
group on Tyr 6 can interact with positions 11 and 18. In the x-ray crystal structure, two Tyr 6
residues interact with Glu and Lys at positions 11 and 18, but the other two Tyr 6 residues do not
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interact with Asp and Lys because they are involved in crystal contacts. In the crystal structure,
Tyr 6 is close to one of the rotamers in the rotamer library, but this rotamer does not allow it to
be packed ideally against the BBA structure.
To obtain better repacking results for Tyr 6, wild-type rotamers were added to the
rotamer library. Wild-type rotamers refers to rotamers taken from the structure on which the
design was done. For example, if the BBAhetT1 crystal structure was used in the design, the
rotamers from the BBAhetT1 crystal structure were used. Using the BBAhetT1 crystal
structure, and expanded rotamer library, two of the four Tyr 6 residues were placed correctly.
Upon using a GB solvation model (with solvent accessible surface area parameter scaled by 7
02
cal/moloA ), rather than EEF, all four Tyr 6 residues were placed in their correct positions when
the expanded library was used. With the designed backbone, only 2 of the 4 were placed
correctly with the GB solvation model. Experience in the lab following this analysis has found
expanding the aromatic rotamers +/- 10° gives improved repacking performance. This expanded
library might have helped in BBA design.
The performance of GB versus EEF at this position indicates that GB may model the
hydrophobic effect better than EEF. Regardless of whether the 11/18 salt bridge forms, Tyr 6
packs in the same manner. Further, Tyr 6 packs in the same manner in BBAT2. Therefore, the
problem is most likely due to hydrophobic interactions and not interaction with positions 11 and
18. Solvating the largely hydrophobic Tyr 6 probably incurred a much larger penalty with GB
than it did with EEF. This may have caused Tyr 6 to pack against BBA in structures repacked
using GB. Positions 11 and 18 in BBAT2 do not interact with Tyr 6, so Tyr 6 in BBAT2 would
not be biased by those positions if it were repacked. Repacking the homotetramer structure
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should be done before conclusions are drawn as to whether GB modeled the hydrophobic effect
or charged interactions better than EEF.
Overall, adding wild-type rotamers to design calculations yielded slight improvements in
side-chain placement in repacking tests. Improvements were seen regardless of backbone or
energy function used. In a few cases, there was a slight decrease in the percentage of correctly
placed rotamers when wild-type rotamers were added, but overall there was some improvement.
Therefore, incorporating wild-type rotamers into design might be useful without adding a great
deal of computational time. In addition, the GB solvation energy function was better at
modeling Tyr 6.
The most striking difference between the designed and x-ray crystal structures was the
formation of salt bridges. In the BBAhetT1 crystal structure, nearly all designed surface
residues made some sort of crystal contact, with only two out of six designed intratetramer salt
bridges forming. Modeling the crystal lattice and accounting for crystal contacts in design
calculations was impossible because the space group in which the protein crystallizes cannot be
predicted. In fact, BBAhetT1 crystallized in a different space group than all three of the BBAT2
native and SeMet crystal structures. In the case of the two position 11 to 18 designed salt
bridges that formed, as predicted, in the crystal structure, there were no competing crystal
contacts nearby.
Interesting differences in salt-bridge formation were seen between very similar backbone
structures. When residues were repacked on the BBAhetT1 crystal structure backbone, fewer
designed salt bridges formed than on the designed backbone. Although not very important for
repacking core hydrophobics, the very similar backbones made a larger difference in the
placement of residues on the surface.
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As expected, modeling solvation with GB versus EEF allowed formation of different salt
bridges. Overall, GB yielded fewer designed salt bridges at selected positions (11, 13, and 18),
but about the same number or more total salt bridges. Adding wild-type rotamers to the
calculation caused more salt bridges to form, when GB versus EEF was used. In predicted
structures, salt bridges tended to be further apart when GB versus EEF solvation was used. Any
information taken from this analysis should consider the caveat that crystal contacts, which
influenced salt-bridge formation in BBAhetT1, were not taken into account in this analysis.
Both energy functions should be tested using the crystal lattice of the BBAhetT1 structure to
determine which energy function performs better. Using the lattice, performance in predicting
salt bridges can be more accurately determined. Solution structures of BBAhetT1 would be
necessary to draw definitive conclusions about the effects of backbone, incorporation of wild-
type rotamers, and energy function performance, in regard to salt-bridge formation.
Mitigating Homo-oligomerization - Round 3 Design
For an ideal, highly specific heterooligomer, individual components would not self-
associate. However, in our study, analytical ultracentrifugation experiments indicated the B-Phe
monomer self-associated at concentrations 50 !tM and above. To reduce B-Phe monomer self-
association, another round of design was done.
Both x-ray SeMet BBAT2 crystal structures (bbl and bb2) were used for round 3
calculations, and a "core" and "surface" strategy, similar to the strategy used in round 1, was
used for round 3. Round 1 calculations on layer C were checked again for any other natural
amino-acid combinations that might yield greater heterospecificity, but none seemed promising.
Position 12 was reselected to try to improve heterospecificity.
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The "core" strategy focused on methyl-substituted Phe derivatives at position 12, which
could add stability to the heterotetramer state and also make the B-Phe homotetramer state less
favorable by introducing further steric clashes. The following phenylalanine derivatives, shown
in Figure 3, were added to a restricted library consisting of Leu, Ala, Phe, Abu, and Nle for
round 3 selections: 2-methyl-L-phenylalanine (Otl), 4-methyl-L-phenylalanine (Tol), and 3-
methyl-L-phenylalanine (Mtl). Phe rotamer conformations were used for all Phe derivatives.
The results are shown in Table 10Oa nd b. As before, specificity was optimized by maximizing
the following equation: f = -2EABAB + EAAAA + EBBBB. The stability of the homotetramer and
heterotetramer structures were also compared. The stabilities of BBBB and ABAB were
approximated by using the folded energy without subtracting the unfolded state. Because the
BBBB structures were nearly identical, only differing by one or two methyl groups, this was a
reasonable approximation. Heterotetramer structures ABAB could also be compared in this
manner. The stability of ABAB was also calculated as unfolded minus folded energy.
Based on the results of the "core" selection, Otl/Abu and Otl/Ala are predicted to increase
both the stability and the specificity. Mtl was predicted to increase specificity by a great deal,
but to destabilize the structure. The current calculations do not model backbone flexibility;
however stability may not be compromised with Mtl in the core, due to backbone relaxation in
solution. Tol was not predicted to contribute much more to specificity or stability. Destabilizing
the homotetrameric state was the main goal of the third selection round, so efforts were focused
on characterizing structures with Mtl/Abu.
The "surface" strategy involved varying residues at positions 11, 13, and 18 on B-Phe.
The first approach to mitigate self-association of B-Phe involved trying various lysine
derivatives. Lysine residues on the surface of B-Phe have many degrees of freedom, possibly
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making them less effective in preventing self-association by charge repulsion; the lysine
residues may be able to make alternative interactions, preventing charge repulsion from being an
effective negative design strategy. Removing methylene groups eliminates many degrees of
freedom, causing the side chain to make a more defined interaction. In addition, the helices are
closer on either end of the helix than in the middle. In some of the predicted structures, the
Lys/Glu and Lys/Asp pairs would have been able to make better interactions had a methylene
been removed from one of the amino acids. Two lysine derivates, L-ornithine (Orn) and 2,4-
diaminobutyric acid (Dab), (shown in Figure 4) differ by one and two methyl groups from
lysine, respectively, and were computationally tested to determine if the mutations would
mitigate self-association of B-Phe and increase heterospecificity of BBAhetT2.
Positions 11 and 18 were selected in one calculation, and position 13 was selected in
another. In the position 13 calculation, all combinations of the following amino acids were
computed: Ala, Orn, Lys, Arg, Glu, Asp, Dab. The results shown in Table 11 favor retaining
Glu on A-Abu and Lys on B-Phe. Therefore, Glu and Lys were kept at position 13.
In the position 11 and 18 selection, all combinations of the following amino acids were
computed: Glu, Arg, Orn, Lys, Asp, Dab. The results are shown in Table 12. Based on the
calculations, two Lys residues at 11 and 18 on B-Phe still appear to provide the most specificity.
In the bb2 model, the Orn/Orn and Orm/Dab pairs are more stable on B-Phe than the Lys/Lys
pair, whereas the Lys/Lys pair is more stable on B-Phe than Orn/Orn and Orn/Dab in the bbl
model calculation. Therefore, the stability results are ambiguous when both backbones are
considered. All three pairs, Lys/Lys, Orn/Orn, and Orm/Dab, are capable of making salt bridges
with residues on A-Abu in the heterotetramer based on modeling studies.
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The second approach to mitigate self-association of B-Phe involved changing positions
11 and 18 to arginine. With a pKa of 10.4, some of the lysines on B-Phe may deprotonate upon
association, causing less charge repulsion (and perhaps even allowing hydrogen bonding) in the
homotetrameric state. Arginine has a pKa of 12, which is much higher than Lys, making Arg
harder to deprotonate. Our calculations used EEF for solvation energy, which does not include a
model for neutral Lys; thus, this could not have been computationally tested using our methods.
Based on modeling in the heterotetramer state, arginine did not appear optimal at position 11 and
18 due to its longer side chain. However, Arg might eliminate the homotetrameric state by
providing more repulsion in the homotetrameric state.
A final calculation was conducted to determine the heterospecificity and stability of
simultaneous core and surface mutations, shown in Table 13a and b, before deciding on peptides
to test. The final peptides tested are listed in Table 14. Briefly, B3 changed positions 11 and 18
to arginine to address the pKa argument. B4 and B5 changed positions 11 and 13 to shorter
lysine derivatives, decreasing the degrees of freedom the side chain can sample. B6-B8 added
more steric clashes to the core to decrease self-association. The peptides were synthesized and
biophysically characterized by Mayssam Ali. All BASE peptides showed very little structure via
CD at 50 ,tM, but all show some amount of self-association by AUC when concentrations from
50 gM to 1 mM are fit to a stoichiometric model (shown in Table 15). In experiments, arginine
was more effective than Lys at keeping homotetramers from forming, most likely due to the pKa
argument. Based on AUC experiments, Arg on the surface was more effective in preventing
homotetramerization than designing additional steric clashes in B-Phe. The design calculations
do not take pKa into consideration, so this element of potential specificity was introduced
rationally. The Mtl substitution also reduced some homotetramerization in experiments. If Mtl
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in the core and arginine at positions 11 and 18 were combined in a designed peptide, the
homotetramerization at high concentration may be substantially reduced.
Future Directions
Heterospecificity is an important design concept. A molecule that can form
heterospecific interactions with no self-association would be useful for biomaterials or targeting
applications, such as drug delivery or protein purification. In additional attempts to prevent B-
Phe from self-associating, a subsequent round of design was done. Leu 15, located at the helical
interface, was used as an additional target site. Leu 15 residues on adjacent helices face one
another. Promising solutions emerged from this round of design, but were not experimentally
tested. Steric and charge complementarity both emerged at position 15 as viable means for
making heterospecific peptides. For instance, the following pairs of residues (listed as Leu 15 on
helix A / Leu 15 on helix B) were found to be highly heterospecific and also stabilizing:
Ala/Tyr, Leu/Tyr, Glu/Arg, Asp/Arg. This round of design offers an additional method to
prevent self-association of B-Phe.
Simultaneously optimizing for stability and specificity
Future research in this area should focus on methods for optimizing both specificity and
stability simultaneously during the design process. In the BBA heterotetramer design, specificity
and stability were optimized separately. The solutions that ranked extremely high in the
specificity optimization did not rank at the top of the stability optimization. This makes sense, as
stability was often sacrificed for specificity in previous studies (1, 2, 9). However, optimizing
for specificity and stability simultaneously may yield better solutions. Havernak and Harbury
successfully simultaneously optimized for stability and specificity by including the unfolded,
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aggregated, and undesired coiled-coil state in their optimization for homo- or heterospecific
coiled coils (10). We know that if only stability is taken into account, the solutions are often not
completely heterospecific (9).
Both specificity and stability could be incorporated into one design calculation by
defining an objective function that would effectively weight both stability and specificity into a
score, as done by Havernak and Harbury. However, this was tried in a couple BBA selections
and was found to be difficult due to large scores that often result from steric clashes in specificity
calculations, placing stability and specificity energies on different scales. Thus, a weighting
system may not be effective due to large specificity scores, and scale factors would most likely
need to be experimentally determined. An alternative is a score that incorporates both elements
without use of raw energies, perhaps as a function of rank (11). Evaluating based on rank would
cause the stability and specificity score to be of a similar magnitude. Essentially, this is what
was done manually in the BBA heterotetramer design. In addition, steric clashes that cause the
large specificity scores could be relieved with a small amount of minimization or backbone
flexibility, making the specificity and stability scores more comparable.
Realistic negative design
Incorporating minimization, a larger rotamer library, or backbone flexibility into the
design process may also be useful in quantifying specificity, as large rotamer clashes will be
reduced, and energy will be reduced as a result (as shown in Figure 9a and b). Alternatively, the
repulsive term in the Leonard Jones potential could be modified such that repulsive energies stay
within reasonable limits. Ideally, the specificity score that results from a steric clash will be the
same order of magnitude as specificity resulting from an electrostatic clash. However, the
energies from the steric clashes in this design far exceeded the score from electrostatic clashes.
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Part of the success of the BBA design was due to the separation of the "core" and "surface",
separating the steric and the electrostatic clashes, allowing them to be evaluated on their relative
scales. Given the performance of the various peptides, it would be interesting to determine how
the peptides score if minimization and / or backbone flexibility are incorporated into design. In
this study, minimization was only used before the structures were examined and was not an
element in the design process. Further, testing the plasticity limits of the BBA backbone by
introducing more steric bulk into the core would also be interesting to test experimentally. Given
the crystal structure of both the homo- and heterostructures, this system could give additional
insights into the design software with a little more computation and experimentation. Because
steric matching is an important design technique, it is important to make attempts to improve this
in the present design algorithm.
Other Potential Improvements
The computational design program used in the BBA heterotetramer design eliminates
high-energy rotamers based on an energy cutoff. Ideally, the undesired state will pack poorly
and have many steric clashes, and the desired state will pack well and have few steric clashes.
To calculate specificity, the energies of both states must be calculated, however this may not be
possible if the undesired state is extremely poor. In an extremely poor undesired state, all
rotamers may be eliminated at a position, preventing the specificity score from being calculated.
Unfortunately, these sequences are of the most interest for introducing heterospecificity because
the energy of the undesired state should not be favorable. The extent to which this happens has
not been explored.
Experimentally, the A-Ala and A-Abu showed no self-association, even at high
concentrations. This was surprising, as the majority of specificity in the calculations came from
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steric clashes on B-Phe, not A-Ala and A-Abu. Therefore, the current energy function does not
penalize a sparsely packed core nearly to the extent that steric clashes are penalized. However,
based on the results, the sparsely packed core may be a better negative design technique.
Perhaps, exaggerating the attractive component of the Leonard-Jones potential would cause the
energies to appear to favor packing in the core versus a cavity. Checking potential solutions with
a program, such as PROVE (12), that checks for the quality of packing in the core may be useful
for both desired and undesired structures.
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TABLES
Ph~lIILtul6 (I.ay~r D & D',
bb I Spec. Score bb2 Spec. Score
AIB AAAA-bbi AAAA-bb2 DDDD-bbi BBBB-bb2 ADAD-bbl
(Rank) (Rank)
PHEIARG
-180.54 -182.03 592.67 321.25 -134.79 681.71(1) 381.76(59)
TRPrrYR
1'1 .. :11:; I.lJ
-161.15 .177.82 592.67 3:n.15 -125.09 68\.68 (2) 378.19 (188'
TRP/rYR
TRP/rYR
592.67 321.15 -52.37 .58.14 -70.29 680.87(5) 381.74(61)
PIIMI.E
HISIARG
-200.77 -198.89 592.67 321.25 -142.71 677.32(32) 384.73(24)
TRPrrYR
H1SrrHR
-132.05 -135.35 592.67 321.25 -108.08 676.78(35) 383.22(33)
TRPrrYR
ASPtGLU
-174.62 .181.54 592.67 321.25 -129.22 676.49(39) 383.28(31)
TRPrrYR
HISISER
-145.12 -148.36 592.67 321.25 -113.34 674.22(61) 380.81(95)
TRPITYR
TRP/rYR
592.67 321.15 27.76 .:2.02 .26.48 673.39(85) 380.39( 115)
IUNA I.
TRPrrYR
592.67 321.25 -163.83 -161.12 -122.08 672.98(114) 382.64(42)
METIARG
ASNIARG
-197.95 -192.68 592.67 321.25 .138.81 672.34(157) 382.25(51)
TRPrrYR
'rYRlrYR
3n.01 187.5' .52.37 -69.44 -66.969 458.57(445) lli.4I(1886)
PIIMI.E
lIIS1rYR
319047 187.59 -67.74 "',.44 -79.46 410.65 (62.14) 2S5AI (1351)
IIISIVAI.
HISrrYR
319.49 -26.29 131.8 29.57(24211)
SERlPIIE
lI.t:lAI"\
-29.07 -60.79 -10.92 5'-'5 .80.24 120A9(1I 153) 170.48(4067)
IIIS1fRP
TYRlfRI'
-4...14 5'.55 -29.07 -60.79 .73.91 114AI(I304\) 166.85(4865)
lI.t:lAI"\
PIIMI.E
-52..17 .SlL14 -31.26 .JUS .98.6 113.58( 132.13) 115.88( 10706)
1IIS1\'1IE
VALITYR
391.03 106.03 160.81 227.9 22349 104.87(\4391) 412.47(1 )
TRPrrRP
TIIRrrYR
359.67 75.36 160.81 227.9 208.28 103.93( 14544) 402.32(13)
TRPrrRP
ILEITYR
418.12 109.11 160.81 227.9 237.58 103.78(14558) 402.93(11)
TRPITRP
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GLUffYR
326.93 43.95 160.81 227.9 192.25 103.25( 14629) 409. 14(3)
TRPffRP
ALAffYR
372.18 85.58 160.81 227.9 215.11 102.77(14689) 393.38(17)
TRPrrRP
METffYR
359.38 91.18 160.81 227.9 210.57 99.04 (14979) 408.09(5)
TRPrrRP
GLNffYR
327.19 49.09 160.81 227.9 194.55 98.91 (14983) 407.83(7)
TRPrrRP
ASNffYR
326.59 51.78 160.81 227.9 194.76 97.88 (15068) 395.25(15)
TRPrrRP
LYSffYR
322.62 56.35 160.81 227.9 193 97.43 (15100) 404.72(9)
TRPrrRP
JnSIILE
-74.77 321.~ 384.57(26)
TRPffYR
Table la: Energies for layer B. Energies of undesired homotetramer states, desired
heterotetramer states, and specificity scores for both backbones in layer B are shown. In the far
left hand column, the residues are represented as A8/A16 over B8/B16. Therefore, A8 and B16
would form a layer and A16 and B8 would form a layer, due to the antiparallel orientation of the
helices. The rows in bold were ones considered the most promising, as no charged residues were
present in the solution. The energy function consisted of VDW, EEFI solvation, and distance-
dependent dielectric energy terms. The following equation was maximized: .
f = -2E ABAB + EAAAA + EBBBB' A sequence predicted to be very specific for the heterotetramer
has a large positive specificity score. EABAB, EAAAA, and EBBBB are Efolded energies. Rank refers
to the solution's overall rank relative to other solutions within the individual specificity selection.
A and B do not refer to ACID and BASE, at this point in the calculation.
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Rotamers for bbl Phe8ILeul6 (Layer Band B')
Rank
specificityiEABAB A 16A ~A 16A ISB 16B IsB 16B
125.087 PHE.02 pLU.26 IPHE.02 GLU.23 rRP.03 :'YR.04 ffRP.05 trYR.05
:> 70.2853 RP.03 rrvR.04 ITRP.05 fYR.05 PHE.02 LE.Ol IPHE.02 LE.Ol
85 26.4832 TRP.03 ITYR.04 trRP.05 TYR.05 LE.03 VAL.02 LE.03 VAL.02
q45 66.9631 TYR.03 rrvR.04 trYR.02 fYR.05 PHE.02 LE.Ol IPHE.02 LE.OI
6432 79.46 HIS.03 ITYR.04 IHIS.02 TYR.05 HIS.03 VAL.02 II-IIS.02 VAL.02
11153 80.2421 LE.04 ~LA.OO LE.04 ALA. 00 HIS.03 [rRP.08 HIS.02 rRP.08
13041 73.9105 TYR.03 [rRP.08 trYR.02 TRP.08 LE.04 IALA.DO LE.04 ALA.DO
13233 98.6025 PHE.02 LE.O I IPHE.02 LE.OI HIS.03 PHE.05 HIS.02 PHE.05
Rotamers for bb2 Phe8ILeul6 (Layer Band B')
Rank
specificity;EABAB 8A 16A ~A 16A 8B 16B 8B 16B
61 59.3136 TRP.OS rn'R:04 TRP.03 TYR.04 PHE~OZ: LE.O I PHE.02 LE.OI
lIS 30.5791 TRP.QS ~.04 f1Wo3 TYR.04 1LE.04 VAL.02 LE.04 VAL.02
, .
188 114.38 PHE.02 PLU.23 PHE.02 '! GLU.26 .nP.OS m.04 ~.O3 TYR.04
"
1351 68.6267 "IS.03 TYR.04 RIS:03 rrYR.04 ~.02 ~AL.02 HIS.02 VAL.02
1886 60.30 trYR.02 TYR.04 1tYR.02 trYR.04 PHJ!:.b2'~ LE.O I PHE.02 LE.OI
14067 85.8107 LE.04 ALA.OO LE.04 IA0\.OO IfOS.03 .; trRP.07 "IS.02 trRP.08
14865 84.0482 frYR.02 TRP.07 m.02 ITRP.08 LE.04 [ALA.OO LE.04 IALA.QO
10706 102.431 PHE.02 LE.OI PHE.02 LE.OI JUS.03 IPHE.05 IHIS.02 IPHE.05
Table 1b. Rotamer conformations for the selection of layer Band B'. Based on probabilities in
the Dunbrack backbone-dependent rotamer library,rotamers that occur frequently in the PDB are
shown in color. If there were 10 or less rotamers in the library for an amino acid, rotamers with
probabilities below 0,1 were considered low-probability rotamers, For amino acids with greater
than 10 rotamers, rotamers with probabilities within the top quarter to half of rotamers for a
particular amino acid were considered high-probability, Rank refers to the solution's overall
rank relative to other solutions within the individual specificity selection, The energy function
consisted of VDW, EEF 1 solvation, and distance-dependent dielectric energy terms. EABAB
refers to the folded-state energy, so a more negative number indicates greater stability, To
calculate stabilityaccurately. the unfolded-state energy would need to be subtracted, but this
method provides a rough estimate. A and B do not refer to ACID and BASE, at this point in the
calculation.
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Leu12 Layer (Layer C)
bb1 Spec. Score bb2 Spec.
AlB AAAA-bb1 AAAA-bb2 BBBB-bb1 B888-bb2 ABAB-bb1 (Renk) Score (Renk)
PHEIALA 233.08 .'US -89.33 -87_ -105.49 354.74 (5) 397.93 (47)
TYRISER 230.60 299.66 .108.90 -97.82 -115.23 352.18( 9) 352.18 (9)
PHEIILE 233.08 287.35 -60.36 -49.11 -81.41 33357 (19) 396.52 (52)
TRP/ALA 265.92 -.02 -89.33 -78.47 -73.24 323.07(23) 661.48(1)
TRPISER 265.92 ~02 -108.90 ,87.82 -81.97 320.97(25) 661.17 (3)
PHEIMET 233.08 -106.07 -94.52 -94.58 316.19(29) 39295 (59)
TRPITHR 265.92 .105.30 -94.40 ~.97 292.56 (41) 651.07(5)
TRPnLE 230.59 -60.36 -49.11 -22.67 250.82 (66) 634.12(7)
PHEILEU 233.08 -93.93 -82.34 -52.36 243.89(69) 359.42(77)
Table 2a. Energies for layer C. Energies of undesired homotetramer states, desired
heterotetramer states, and specificity scores for both backbones are shown. The energy function
consisted of VDW, EEFI solvation, and distance-dependent dielectric energy terms. The
following equation was maximized: f = -2EABAB + EAAAA + EBBBB• EABAB, EAAAA, and EBBBB are
Efolded energies. A sequence predicted to be very specific for the heterotetramer has a large
positive specificity score. Rank refers to the solution's overall rank relative to other solutions
within the individual specificity selection. A and B do not refer to ACID and BASE, at this point
in the calculation.
Rotamers for bb2 Leu121Leu12 (Layer C) Rotamers for bbl Leu121Leu12 (Layer C)
HetE A A 8 8 HetE A A B B
-94.5293 PHE.o2 PHE.02 ALA.OO ALA.OO -10SA91 PHE.02 PHE.02 ALA.OO ALA.OO
-79.1424 PHE.02 PHE.02 ILE.03 ILE.08 -80.4182 PHE.02 PHE.02 ILE.08 ILE.08
-88.6506 TYR.02 TYR.02 VAL.Ol VAL.Ol -57.2019 TYR.02 TYR.02 VAL-OO VAL-OI
-108.983 TYR.02 TYR.02 SER.02 SER.02 -115.24 TYR.02 TYR.02 SER.OO SER.OI
Table 2b. Rotamer analysis of some of the top solutions from the initial selection for layer C.
Favorable rotamer conformations are shown in color. Based on probabilities in the Dunbrack
backbone-dependent rotamer library, rotamers that occur frequently in the PDB are shown in
color. If there were 10 or less rotamers in the library for an amino acid, rotamers with
probabilities below 0.1 were considered low-probability rotamers. For amino acids with greater
than 10 rotamers, rotamers with probabilities within the top quarter to half of rotamers for a
particular amino acid were considered high-probability. The energy function consisted of VDW,
EEFI solvation, and distance-dependent dielectric energy terms. EABAB refers to the folded-state
energy, so a more negative number indicates greater stability. To calculate stability accurately,
the unfolded-state energy would need to be subtracted, but this method provides a rough
estimate. A and B do not refer to ACID and BASE, at this point in the calculation.
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Pos 13
AIB AAAA-bbi AAAA-bb2 BBBB-bbi BBBB-bb2 ABAB-bbl ABAB-bb2 Spec bbl
lulLys -281.01 -293.63 -295.0054 -305.03 -290.45 -302.0694
-295.005 -305.03 -281.0173 -293.63 -290.45 .302.0679
-279.46 -291.01 -295.0054 -305.03 -288.68 -299.38
-295.01 -305.03 -279.4677 -291.01 -288.68 -299.38
-336.25 -336.25 -279.46 -291.01 -304.ot -314.66
-299.46 -291.01 -326.411 -336.25 -304.01 -314.66
lulA~ -281.01 -293.63 -326.411 -336.25 -304.73 -316.65
-326.4107 -336.25 -281.01 -293.63 -304.73 -316.65
Table 3. Design of position 13. Energies of undesired homotetramer states, desired
heterotetramer states, and specificity scores for both backbones are shown. The energy function
consisted of VDW, EEFI solvation, and distance-dependent dielectric energy terms. The
following equation was maximized: f = -2EABAB + EAAAA + EBBBB• EABAB, EAAAA, and EBBBB are
Efoldedenergies. A sequence predicted to be very specific for the heterotetramer has a large
positive specificity score. Rank refers to the solution's overall rank relative to other solutions
within the individual specificity selection. A and B do not refer to ACID and BASE, at this point
in the calculation.
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Spedtldly bbl Sprdlldly bb2
All/AIH BIlIBIH AAAA-bbi AAAA-bb2 BBBB-bbi BB1III-bb2 ABAB-bbl (rank) (rank)
11eILeu TrtYJlis -156.05 -199.68 -295.04 -316.83 -248.49 45.87 (I) 39.85 (385)
lie/Asp ArglArg -204.09 -230.39 -369.34 .3lII.19 -3011.33 4.1.22(23) 44.114(6)
lie/Asp LyslArg .204.09 .230.39 .34.-'-66 -354M1 -295.271 42.78(25) 44.ll1(7)
IleILys GlulGlu .295.04 .ns.51 .285.52 .334.76 .297.27 4O.8lI (4216) 4.5.977(1)
I'heffrp IkJSer -268.71 .181.78 -244.546 38.60(178)
Arg/Ser lle/Glu -321.06 -331.89 -208.57 -235.97 -283.96 38.28(203) 39.98(359)
LyslVaJ IIeIAsp .261.49 .273.09 -204.09 -230.39 -2.'11.63 37.68(264) 40.76(200)
Asnffrp IIeIGIn -306.18 -317.534 -209.06 .233.38 -275.46 35.68(819) 38.87(768)
GIuIAsp LyslLys .316.08 -330.23 .3 I5.ll .325.9 -324.91 17.93(3917) 18.07(3641)
GIuIGlu LyslLys -320.4.5 -334.76 .315.8 .325.1 .326.08 15.9(4051) 17.007(3701)
Asp/Asp LyslLys -304.71 -320.57 .315.8 -32.'1.8 -317.75 14.96(4142) 14.85(4004)
Table 4. Design of position 11 and 18. Energies of undesired homotetramer states, desired
heterotetramer states, and specificity scores for both backbones are shown. Salt-bridging pairs
are All/B18 and B1l/A18. The energy function consisted ofVDW, EEF1 solvation, and
distance-dependent dielectric energy terms. The following equation was maximized:
f = -2E ABAB +EAAAA +EBBBB' EABAB'EAAAA'and EBBBBare Efoldedenergies. A sequence
predicted to be very specific for the heterotetramer has a large positive specificity score. Rank
refers to the solution's overall rank relative to other solutions within the individual specificity
selection. A and B do not refer to ACID and BASE, at this point in the calculation.
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362 316.08 330.23 339.95 7.36
334.76 343.66 354.08 341.12 6.39
320.57 304.71 334.76 333.23 16.36
316.08 330.23 315.8 325.9 324.91 18.D7
369.33 380.29 320.46 354.08 353.31 14.89
320.45 334.76 325.8 325.8 326.08 17.01
315.8 320.57 325.8 325.8 317.75 14.85
Table 5. Energies for position 11 and 18 selection. Energies of undesired homotetramer states,
desired heterotetramer states, and specificity scores for both backbones are shown. Positions 11
and 18 were reselected with a restricted library. Salt-bridging pairs are All/B18 and BIl1A18.
The energy function consisted of VDW, EEFI solvation, and distance-dependent dielectric
energy terms. The following equation was maximized: f = -2E ABAB +EAAAA + EBBBB' EABAB,
EAAAA, and EBBBB are Erolded energies. A sequence predicted to be very specific for the
heterotetramer has a large positive specificity score. A and B do not refer to ACID and BASE, at
this point in the calculation.
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Spec-bbl Spec-bbl
AAAA-bbl AAAA-bb2 BBBB-bbl BBBB-bb2 ABAB-bbl Stability bbl
(rank) (rank)
PheJAla -132.63 -82.23 -460A9 -461.64 -492.69 392.25 (I) 426.62(5) 139.88
Trp/A1a -124.14 197.78 -460.49 -461.64 -466.74 348.86 (3) 689.31(1 ) 102.55
LeuIPhe -454.83 -475.70 -138.67 -82.23 -437.87 282.24 (5) 388.54(8) 87.43
Table 6. Results of final round 1 selection. The energy function consisted of VDW, EEFI
solvation, and distance-dependent dielectric energy terms. The following equation was
maximized for the specificity calculation: f = -2EA8A8 + EAAAA + E8888. EABAB, EAAAA, and
EBBBB are Efolded energies. A sequence predicted to be very specific for the heterotetramer has a
large positive specificity energy. The following equation is maximized for the stability
calculation: f = -Efolded + Eunfolded'so a large, positive stability energy indicates a stable
molecule. A and B refer to the ACID and BASE peptide.
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bbl
AAAA BBBB ABAB Spec-bbl (rank) Stability
Phe/Ala -138.67 -454.79 -492.41 391.38 (2) 139.61
PheILeu -138.67 -454.83 -437.88 282.26 (5) 87.44
LeuILeu -36\.98 -364.25 -376.63 27.03 134.82
Native ----------- ------------ ---------- ---------------- 91.84
bb2
AAAA BBBB ABAB SDec-bb2 (rank) Stability
Phe/Ala .96.29 -447.8 -485.25 426.40 (6) 133.97
PheILeu -96.29 -461.75 -473.28 388.53 (8) 124.42
LeuILeu -372.99 -371.39 -389.14 27.91 142.22
Native -------- --------- -------- -_ ......- ... ---_ ........ --- 90.83
Table 7. Final energies for round I. Energies of undesired homotetramer states, desired tetramer
states, specificity, stability. The energy function consisted of VDW, EEFI solvation, and
distance-dependent dielectric energy terms. The following equation was maximized:
f = - 2E ABAB + E AAM + E BBBB' EABAB, EAAAA, and EBBBB are Efoldedenergies. A sequence
predicted to be very specific for the heterotetramer has a large positive specificity score. The
following equation is maximized for the stability calculation: f = -E folded + Eunfolded ' SO a large,
positive stability energy indicates a stable molecule. A and B refer to the ACID and BASE
peptide.
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Leu12 AAAA-bbi BBBB-bbi ABAB-bbl Soecificitv-bbl Stabilitv-bbl
Phe/Ala -132.64 435.84 474.78 381.08(6)
129.68
Phe/Abu -132.64 438.57 476.68 382.15(2)
132.47
PhelNle -132.64 -443.64 478.93 381.58(4 )
135.1
Phe/Leu -132.64 -440.54 -422.06 270.95(8)
79.22
Leu12 AAAA-bb2 BBBB-bb2 ABAB-bb2 Soecificitv-bb2 Stability-bb2
Phe/Ala -96.29 -447.8 48S.2S 426.40 (4)
133.97
Phe/Abu -96.29 -449.02 -483.63 421.95 (7)
133.29
PhelNle -96.29 -456.41 -486.73 420.75 (11)
136.79
124.42
Phe/Leu -96.29 -461.75 -473.29 388.53 (348)
Table 8. The results of round 2 selection. Only the Base/Acid combination is shown in this
table. The energy function consisted of VDW, EEFI solvation, and distance-dependent
dielectric energy terms. The following equation was maximized: f = -2E ABA~ + E AAAA + E BBBB •
EABAB, EAAAA, and EBBBB are Efolded energies. A sequence predicted to be very specific for the
heterotetramer has a large positive specificity score. The following equation is maximized for
the stability calculation: f = -E folded+ Eunfolded' SO a large, positive stability energy indicates a
stable molecule. A and B refer to the ACID and BASE peptide.
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Backbone 1
A/B AAAA BBBB ABAB Specificity
A-AIa/B-Phe -454.7 -138.7 -492.4 391.4
A-Leu/B-Leu -364.3 -362.0 -376.6 26.9
Backbone 2
A/B AAAA BBBB ABAB Specificity
A-AIa/B-Phe -447.8 -96.3 -485.3 426.5
A-Leu/B-Leu -377.4 -373.0 -389.1 27.8
Table 9a. Energies of different complexes according to the energy function employed for
sequence selection. AAAA, BBBB, and ABAB are homotetramers and heterotetramers,
respectively, of the peptides indicated in the first column. The energies reported are Efold-Eunfold.
Specificity is defined as (EAAAA+EBBBB-2 EABAB) and is positive when the heterotetramer is
preferred. The B-Phe homotetramer is severely disfavored by steric clashes. The A-Ala
homotetramer is predicted to be more stable than the A-Leu homotetramer because the geometry
of Leu packing is non-ideal in these structures.
Backbone 1
A/B AAAA BBBB ABAB Specificity
A-Ala/B-Phe -439.1 -421.0 -485.3 109.8
A-Leu/B-Leu -467.5 -442.1 -474.8 40.0
Backbone 2
A/B AAAA BBBB ABAB Specificity
A-AIa/B-Phe -395.1 -366.6 -428.7 95.7
A-Leu/B-Leu -426.8 -423.0 -439.2 28.6
Table 9b. Refined energies of minimized complexes. Structures from the design calculations
were relaxed using ten steps of steepest decent minimization to relieve steric clashes of the side
chains. The backbone was fixed during minimization. Energies were evaluated included the
following terms for folded and unfolded states: 100% van der Waals energy with 100% radii
from CHARMM paraml9, 4/4 Coulomb interaction, 4/4 4/80 screening estimated by a
Generalized Born model, and EEF1 desolvation. Side-chain relaxation makes the energies of all
complexes more comparable, and the A-Leu homotetramer is now correctly predicted to be more
stable than the A-Ala homotetramer.
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12112 AAAA-bbi BBBB-bbi ABAB-bbl Specificily-bbI Slabilily-bbI
MTUABU 252.28 -355.63 -358.36 613.37 97.23
ABUIMTL -355.63 252.28 -358.34 613.31 97.21
MTUALA 252.28 -352.94 -355.92 611.18 93.89
ALAIMTL -352.94 252.28 -355.90 611.14 93.87
MTUNLE 252.28 -360.67 -359.37 610.35 98.65
NLElMTL -360.67 252.28 -359.35 610.31 98.63
TOUALA 40.51 -352.94 -363.80 415.17 100.37
ALAffOL -352.94 40.51 -363.78 415.14 100.35
OTUABU -13.70 -355.63 -370.69 372.05 113.26
ABUIOTL -355.63 -13.70 -370.69 372.04 113.25
OTUNLE -13.70 -360.67 -372.00 371.63 115.97
NLEJOTL -360.67 -13.70 -372.99 371.62 115.96
OTUALA -13.70 -352.94 -368.79 370.95 110.45
ALA/OTL -352.94 -13.70 -368.79 370.95 110.45
PHE/ABU -30.50 -355.63 -370.97 355.80 109.01
ABU/PHE -355.63 -30.50 -370.96 355.79 109.00
PHEJNLE -30.50 -360.67 -373.16 355.15 111.60
NLEJPHE -360.67 -30.50 -373.15 355.14 111.60
PHEJALA -30.50 -352.94 -369.09 354.74 106.22
ALAIPHE -352.94 -30.50 -369.08 354.73 106.22
TOUABU 40.51 -355.63 -325.15 335.17 62.62
ABUrrOL -355.63 40.51 -325.14 335.16 62.62
TOUNLE 40.51 -360.67 -325.85 331.54 63.73
NLEJTOL -360.67 40.51 -325.84 331.53 63.72
Table lOa. Round 3 results for position 12 with one backbone, bbl. The energy function
consisted ofVDW, EEFI solvation, and distance-dependent dielectric energy terms. The
following equation was maximized: f = -2E ABAB + E AAAA + E BBBB. EABAB' EAAAA' and EBBBB are
Efolded energies. A sequence predicted to be very specific for the heterotetramer has a large
positive specificityscore. The following equation is maximized for the stabilitycalculation:
f = -E folded + Eunfolded ' SO a large, positive stabilityenergy indicates a stable molecule. A and B
refer to the ACID and BASE peptide. The round 2 peptide is shown in italics,and the peptides
tested in round 3 are in bold.
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Specificity-bb2
12/12 AAAA-bb2 BBBB-bb2 ABAB-bb2 (rank) Stability-bb2
MTUALA 1093.97 414.16 419.30 1518.40(1) I08A6
ALA/MTL 414.16 1093.97 419.22 1518.24(2) 108.37
MTUABU 1093.97 415.30 418.14 1514.94(3) 108.23
ABU/MTL 415.30 1093.97 418.05 1514.76(4) 108.14
MTUNLE 1093.97 422.63 -418.73 1508.79(5) 109.23
NLElMTL -422.63 1093.97 -418.64 1508.62(6) 109.14
TOUALA 21.39 -414.16 -431.03 469.28(9) 118.78
ALAITOL -414.16 21.39 -431.02 469.27(10) 118.77
TOUABU 21.39 -415.30 -418.13 442.35(11) 106.82
ABUrrOL -415.30 21.39 -418.11 442.32(12) 106.80
TOUNLE 21.39 422.63 -417.19 433.13(13) 106.28
NLEffOL -422.63 21.39 -417.17 433.11(14) 106.27
ALA/OTL -414.16 -36.05 -430.19 410.17(15) 123.05
OTUALA -36.05 414.16 -430.19 410.17(16) 123.05
OTUABU -36.05 -415.30 -428.49 405.63(17) 122.28
ABU/OTL -415.30 -36.05 -428.48 405.62(18) 122.28
OTUNLE -36.05 422.63 -431.51 404.33(19) 125.71
NLEIOTL 422.63 -36.05 -431.50 404.32(20) 125.70
PHEIALA -48.24 414.16 -430.17 397.93(21) 118.49
ALA/PHE 414.16 -48.24 -430.16 397.93(22) 118.48
PHEIABU -48.24 -415.30 -428.50 393.47(23) 117.75
ABUIPHE -415.30 -48.24 -428.49 393.45(24) 117.74
PHEfNLE 48.24 422.63 -431.55 392.22(25) 121.21
NLEIPHE -422.63 -48.24 -431.54 392.20(26) 121.20
Table lOb. Round 3 results for position 12 with one backbone, bb2. The energy function
consisted of VDW, EEFI solvation, and distance-dependent dielectric energy terms. The
following equation was maximized: f = -2EABAB +EAAM + EBBBB• EABAB, EAAAA, and EBBBB are
Efolded energies. A sequence predicted to be very specific for the heterotetramer has a large
positive specificity score. The following equation is maximized for the stability calculation:
f = -Ejolded + Eunfolded' so a large, positive stability energy indicates a stable molecule. A and B
refer to the ACID and BASE peptide. The round 2 peptide is shown in italics, and the peptides
tested in round 3 are in bold.
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Specificity-bb 1
13/13 AAAA-bbl BBBB-bbl ABAB-bbl (rank) Stabilitv-bb 1
GLUILYS -281.02 -295.01 -290.46 4.89(2) 94.75
LYSIGLU -295.01 -281.02 .290.46 4.89(1) 94.75
GLUIORN -281.02 -258.71 -271.11 2.49(6) 93.40
ORN/GLU -258.71 -281.02 -271.11 2.49(5) 93.40
GLUIDAB -281.02 -255.25 -269.30 2.33(12) 92.52
DAB/GLU -255.25 -281.02 -269.30 2.33(11) 92.52
ARGIGLU -326.41 -281.02 -304.73 2.04 (16) 93.18
GLU/ARG -281.02 -326.41 -304.74 2.04 (15) 93.18
13113 AAAA-bb2 BBBB-bb2 ABAB-bb2 Specificity-bb2 Stabilitv-bb2
LYSIGLU -305.G4 -m.64 -302.07 5.47(1) 107.26
GLUILYS -m.64 -305.03 • -302.07 5.47(2) 107.26
ARGIGLU -336.25 -293.64 -314.66 3.41(3) 105.96
GLUIARG -293.64 -336.25 -314.66 3.41(4) 105.96
ORN/GLU -268.06 -293.64 -299.39 2.41(9) 105.23
GLUIORN -293.64 -268.06 -299.38 2.41(10) 105.23
GLUIDAB -293.64 , -265.14 -279.23 2.28(14) 104.61
DAB/GLU -265.14 -293.64 -279.23 2.28(13) 104.61
Table 11. Round 3 results for position 13 with both backbones. The energy function consisted
of VDW, EEFI solvation, and distance-dependent dielectric energy terms. The following
equation was maximized: f = -2E ABAB + E AAAA + E BBBB. EABAB, EAAAA, and EBBBB are Brolded
energies. A sequence predicted to be very specific for the heterotetramer has a large positive
specificity score. The following equation is maximized for the stabilitycalculation:
f = -Ejolded + Ewifolded'so a large, positive stabilityenergy indicates a stable molecule. A and B
refer to the ACID and BASE peptide.
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11/18 11/18 AAAA-bb1 BBBB-bb1 ABAB-bb1 Specificitv-bb 1 Stabi1ity-bb 1
GLU/ASP LYSILYS -316.08 -315.80 -324.91 17.93(11) 100.04
LYSILYS GLU/ASP -315.80 -316.08 -324.91 17.93(12) 100.04
GLU/ASP ARG/ARG -316.08 -369.34 -351.36 17.31(13) 94.72
ARG/ARG GLU/ASP -369.34 -316.08 -351.36 17.31(14) 94.72
ORN/DAB GLUIASP -235.00 -316.08 -283.39 15.69(35) 95.56
GLU/ASP ORN/DAB -316.08 -235.00 -283.38 15.68(36) 95.56
GLUIASP DAB/DAB -316.08 -229.79 -280.53 15.19(45) 93.47
DABIDAB GLUIASP -229.79 -316.08 -280.52 15.17(46) 93.47
ORN/ORN GLUIASP -238.83 -316.08 -285.oI 15.11(51) 96.14
GLU/ASP ORN/ORN -316.08 -238.83 -284.00 15.09(52) 96.14
11/18 11/18 AAAA-bb2 BBBB-bb2 ABAB-bb2 Specificity-bb2 Stabilitv-bb2
GLU/ASP LYSILYS -330.23 -325.91 -337.11 18.07(3) 114.48
LYSILYS GLU/ASP -325.91 -330.23 -337.10 18.05(4) 107.27
GLU/ASP ORNIDAB -330.23 -244A9 -295.76 16.79(11) 110.10
ORNIDAB GLU/ASP -244A9 -330.23 -29!.75 16.79(12) 110.10
ARG/ARG GLU/ASP -380.29 -330.23 -363.09 15.66(39) 108.72
GLUIASP ORN/ORN -330.23 -248.75 -297.21 15.44(41) 110.58
ORN/ORN GLUIASP -248.75 -330.23 -297.21 15.43(42) 110.58
GLUIASP DABIDAB -330.23 -240.65 -292.66 14.43(68) 107.89
DABIDAB GLUIASP -240.65 -330.23 -292.66 14.43(69) 107.89
GLUIASP ARGIARG -330.23 -380.29 -359.59 13.20(95) 108.72
Table 12. Round 3 results for positions 11 and 18 with both backbones. The energy function
consisted ofVDW, EEFI solvation, and distance-dependent dielectricenergy terms. The
following equation was maximized: f = -2EABAB + EAAAA + EBBBB• EABAB, EAAAA, and EBBBB are
Efolded energies. A sequence predicted to be very specific for the heterotetramer has a large
positive specificityscore. The following equation is maximized for the stabilitycalculation:
f = -E fold~d+ Eunfold~d'so a large,positive stabilityenergy indicates a stable molecule. A and B
refer to the ACID and BASE peptide.
210
Pos II, 13, 18 Pos II, 13, 18 Pos 12 AAAA-bbi BBBB-bb1 ABAB-bbl Specificitv-bbI Stabilitv-bbI
LYSlLYSILYS GLU/GLU/ASP MTUABU 149.48 -438.5S -464.53 639.96(4) 109.30
LYSlLYSILYS GLU/GLU/ASP MTUALA 149.48 -435.84 -461.06 637.76(14) 105.93
LYSlLYSlLYS GLUlGLUlASP TOUALA -61.76 -435.84 -469.59 441.57(112) 112.06
L YSiLYSIL YS GLU/GLUI ASP OTUABU -1l7.12 -438.58 -477.19 398.68(149) 125.65
LYSlLYSlLYS GLUIGLUI ASP OTUALA -1l7.12 -435.84 -475.27 397.57(16)) 122.83
..
382.16(2301LYSlLYSlLYS GWIGLUIASP PRE/ABU -132.64 -438.58 -476.69 120.63
LYSlLYSILYS GLUIGLUIASP PHF/ALA -132.64 -435.84 -474.78 381.08(243) 117.81
LYSlLYSlLYS GLUIGLU/ASP TOUABU -61.76 -438.58 -431.18 362.03(349) 74.56
ORNILYSIORN GLU/GLU/ASP MTUABU 226.24 -438.5S -424.64 636.94(22) 105.41
ORNILYSIORN GLU/GLU/ASP MTUALA 226.24 -435.84 -422.17 634.75(48) 102.05
ORNILYSIORN GLUlGLUlASP TOUALA 15.00 -435.84 -429.70 438.56(20) 108.17
ORNILYSIORN GLUlGLUlASP OTUABU -40.36 -438.58 -437.30 395.67(175) 121.77
ORNILYSiORN GLU/GLUIASP OTUALA -40.36 -435.84 -435.38 394.56(190) 118.94
ORNILYSIORN GLU/GLU/ASP PHFJABU -55.88 -438.5S -436.80 379.14(262) 116.74
ORNILYSIORN GLU/GLU/ASP PHFJALA -55.88 -435.84 -434.90 37S.()6(286) 113.93
ORNILYSiORN GLU/GLUIASP TOUABU 15.00 -438.58 -391.30 359.02(371 ) 70.67
ORNIL YSIDAB GLU/GLU/ASP MTUABU 230.00 -438.5S -422.96 637.34(17) 104.7S
ORNIL YSIDAB GLU/GLUIASP MTUALA 230.00 -435.84 -420.50 635.15(45) 101.41
ORNILYSIDAB GLUlGLUlASP TOUALA 18.76 -435.84 -428.02 438.96(118) 107.53
ORNILYSIDAB GLUlGLUlASP OTUABU -36.60 -438.58 -435.62 396.07(172) 121.13
ORNILYSIDAB GLUIGLUIASP OTUALA -36.60 -435.84 -433.70 394.96(184) 118.30
ORNILYSIDAB GLU/GLU/ASP PHFJABU -52.12 -438.5S -435.12 379.54(25S) 116.10
ORNILYSIDAB GLU/GLU/ASP PHFJALA -52.12 -435.84 -433.22 37S.47(275) 113.29
ORNILYSIDAB GLU/GLUIASP TOUABU 18.76 -438.58 -389.61 359.42(369) 70.03
Table 13a. Complete round 3 selection with positions 11, 12, 13, and 18 with bb 1. The energy
function consisted of VDW, EEFI solvation, and distance-dependent dielectricenergy terms.
The following equation was maximized: f = -2EABAB +EAAAA +EBBBB. EABAB, EAAAA' and
EBBBB are Erolded energies. A sequence predicted to be very specific for the heterotetramer has a
large positive specificityscore. The following equation is maximized for the stability
calculation: f = -Efolded + EUnfoldtd ' so a large, positive stabilityenergy indicates a stable
molecule. A and B refer to the ACID and BASE peptide. The round 2 peptide is shown in
italics,and the peptides tested in round 3 are in bold.
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Pas II, 13. 18 Pas I\, 13. 18 Pas 12 AAAA-bb2 BBBB-bb2 ABAB-bb2 Specificitv-bb2 Stabilities-bb2
LYSlLYSILYS GLU/GLU/ASP MTI.JALA 690.6352 -447.8011 -474.6799 1192.19392(1 ) 120.55314
LYSlLYSILYS GLU/GLU/ASP MTI.JABU 690.6352 -449.0266 -473.5395 1188.68754(15) 120.3411
LYSlLYSlLYS GLU/GLUI ASP TOUALA -22.9095 -447.8011 -486.1679 501.62526(109) 130.65541
LYSlLYSlLYS GLU/GLUIASP TOUABU -22.9095 -449.0266 -473.3273 474.71856(136) 118.7432
LYSlLYSlLYS GLU/GLUI ASP OTUALA -81.4939 -447.8011 -486.0323 442.76969(190) 135.57483
LYSlLYSlLYS GLU/GLUI ASP OTUABU -81.4939 -449.0266 -484.3858 438.25111(210) 134.85669
LYSlLYSlLYS GLUIGLUI ASP PHFJALA -96.2967 -447.8011 -485.2504 426.40309(271) 130.16659
LYSlLYSlLYS GLUIGLUIASP PRE/ABU -96.2967 -449.0266 -483.6387 421.95417(290) 129.48328
ORNIL YSiORN GLU/GLU/ASP MTI.JALA 768.0355 -447.8011 -434.9324 1190.09921(6) 116.79741
ORNIL YSiORN GLU/GLU/ASP MTUABU 768.0355 -449.0266 -433.7902 1186.58938(29) 116.58364
ORNIL YSIORN GLUlGLUlASP TOUALA 54.5479 -447.8011 -446.4202 499.58727(114) 126.89955
ORNIL YSIORN GLUlGLUlASP TOUABU 54.5479 -449.0266 -433.5781 472.67755(141) 114.98583
ORNIL YSIORN GLUlGLUlASP OTUALA -4.0414 -447.8011 -446.2847 440.72698(195) 131.81903
ORNIL YSIORN GLUIGLUI ASP OTUABU -4.0414 -449.0266 -444.6369 436.20587(225) 131.09962
ORNIL YSiORN GLU/GLU/ASP PHEIALA -19.1217 -447.8011 -445.532 424.14135(276) 126A3999
ORNIL YSiORN GLU/GLUIASP PHFJABU -19.1217 -449.0266 -443.9191 419.6899(306) 125.75541
ORNIL YSIDAB GLU/GLU/ASP MTI.JALA 772.2246 -447.8011 -433A433 1191.31014(4) 116.28679
ORNIL YSIDAB GLU/GLU/ASP MTUABU 772.2246 -449.0266 -432.3 1187.79789(23) 116.07181
ORNIL YSIDAB GLUlGLUlASP TOUALA 58.7488 -447.8011 -444.9317 500.8111(112) 126.38945
ORNIL YSIDAB GLUlGLUlASP TOUABU 58.7488 -449.0266 -432.0887 473.89956(139) 114.47483
ORNIL YSIDAB GLUIGLUI ASP OTUALA 0.1596 -447.8011 -444.7957 441.94998(193) 131.30846
ORNIL YSIDAB GLUIGLUI ASP OTUABU 0.1596 -449.0266 -443.1472 437.42737(216) 130.58831
ORNILYSIDAB GLU/GLU/ASP PHFJALA -14.9669 -447.8011 -444.0782 425.38841(274) 125.96461
ORNIL YSIDAB GLU/GLU/ASP PHFJABU -14.9669 -449.0266 -442A645 420.93547(297) 125.27928
Table 13b. Complete round 3 selection with positions 11, 12, 13, and 18 with bb2. The energy
function consisted ofVDW, EEFI solvation, and distance-dependent dielectric energy terms.
The following equation was maximized: f:: -2EABAB +EAAAA +EBBBB' EABAB, EAAAA, and
EBBBB are Eralded energies. A sequence predicted to be very specific for the heterotetramer has a
large positive specificity score. The following equation is maximized for the stability
calculation: f:: -E folded + Eun/olded ' SO a large, positive stability energy indicates a stable
molecule. A and B refer to the ACID and BASE peptide. The round 2 peptide is shown in
italics, and the peptides tested in round 3 are in bold.
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- hairpin -- helix
Peptide 123 456 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
B3 Ac Y R I P S Y D F a D R F K K L L R R A Z G NH2
B4 Ac Y R I P S Y D F a D Om F K K L L R Om A Z G NH2
B5 Ac Y R I P S Y D F a D Om F K K L L R Dab A Z G NH2
B6 Ac Y R I P S Y D F a D K MIl K K L L R K A Z G NH2
B7 Ac Y R I P S Y D F a D Om Mil K K L L R Om A Z G NH2
B8 Ac Y R I P S Y D F a D Om Mil K K L L R Dab A Z G NH2
Table 14. Sequences of B3, B4, B5, B6, B7, and B8. Abbreviations: p=D-proline, a = D-alanine,
Z= benzoylated L-a.,f3-diaminopropionic acid, Mtl= m-methylphenylalanine, Dab= L-a.,f3-
diaminobutyric acid (adapted from (13)).
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Peptide B3 B4 B5 B6 B7 B8Peptide
All Data
NONLIN 2.9 3.2 3.3 3.3 3.6 3.7
SEDPHAT 3.0 3.4 3.5 3.5 3.7 3.8
Lowest Concentration Data
NONLIN 2.0 3.4 3.2 2.8 4.0 4.8
SEDPHAT 1.7 3.4 3.1 2.7 3.0 4.5
Table 15. Results of AUC experiments with peptides from round 3. Stoichiometries reported
correspond to the weight-average molecular weight found by NONLIN or SEDPHAT.
1. Peptide concentrations are B3: 100, 300, 600 /M, B4: 200, 600, 1000 M, B5: 100, 300, 600
/xM, B6: 50, 300, 700, B7: 50, 500, 1000 M, B8: 50, 300, 600 M (adapted from (13)). This
experiment was run by Mayssam Ali.
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FIGURES
Layer A
Layer B
LayerC
Layer B'
Layer A'
Figure 1. BBA homotetramer crystal structure. The BBA core consists of five palindromic
layers (A, B, C, B', and A'). The layers are shown above: A and A' (DapBz/Ile), Band B'
(PhelLeu), and C (LeulLeu).
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Serine L-C-aminobutyric acid (Abu)
HN 0
H2!
N
OH
CH3
CH 3
Methionine 2-aminohexanoic acid (Nle)
Figure 2. Structures of amino acids analyzed in round 2 for their potential to stabilize the
heterotetramer.
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CH3
3-methyl-L-phenylalanine (Mtl) 2-methyl-L-phenylalanine (Otl)
Figure 3. Structures of amino acids evaluated in round 3 for their potential to add additional
specificity in the core.
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H,
OH
L-ornithine (Orn)
H
2,4-diaminobutyric acid (Dab)
Figure 4. Structures of amino acids evaluated in round 3 for their potential to add additional
specificity on the surface.
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Figure 5. CD spectra of peptides designed in round 3 alone and in combination with A-Ala
(A2) and A-Abu (A3). All spectra are compared to A3-B2 (A-Abu/B-Phe). A: Peptide B3. B:
Peptide B4. C: Peptide B5. D: Peptide B6. E: Peptide B7. F: Peptide B8. (Taken from (13)).
These experiments were run by Mayssam AlL
J
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APPENDIX B
Allosteric Inhibition of Zinc-Finger Binding in
the Major Groove of DNA by Minor-Groove
Binding Ligands
Reprinted from:
I)oan H. Nguyen-Hackley, Elizabeth Ramm, Christina M. Taylor, J. Keith Joung, Peter B.
I)ervan, and Carl O. Pabo. Biochemistry (2004), 43(13), 3880-3890.
C.M.T. did the computer modeling section, some of the protein purification, and helped with the
gel shift assays.
221
ABSTRACT
In recent years, two methods have been developed that may eventually allow the targeted
regulation of a broad repertoire of genes. The engineered protein strategy involves selecting
Cys2His2 zinc finger proteins that will recognize specific sites in the major groove of DNA. The
small molecule approach utilizes pairing rules for pyrrole-imidazole polyamides that target
specific sites in the minor groove. To understand how these two methods might complement
each other, we have begun exploring how polyamides and zinc fingers interact when they bind
the same site on opposite grooves of DNA. Although structural comparisons show no obvious
source of van der Waals collisions, we have found a significant "negative cooperativity" when
the two classes of compounds are directed to the overlapping sites. Examining available crystal
structures suggests that this may reflect differences in the precise DNA conformation, especially
with regard to width and depth of the grooves, that is preferred for binding. These results may
give new insights into the structural requirements for zinc finger and polyamide binding and may
eventually lead to the development of even more powerful and flexible schemes for regulating
gene expression.
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INTRODUCTION
Recent developments in the design and selection of Cys2His2 zinc fingers (1, 2) and in the
design of novel polyamides (3, 4) suggest that each method can be used to target specific sites in
the genome. Cys2His2 zinc finger proteins, in which each domain contains 28-30 amino acid
residues, are the most common DNA-binding motif in higher eukaryotes. Each zinc finger has a
conserved Bloc motif, and amino acids near the N-terminus of the a-helix contact bases in the
major groove of B-DNA (2, 5-7). The X-ray crystal structure of the three-finger Zif268 protein
(Figure A, refs 6, 7) illustrates the basic features of recognition and has provided the basis for
most of the subsequent work in this field. The Cys2His2 zinc finger framework appears to be
very adaptable, and specific variants have been selected that bind to many different desired target
sites in duplex DNA (8-11).
Another strategy for recognition and regulation has been developed that uses polyamides
consisting of N--methylpyrrole (y)l and N-methylimidazole (Im) rings, which can be linked
together to recognize a predetermined DNA sequence (3, 4). Sequence-specific polyamide-DNA
recognition depends on binding in the minor groove with side-by-side amino acid pairings.
Simple rules were developed for designing polyamides that can target desired DNA sequences
(4). These rules have been carefully validated through characterization of synthesized
polyamides via DNase I footprinting, affinity cleavage, two-dimensional nuclear magnetic
resonance (NMR) (12), and X-ray crystallographic methods (13-15). To illustrate the docking
arrangement, Figure B shows the X-ray crystal structure of a polyamide (15) bound in the
minor groove of B-DNA.
In this work, we have begun studies to investigate how polyamides and zinc fingers may
interact as they bind to overlapping sites on double-stranded DNA. Earlier studies have explored
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how polyamides interfere with the binding of several classes of transcription factors (16-23).
Polyamides have inhibited minor-groove binding proteins such as TATA-binding protein (TBP),
as well as minor groove contacting proteins like the lymphoid enhancer factor (LEF-1) (17). In
the case of the purely major-groove binding protein GCN4, polyamides were clearly shown to
co-occupy in the minor groove of the GCN4 binding site (21). An extended Arg-Pro-Arg
tripeptide attached to a polyamide did inhibit GCN4 binding by neutralizing a phosphate contact
made by the protein with the DNA backbone (22). Polyamides have been shown to inhibit the
binding of a zinc finger protein, TFIIIA (16, 20). However, inhibition of this zinc finger protein
was the result of the polyamide being targeted to and displacing the minor-groove-spanning
fourth finger of the nine-finger protein. Therefore, studies to date on polyamide/protein
interactions would suggest that an unmodified polyamide should co-occupy the minor groove
face of a purely major groove zinc finger protein binding site.
In this study, the interaction of polyamides and zinc fingers that bind to opposing grooves
of the same DNA target site was explored. The zinc finger proteins chosen for this study
included Zif268 and a set of Zif268 variants that had been selected to recognize rather different
DNA sequences (9). These three other variants had been selected to recognize the TATA box,
the nuclear receptor element, and the p53 binding sites, and they are referred to (respectively) as
TATAZF, NREzF, and p53 ZF. All these proteins bind their sites with nanomolar dissociation
constants, recognizing sites in the DNA major groove and discriminating effectively against
nonspecific DNA (9, 24). For this project, polyamides 1-4 were designed to specifically target
the very same TATA, NRE, p53, and Zif268 binding sites. These hairpin polyamides bind their
sites with at least nanomolar dissociation constants, as determined by quantitative DNase I
footprinting experiments (25-28). Biochemical studies, using gel mobility shift experiments and
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DNase I analysis, give information about how these compounds interact as they bind. Computer
modeling based on previous structural studies of zinc finger-DNA and polyamide-DNA
complexes help us to interpret these results.
MATERIALS AND METHODS
Protein Production and Purification
The Zif268 zinc finger region (residues 333-421) was subcloned into a pET-21d
expression vector (Novagen) and was transformed into the Escherichia coli strain BL21(DE3)
containing the pLysE plasmid. Cultures were grown and induced as described (Novagen). After
the cells were harvested, they were lysed and sonicated as recommended (Novagen). The
peptides were denatured and reduced in 6.4 M guanidineHCl, 150 mM DTT, and 50 mM Tris-
HCl, pH 8.0, at 75 °C for 30 min and acidified to pH - 2.0 by addition of 10% trifluoroacetic
acid (TFA). The peptides were purified by reverse-phase batch extraction on Sep-pack C-18
cartridges (Waters) as described (29), followed by purification on a C4 reversed-phase (Vydac)
high-performance liquid chromatography column using a gradient of 22-35% acetonitrile (ACN)
containing 0.1% TFA. The purified peptide fractions were then refolded anaerobically in the
binding buffer that we used for gel shifts, after supplementing it with a 0.5 M excess of ZnCl2.
Refolded peptides were stored at -80 °C in 10 gL aliquots; each aliquot was used once for
binding studies and then discarded. The active concentrations of peptides were determined in
stoichiometric competition experiments.
TATAzF, NREzF, and p5 3zF zinc finger peptides, selected from residues 333-421 of
Zif268 (24), used in these studies were purified by Scot A. Wolfe, Robert Grant, and Sandra Fay-
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Richard, respectively. Since they were preparing these samples for crystallographic studies, they
used several additional purification steps, essentially as described (30).
Hairpin Polyamide Syntheses and Characterization
The pyrrole-imidazole hairpin polyamides 1-4 were prepared by manual and machine-
assisted solid-phase methods (31) (Figures 2 and 3). Purity and identity of each compound were
verified by a combination of analytical HPLC, 1H NMR, and matrix-assisted laser desorption
ionization time-of-flight mass spectrometry (MALDI-TOF). Polyamides 1-3 have been
described previously (32, 33) and polyamide 4, Pylm-[-Im-(R)H2N-PymPyPy-P-Dp, is
described here: UV (H20) Xmx,304 (60 800); MALDI-TOF MS 1230.65 (1230.59 calcd for [M +
H] C 55H 72N 230 1l). Lyophilized samples of polyamides were stored in at -80 °C. Polyamide
concentrations were determined spectrophotometrically with extinction coefficients estimated
based on the number of aromatic rings using the relation 8690 M- l cm-' per aromatic ring for the
absorption maximum at 290-315 nM (28).
Gel Mobility Shift Assay
Double-stranded oligonucleotides used for gel mobility shift assays were essentially
identical to DNA sites used (9) when selecting the TATAZF, NREzF, and P53zF zinc finger
proteins. A few nucleotides in the sequence flanking the zinc finger binding sites also were
changed so that the zinc fingers and polyamides would have overlapping binding sites. The 27
bp DNA duplexes that were used for gel mobility shift assays are boxed in Figure 4, and the nine
base pair zinc finger target sites near the center of each duplex are underlined. (Note that in the
form shown in Figure 4, 27 bp duplexes are embedded within larger DNA segments that were
later used for footprinting studies.) The oligonucleotide binding site for wt Zif268 was slightly
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different from that used by Greisman et al. (9) containing GCGGGGGCG rather than
GCGTGGGCG. However, this construct was advantageous because it readily provided an
overlapping polyamide binding site and should have no other effect. (Zif268 binds extremely
well to either site and there is no direct contact with this base in the crystal structure (6)). Each
27 bp strand of these binding sites was synthesized using standard phosphoramidite chemistry on
an Applied Biosystems model 392 DNA synthesizer. Following deprotection, oligonucleotides
were purified by denaturing polyacrylamide gel electrophoresis. Duplexes were annealed and
quantified, and then 0.3 pmol of each DNA fragment were end-labeled with [a-32P]-ATP (New
England Biolabs) using Klenow exo- to fill-in the overhangs. Unincorporated nucleotides were
removed by use of Sephadex G-25 quick spin columns (Boehringer Mannheim), and the DNA
was resuspended in 1 mL of the buffer used for all gel shift experiments, which contained 5 mM
HEPES, pH 7.8, 50 mM KCl, 50 mM KGlu, 50 tM KoAc, 5 mM MgCl2, 5% glycerol, 0.1% NP-
40, 20 ptM ZnSO4, 100 tg/mL BSA, 1 mM CaCl2, and 1 mM DTT. The nucleotides were stored
at -20 °C.
Using the buffer above, we performed binding reactions and equilibrium binding studies
for zinc finger proteins in both the presence and absence of polyamides. Zinc finger dissociation
constants were determined as previously described (9), except that 0.5 pM of labeled duplex
DNA was used and equilibration was done at room temperature for 16-18 h for all gel shift
experiments. The reaction mixtures were then subjected to 12% native polyacrylamide gel
electrophoresis for about 2 h with 0.5x TBE running buffer. Radioactive signals were
quantitated by PhosphorImage analysis (Molecular Dynamics).
Equilibrium dissociation constants (KD's) were determined by linear regression using the
Scatchard equation:
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O/[P] = /KD- O/KD (1)
in which E) equals the fraction of DNA bound ([PD]/([PD] + [D])), and [P] equals the free
protein concentration (after applying corrections to account for the percent of the protein that
was active for DNA binding).
DNase I Footprinting
Oligonucleotides used for footprinting experiments (Figure 4) were designed so that they
included the sequences of the 27 bp duplexes that had been used for gel mobility shift assays,
and additional six to seven base pair "spacers" were added so that the protein-binding sites would
be slightly further apart. Oligonucleotide 1 contains binding sites for TATAzF, NREzF, and
p5 3 ZF; oligonucleotide 2 contains binding sites for Zif268, TATAzF, and p5 3zF. The synthetic
duplexes were designed such that the ends were ready for cloning into a pBluescript II SK(+)
plasmid (Stratagene) that had been cut with EcoRI and BamHI. After growth in E. coli, DNA
probes for footprinting were prepared by digestion of the appropriate plasmids with EcoRI and
NotI restriction enzymes, giving a 134 bp fragment for oligonucleotide 1 and a 143 bp fragment
for oligonucleotide 2. After digestion, these DNA fragments were radioactively labeled by using
Klenow enzyme (New England Biolabs) and a-32P labeled nucleotides to fill in the overhanging
ends. The labeled oligonucleotides were purified using 5% native PAGE, were precipitated with
EtOH, and were counted for specific activity.
Footprinting experiments were done essentially as previously described (25-28).
Quantitative footprinting for polyamides 1-4 was performed using the appropriate restriction
fragment (oligonucleotide 1 or 2) in triplicate under both conventional TKMC buffer (10 mM
Tris-HCl (pH 7.0), 10 mM KCl, 10 mM MgCl2, and 5 mM CaC12) and the same binding buffer
used in the gel shift experiments. Polyamide/DNA solutions were allowed to equilibrate at 22
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°C for 16-18 h. Footprinting reactions were initiated by the addition of the appropriate amount
of DNase I to give -50% intact DNA and allowed to proceed for 7 min at 22 °C. The reactions
were stopped by addition of 50 iL of a solution containing 1.25 M NaCl, 100 mM EDTA, 0.2
mg/mL glycogen, and 28 pM base-pair calf thymus DNA and ethanol precipitated. The
reactions were resuspended in 1 tL of TBE/80% formamide loading buffer, denatured by
heating at 80 °C for 10 min, and placed on ice. The reaction products were separated by
electrophoresis. Radioactive signals were visualized with a Molecular Dynamics Typhoon
phosphorimager followed by quantitation using ImageQuant software (Molecular Dynamics).
Equilibrium association constants for the polyamides were calculated as previously described
(29) and found to be identical in both TKMC buffer and the gel shift buffering conditions.
Computer Modeling Experiments
Structures of polyamide-DNA complexes were taken from the Protein Data Bank (13-15)
and were compared with known zinc finger-DNA complexes for TATAzF (34), p53zF (35), and
Zif268 (6). The structures were aligned (using the PROTEUS Program (36)) via phosphorus
atoms, C 1' atoms, or common atoms in the set of superimposed base pairs. Several different
alignment strategies were tested, including schemes in which (1) the entire zinc finger DNA
binding site was aligned with the polyamide DNA, (2) the polyamide binding sites in the known
polyamide-DNA structures were aligned with the expected polyamide binding sites on the zinc
finger DNA, (3) the GC or AT base pair in the polyamide-DNA structure was aligned with the
corresponding base pair in the DNA-zinc finger structure, or (4) all the common atoms in a base
pair were aligned. The RMS deviation was noted for each of the alignments, and a visual
inspection of the alignment was made using Insight (37).
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As another strategy for comparison of the DNA structures, Curves (38) was run on all the
polyamide-DNA complexes and all the zinc finger-DNA complexes. In addition, Curves also
was run on B-DNA (39). Comparisons of the output from Curves focused on the width and
depth of the major and minor grooves and on base pair parameters such as buckle, shear,
propeller twist, opening, and X and Y displacement. For major and minor groove comparisons,
the groove dimensions were taken from (1) the region of the polyamide-DNA complex closest to
the polyamide binding site and (2) the region on the zinc finger-DNA complex that was closest
to the expected polyamide binding site present in our experiments. The average of the buckle,
shear, propeller twist, and opening parameters were taken from the global base-base parameter
output of Curves. Parameters for individual base pairs were also compared separately.
RESULTS
Gel mobility shift experiments and DNase I footprinting experiments were used to
analyze binding of the zinc finger proteins, binding of polyamides, and interactions between the
zinc fingers and the match polyamides that recognized overlapping sites. In competition studies,
control experiments also were performed with mismatch polyamides to help ensure the
specificity of the observed effects. To facilitate comparison of different studies, all experiments
were carried out with identical buffer conditions, temperature, equilibration times of the binding
reactions, and order of the addition of the components into the reaction mixtures.
Polyamide Equilibrium Dissociation Constants
A set of pyrrole-imidazole polyamides was designed, synthesized, and purified for our
competitive binding studies. Structures of these polyamides and their expected modes of binding
with the DNA minor groove, as predicted on the basis of "pairing rules" (4), are shown in Figures
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2 and 3. Polyamides 1-4 are referred to as PAp5 3 , PATATA, PANRE, and PAzif2 6 8 (where our
nomenclature indicates which binding site each polyamide has been designed to recognize).
We used quantitative DNase I footprint titration analysis to determine the apparent
dissociation constants for the polyamides. Oligonucleotide 1 was used for PAps3 and PANRE;
oligonucleotide 2 was used for PATATA and PAzif 268 (Figure 4). The oligonucleotides were
labeled from the 3'-end. DNase I footprinting experiments (Figure 5), done at a series of
different polyamide concentrations, reveal the location of the binding site for each polyamide
and allow determination of the binding constants. These footprinting experiments (Figure 5)
show that PATATA and PAzif 26 8 polyamides also bind specifically to other match and single base
pair mismatch sites (as defined by the pairing rules) found on the restriction fragment at the same
or higher concentration, respectively. Quantitative analysis of the degree of protection observed
at each polyamide concentration allowed us to present the data of the DNase I footprinting
experiments as binding isotherms (Figure 6). The apparent KD, equal to 1/KA, was determined
from the binding isotherms by fitting the data points with a modified Hill equation, as previously
described (28). These binding isotherms and apparent dissociation constants for each polyamide
represent the average of three independent experiments, and all these polyamides have at least
nanomolar affinity for their expected target sites.
Determination of Zinc Finger Dissociation Constants
This study used Zif268 and three variants, specific for the p53, NRE, and TATA binding
sites, that had been selected via phage display. (Note that the sequential selection protocol (9)
used to obtain these variants allowed extensive changes in the recognition site, since six amino
acids in each finger had been randomized.) Quantitative gel shift analysis was used to determine
the fraction of the DNA fragment bound at a series of protein concentrations (Figure 7), and KD
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values were calculated from the slope of Scatchard plots. Corrections were made for the active
concentration of each protein, which was estimated using stoichiometric competition
experiments.
The sequences of the 27 bp oligonucleotides used in gel mobility shift experiments are
boxed in Figure 4. (Note that in this figure the oligonucleotides are shown embedded within
larger sites that were later used for DNase I footprinting.) The dissociation constants for the zinc
fingers (Table 1) were determined from the average of three independent experiments, and the
values are comparable to those previously reported (9), even though slightly different buffers
were used.
Dissociation Constant of Zinc Finger Protein in the Presence of Specific Polyamides
Binding of the polyamides could not be directly observed in our gel shift experiments,
but competition studies clearly revealed that the polyamides affected formation, stability or both
of the zinc finger-DNA complexes. Two types of competition experiments were done to analyze
the effects of polyamides on zinc finger binding.
The first set of experiments used a fixed polyamide concentration that would have given
-90% occupancy of the free DNA site, and gel shift experiments were used to determine the
apparent binding constant of the zinc finger proteins under these conditions. These gel shift
experiments were essentially identical to those done with the protein alone. The long
equilibration time, done for all gel shift experiments, ensured that the apparent binding did not
depend on the order of addition of the components. Figure 7 shows one set of gel shift
experiments, where the apparent binding constant of Zif268 is determined in the presence and
absence of the polyamide that recognizes an overlapping site. Binding isotherms for this
reaction are shown in Figure 7C, and similar results were obtained for the other polyamide/zinc
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finger competitive binding titrations. In every case, the presence of the corresponding polyamide
significantly decreases (by 13-35-fold) the apparent affinity of the zinc finger protein for the
binding site (Table 1).
Interactions between the polyamides and zinc fingers were also studied in experiments
that used fixed zinc finger protein concentrations with variable amounts of polyamide. In each
of these experiments, the zinc finger proteins were present at active concentrations equal to lOx
their respective dissociation constants, and thus about 90% of the DNA was initially shifted by
the proteins. Similar binding reactions with increasing amounts of polyamide were conducted,
and after allowing for full equilibration, we monitored the effect of the polyamides on formation
of the zinc finger-DNA complexes. Gel shift results obtained with the PAzif268 polyamide and
the Zif268 protein (Figure 8A) show that the polyamide interferes with formation or stability of
the zinc finger-DNA complex. Similar results were obtained using other zinc finger proteins and
polyamides that compete for the same binding sites. Protein bound was calculated as a function
of polyamide concentration, each data point representing the average of three independent
experiments. Data were fit with the modified Hill equation (28), enabling us to estimate
"inhibition constants". These represent the polyamide concentrations that give 50% inhibition of
formation of the respective protein-DNA complex, and we find that these "inhibition constants"
are in the subnanomolar range (Table 2).
Testing for Specificity of Zinc Finger/Polyamide Interference Effects
Several types of experiments were done to test the specificity of the observed interference
effects between polyamides and zinc fingers. For example, Figure 8 shows gel shift data
obtained with the Zif268 protein-DNA complex. This figure compares the interference effects
observed with PAzif268 (the match polyamide with specific binding for this site) and interference
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effects observed with PANRE (which is specific for the NRE site and a mismatch polyamide with
no binding site on the 27 bp Zif268 oligonucleotide). There is marked interference by PAzif268,
as indicated by the gel shift results in Figure 8A and the sigmodal plot shown in Figure 8C.
However, similar concentrations of PANRE have no measurable effect at this site, as there is no
reduction in Zif268 binding even at high polyamide concentrations (Figure 8B,C). Similar data
were obtained using other zinc finger/polyamide combinations, and these results show that
interference is dependent on having a polyamide that can compete for the same binding site.
Competitive DNase I Footprinting Experiments
Since binding of polyamides could not be directly observed in any of our gel shift
experiments, we used DNase I footprinting to further explore the mechanism of polyamide/zinc
finger interference effects. In principle, these experiments should allow us to directly monitor
polyamide-DNA interactions, zinc finger-DNA interactions, and possible formation of the
ternary complex.
Figure 9 shows the results of DNase I footprinting experiments that explored interference
effects between the Zif268 protein and the PAzif268 polyamide. These experiments used
oligonucleotide 2 (Figure 4), labeled from the 5' end, to provide a Zif268 protein and PAzF
polyamide binding site. The PANRE polyamide, which does not have a binding site on this
oligonucleotide, was used as a "mismatch" control. Six sets of experiments were performed,
using the PAzif268 polyamide at concentrations of 1, 5, and 10 nM (panel A) and then using the
PANRE polyamide at corresponding concentrations (panel B). When the Zif268 protein was
present, it was used at a concentration that would have been expected to give approximately 90%
occupancy of the free DNA site. As indicated at the top of the respective lanes (Figure 9), four
conditions were tested within each set of reactions: (1) the first lane within each set has no
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protein and no polyamide; (2) the second lane has Zif268 protein but no polyamide; (3) the
third lane has Zif268 protein and one of the polyamides; (4) the fourth lane has the same
polyamide but contains no protein.
We used Gilbert-Maxam G+A sequencing reactions to determine the precise base
positions where cleavage occurred in these footprinting experiments and to locate the binding
sites for the Zif268 protein and for the PAzif2 6 8 polyamide, which are marked on the left side of
the gels. (Note that experiments in panel B used the PANRE polyamide, which does not have a
binding site on this oligonucleotide.) As expected, there is significant overlap between the region
where Zif268 footprints and the region where PAzif268 footprints: the PAzif268 binding site
includes bases 32-39, while the Zif268 protein binding site includes bases 35-43 (when counting
from the 5' end). However, it appears that band 43, at the far end of the Zif268 binding site, can
only be effectively protected by the protein.
Results obtained with the mismatch polyamide (panel B) are entirely straightforward:
Zif268 occupies its binding site in lanes 2 and 3 of each experiment, and the PANRE polyamide
(which is present in lanes 3 and 4 but has no binding site in this oligonucleotide) has no effect on
the footprinting patterns. The results with the PAzif268 polyamide (panel A) are somewhat more
complicated, but they are the real crux of the experiment. In this panel, lane 2 of each set
(protein alone) shows the expected footprint for the Zif268 protein. Lane 4 of each set
(polyamide alone) shows the footprints obtained when the PAZif26 8 polyamide is present at
concentrations of 1, 5, and 10 nM. Effects are localized to the expected binding site at low
concentration (1 nM), but additional protection due to specific binding of a single base pair
mismatch site present in the restriction fragment (near the top of the gel) is seen at higher
concentrations.
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Obviously, the most interesting results in each set of reactions from panel A involve lane
3, in which both the Zif268 protein and the PAzif268 polyamide were present. At the higher
polyamide concentrations (5 and 10 nM), the footprinting patterns obtained with the
polyamide/zinc finger combinations (lane 3) appear surprisingly similar to those obtained with
the polyamide alone (lane 4). The simplest interpretation of these patterns is that binding of the
polyamide displaces the zinc fingers, making the patterns look very similar in lanes 3 and 4. It is
somewhat more problematic to explain the pattern obtained in lane 3 of the first set (at a 1 nM
concentration of PAzif268), but this may indicate a mixture of species with the Zif268 protein
bound to some fraction of the DNA sites and the PAZif268 polyamide bound to most of the
remaining DNA.
Computer Modeling of Polyamide and Zinc Finger Structures
In a further attempt to understand the mechanisms of interference, we examined the
structure of various zinc finger-DNA and polyamide-DNA complexes. X-ray crystal structures
are now available for the TATAzF (34), P53zF (35), and Zif268 (6) zinc finger-DNA complexes.
X-ray crystal structures also are available for several polyamide-DNA complexes (12, 13, 15),
and we thought that these structures would be useful for initial modeling, even though the exact
sequences of the polyamides and of the binding sites are somewhat different than those used in
our current experiments. Our first major conclusion is that we do not see any obvious basis for a
steric collision between the zinc fingers and the polyamides. All the polyamide-DNA complexes
indicate that these compounds bind exclusively in the minor groove, while the zinc finger-DNA
complexes show that these proteins bind in the major groove. [The only exception here involves
one lysine (Lys 189) in the TATA structure with a high-temperature factor that might reach into
the minor groove, but the polyamide binds at the opposite end of this site, far from Lys 189.]
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Various zinc finger-DNA and polyamide-DNA complexes were superimposed, and these were
compared in an attempt to understand the basis for the "negative cooperativity" that we had
observed in biochemical studies. Alignments done with the program PROTEUS (36) typically
used 3-4 sets of phosphates or 3-4 sets of C1' atoms to superimpose the complexes. The rms
deviations in these alignments varied from about 0.6 to about 2 A, depending on (1) which
structures were aligned, (2) which atoms were used for alignment, and (3) how many base pairs
were superimposed. However, there were striking and consistent differences in the groove
width, and these were large enough that they could readily explain how the polyamides interfere
with zinc finger binding. In nearly every alignment that we carried out, the polyamide-DNA
complex had a wider and deeper minor groove than that observed in the zinc finger-DNA
complexes. There also were a number of cases where superimposing the complexes indicated
shifts in the precise arrangement of the base pairs, and these could affect the position of
hydrogen bond donors and acceptors that are critical for recognition.
These initial qualitative observations of the structures were confirmed by using the
Curves program (38) to calculate dimensions of the major and minor grooves. We find that the
major grooves in zinc finger-DNA complexes are consistently wider and deeper than the major
grooves in the polyamide-DNA complexes. In this set of structures, the Zif268 complex has the
deepest major groove (6-8 A), while the TATAzF and p5 3ZF complexes have the widest major
grooves (13-14.5 A). The major groove width of the polyamide-DNA complexes ranged from 9
to 10.5 A, while the major groove depth ranged from 3 to 5.5 A. Differences in minor groove
width are not quite as consistent when comparing the two classes of complexes, but there is a
general tendency for the polyamide-DNA complexes to have wider minor grooves than the zinc
finger-DNA complexes.
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The initial superimpositions indicated that the orientations of the bases were slightly
different in the two types of complexes, and these differences were confirmed and analyzed
using the program Curves. In general, we find the following: (1) The two base pairs in the
middle of the binding region have negative opening angles in the polyamide-DNA complexes (-
12.22° ± 5.71 °). No such region is observed in the zinc finger-DNA structures, which on
average have more positive opening angles (1.86° + 4.23 ° averaged over the entire binding
region of all of the complexes). (2) The zinc finger complexes have a larger negative X-
displacement of the base pairs than do the polyamide complexes. Averaged over the respective
binding sites for each set of complexes, the X-displacement values are -1.54 ± 0.28 A for the
zinc finger-DNA complexes and -0.13 ±+ 0.35 A for the polyamide-DNA complexes. (3) X-
displacement parameters for the polyamide-DNA complexes are generally closer to those of B-
DNA, whereas opening angles for zinc finger-DNA complexes are generally closer to those of
B-DNA. [For a typical B-DNA structure (39) averaged over the entire sequence, the values are -
0.52 ± 0.25 A and -0.31° + 5.27°, respectively.] No significant differences in shear or buckle
were noted when comparing the zinc finger and polyamide complexes with those of B-DNA.
DISCUSSION
Compounds that can target specific sites on double-stranded DNA may provide tools for
the regulation of gene expression. Excellent progress has been reported in (1) the design and
selection of Cys2His2 zinc fingers for these purposes (1, 2) and 2) the design of pyrrole-imidazole
polyamides that will bind according to well-defined "recognition rules" (4). These two broad
classes of compounds may provide new reagents for molecular medicine and gene therapy, and
recent studies with zinc fingers specifically designed to turn on the VegF gene have shown that
such designer transcription factors can work effectively in animal models (40).
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Our central goal in this paper was to explore how zinc fingers and polyamides might
interact when targeted to overlapping recognition sites. We thought this would be interesting
from a structural and physical/chemical perspective, and we thought this work also might
provide a basis for the eventual development of new regulatory schemes (perhaps where
polyamides were used to help regulate the binding of zinc finger proteins or visa versa). Our
strategy in these studies was to (1) pick a set of zinc finger proteins that had been carefully
characterized, (2) design polyamides that would target sequences that overlap the binding sites of
these proteins, and (3) carefully characterize the DNA-binding affinity for each set of
compounds under identical buffer conditions. We then used a set of biochemical studies
(involving gel mobility shifts and DNase I footprinting experiments) to see what happened when
zinc fingers and polyamides that recognized the same DNA site were mixed together.
Our central conclusion from these biochemical studies is that polyamides interfere with
the binding of zinc finger proteins when the two compounds recognize overlapping, or partially
overlapping, binding sites on the minor and major groove sides of the DNA, respectively. This
is clearly demonstrated by interference experiments that use the gel mobility shift assay to
monitor zinc finger binding (Figures 7 and 8), and this result holds for every combination of zinc
fingers and polyamides that we have tested, when they recognize overlapping or partially
overlapping binding sites. It also is clear that this "negative cooperativity" requires direct
interactions of the polyamide with the zinc finger binding site: polyamides directed to other
DNA sites show no interference with the binding of a given zinc finger protein (as indicated, for
example, in the data of Figure 8B).
In an attempt to understand the structural and energetic basis for this "negative
cooperativity", we have examined and compared crystal structures that are available for a set of
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zinc finger-DNA and polyamide-DNA complexes. In every case, structures of the relevant zinc
finger-DNA complexes show that the proteins bind in the major groove, while structures of
polyamide-DNA complexes show that these compounds bind in the minor groove. There does
not appear to be any basis for a van der Waals collision (or any other direct contact) between the
protein and the polyamide when they bind to overlapping sites. However, structural comparisons
do show striking differences between the DNA conformations in the polyamide-DNA complexes
and those in the zinc finger-DNA complexes. Differences in the groove dimensions are quite
clear: (1) The minor groove tends to be wider in the polyamide-DNA complexes than in the zinc
finger-DNA complexes (Figure 10), while (2) the major groove tends to be wider (and often
deeper) in the zinc finger-DNA complexes than in the polyamide-DNA complexes. Quantitative
comparison of the DNA structures (using output from the program Curves (38)) reveals many
other differences between zinc finger-DNA and polyamide-DNA complexes, and many of these
differences will affect the precise position and orientation of key hydrogen bond donors and
acceptors within the DNA site. At this stage, it seems very plausible that differences in the
preferred DNA conformations could explain the "negative cooperativity" that we have observed
when zinc fingers and polyamides are targeted to the same site. We assume that (1) the free
DNA is somewhat "plastic" and that each compound can induce an appropriate conformation
when it binds alone but that (2) simultaneous binding is difficult because the two types of
compounds prefer somewhat different DNA conformations. (Note that if the conformational
preferences of a given DNA sequence were more rigid, it might be hard to design polyamides for
one class of sites and might be hard to design zinc fingers for another class of sites. This does
not seem to be the primary problem.) In short, our modeling suggests that negative cooperativity
may involve "allosteric" effects of changes in the DNA structure, and considering differences in
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the relative dimensions of the major and minor groove (Figure 10) makes it easy to picture why
these changes may be so important.
We undertook this study to investigate how polyamides and zinc fingers interact when
they bind to overlapping sites on double-stranded DNA and show here an example of allosteric
inhibition of a major-groove binding protein by unmodified polyamides. One could envision that
designed zinc finger proteins could be displaced by small molecule polyamides, thereby
providing both an on and off switch for gene regulation. Furthermore, phage selection
technology may allow for the generation of artificial zinc finger proteins that only bind their
target DNA sites with high affinity in the presence of a bound polyamide in the minor groove of
the site. The results of this study give key insights into how a zinc finger/polyamide system
might be designed to regulate gene expression.
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TABLES
Table 1: Equilibrium Dissociation Constants and Free Energies of DNA-Zinc Finger Protein
Binding in the Absence and in the Presence of Polyamides
polyamide/protein KD (nM)a
p5 3ZF 0.240 ±+ 0.018
PAp53/p5 3zF 3.200 ±+ 0.283
TATAZF 0.204 ± 0.030
PATATA/TATAzF 4.320 ±+ 0.582
NREzF 0.101 ± 0.009
PANRE/NREzF 3.520 ±+ 0.248
Zif268 0.010 ± 0.003
PAzif268 /Zif268 0.182 ± 0.009
a The reported equilibrium dissociation constants are apparent for the proteins in the presence of
polyamides. All constants are the mean values obtained from three or more gel mobility shift
experiments.
Table 2: Equilibrium Inhibition Constants
polyamide/protein app Ki (nM)a
PAps3/p53zF 0.20 ± 0.07
PATATA/TATAzF 0.04 ±+ 0.02
PANRE/NREzF 16.40 ± 3.90
PAzif2 68 /Zif268 0.03 ± 0.02
a The reported equilibrium inhibition constants are the mean
values obtained from three gel mobility shift experiments.
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(A)
FIGURES
(B)
Figure 1. Crystal structure of Zif268 and polyamide bound to DNA. (A) Crystal structure of
the Zif268 zinc finger protein (red, with ribbon representing protein backbone) bound in the
major groove of B-DNA (blue, with ribbon connecting phosphates) [coordinates are from ref 6]
and (B) crystal structure of a polyamide (red) bound in minor groove of B-DNA (blue)
[coordinates are from ref 15, 1CVY].
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Figure 2. Minor-groove binding models expected for hairpin complexes of ImPyPyPy-y-
ImPyPyPy-,3-Dp (1, PAp53), ImPyPyPy-(R)H2NY-PyPyPyPy_--Dp (2, PATATA), ImImImPy-Y-
PyPyPyPy-3-Dp (3, PANRE), and ImPyPyPy-(R)H2NyPyPyPyPy3P-Dp (4, PAzif26 8) targeted to
their match sites in the minor groove opposite the p53 zF, TATAzF, NREZF, and Zif268zF major-
groove binding sites. Shaded and unshaded circles represent imidazole and pyrrole
carboxamides, respectively, and the 3-alanine residue is represented by an unshaded diamond.
Boxes enclose the nine base pair sites that are recognized by the corresponding zinc finger
proteins.
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OLIGONUCLEOTIDE 
Figure 4. Oligonucleotide sequences used for DNase I footprinting experiments, with each
of the nine base pair target sites for the zinc finger proteins underlined. Oligonucleotide 1
contains the TATAzF, NREzF, and p53 ZF binding sites; oligonucleotide 2 contains the Zif268,
TATAzF, and p53 ZF binding sites. Gel mobility assays used shorter oligonucleotides (27 bp
segments each containing a single binding site), and the corresponding segments used in these
experiments are shown as boxed regions surrounding each of the nine base pair binding sites. In
this orientation, the site that has been cleaved by EcoRI is at the left end of the oligonucleotide;
the site cleaved by NotI is on the right.
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CCCAAGT I CACCCCTTTATGCATGAAACGACAA CCTGTACA AGTACTTTT
AACCTGGATCCACTAGTTCTAGAGC
TTGGACCTAGGTGATCAAGATCTCGCCGG
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ZIF 268 - SITE
5'- AATTCTGCCAATACGTAACGATTTTAGCAGTTAAA CGTGGGCq TAAAATACGTAC
GACGGTTATGCATTGCTAAAATCGTCAATTT GCACCCGq ATTTTATGCATG
TATA - SITE P53 - SITE
TTGGGGGIGCTATAAA CATGGTAAA AACCTGTTTGCTGTT GGACATG1 TCATGAAAA
AAACCCC CGATA TTIIGTACCATTTTTGGACAAACGACAA CTGTAC AGTACTTTT
CCTGGATCCACTAGTTCTAGAGC
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Figure 5. Quantitative DNase I footprint titration experiments used to monitor binding of
polyamides to the oligonucleotides shown in Figure 4. Oligonucleotides were obtained as
EcoRI/NotI restriction fragments from the pBluescript II SK+ plasmid and were 3,-32P-Iabeled.
Panel a contains PAp53 (1) on oligonucleotide 1: lanes 1 and 21, intact DNA; lanes 2 and 20, A-
specific chemical sequencing reaction; lanes 3 and 19, G-specific chemical sequencing reaction;
lanes 4 and 18, DNase I digestion products in the absence of polyamide; lanes 5-17, DNase I
digestion products in the presence of 20, 10, 5, 2, 1, 0.5, 0.2, and 0.1 nM and 50, 20, 10, 5, and 2
pM polyamide, respectively. Panel b contains PATATA (2) on oligonucleotide 2: lanes 1 and 19,
intact DNA; lanes 2 and 18, G-specific chemical sequencing reaction; lanes 3 and 17, DNase I
digestion products in the absence of polyamide; lanes 4-16, DNase I digestion products in the
presence of 5, 2, 1,0.5,0.2, and 0.1 nM and 50, 20, 10, 5, 2, 1, and 0.5 pM polyamide,
respectively. Panel c contains PANRE (3) on oligonucleotide 1: lanes 1 and 21, intact DNA;
lanes 2 and 20, A-specific chemical sequencing reaction; lanes 3 and 19, G-specific chemical
sequencing reaction; lanes 4 and 18, DNase I digestion products in the absence of polyamide;
lanes 5-17, DNase I digestion products in the presence of 100,50,20,10,5,2,1,0.5,0.2, and
0.1 nM and 50, 20, and 10 pM polyamide, respectively. Panel d contains PAzif268 (4) on
oligonucleotide 2: lanes 1 and 19, intact DNA; lanes 2 and 18, G-specific chemical sequencing
reaction; lanes 3 and 17, DNase I digestion products in the absence of polyamide; lanes 4-16,
DNase I digestion products in the presence of 5, 2, 1,0.5,0.2, and 0.1 nM and 50, 20, 10, 5, 2, 1,
and 0.5 pM polyamide, respectively.
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Figure 6. Binding isotherms derived from the DNase I quantitative footprint titration
experiments (Figure 5) as shown for the PAp53 (a), PATATA (b), PANRE (c), and PAzif268 (d)
polyamides. In each case, isotherms represent binding at the match target site in the minor
groove, which has the sequence shown in the lower right panel of the figure and which overlaps
with the nine base pair site in the major groove recognized by the corresponding zinc finger
protein. norm points were obtained using storage phosphor autoradiography and processed as
previously described (28). Each data point represents the average of three independent
quantitative footprint titration experiments, and the solid curves are the best-fit Langmuir
binding titration isotherms obtained from a nonlinear least-squares algorithm where n = 1.
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Figure 7. Gel mobility shift experiment showing that the PAZif268 polyamide interferes
with binding of Zif268 protein. Panel A presents binding of Zif268 protein in the absence of
polyamide, where upper band on the gel represents the protein-DNA complex. Protein was
diluted 1.5x between lanes, and the 27 bp DNA probe had a concentration of 0.5 pM. Panel B
presents a similar binding experiment to that in panel A, but this was performed in the presence
of a constant amount of polyamide. The concentration was chosen as 10 K~A and thus is
expected to give about 90% saturation of the site in the absence of protein. Panel C presents the
Zif268 binding isotherms in the absence (II) and in the presence (.) of PAzif268. Each data point
represents the average of the three independent gel mobility shift experiments. The binding
curves show that a protein concentration of 10 pM gives 50% occupancy when no polyamide is
present; a protein concentration of 182 pM is required to give 50% occupancy when the
polyamide is present.
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Figure 8. Specificity of polyamide interference effects. In these experiments, the active
concentration of protein was constant and equal to 10K ~rol (giving -90% of saturation of DNA
binding sites when no polyamide was present). The DNA probe was present at 0.5 pM, and the
polyamide concentration varies 4-fold between adjacent lanes. Panel A presents representative
gel mobility shift results for Zif268 protein binding to DNA probe in the presence of increasing
concentrations of PAZif268 polyamide. Panel B presents the corresponding experiments using the
Zif268 protein, the Zif268 binding site, and the polyamide PANRE (note that this polyamide will
not bind to the site and thus represents a "mismatch" control for the purposes of this experiment).
Panel C presents the effects of polyamides PAZif268 (.) and PANRE c-> on Zif268 protein binding.
Each data point represents the average of three independent experiments, and the difference
between these curves emphasizes the specificity of polyamide binding and interference.
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Figure 9. DNase I footprinting analysis of polyamide/zinc finger protein interference
effects. Panel A presents reactions using Zif268 protein, Zif268 DNA site, and PAZif268
polyamide. The first lane within each group of four has no protein and no polyamide; the
second lane has protein but no polyamide; the third lane has protein and polyamide; the forth
lane has polyamide alone. When present, the concentration of Zif268 protein was equal to 10Ko;
concentrations of polyamides were 1 nM in the first set of reactions (Le., the first four lanes), 5
nM in the second set of reactions, and 10 nM in the third set of reactions. Lanes labeled G+A
show markers prepared with the Gilbert-Maxam G+A reaction protocol, and binding sites for the
Zif268 protein and PAZif268polyamide are marked on the left side of the gel. Panel B presents
the control experiment (with a similar arrangement of lanes and choice of concentration) using
the Zif268 protein, Zif268 DNA, and PANRE polyamide (note that the PANRE polyamide does not
have a binding site on this oligonucleotide and thus serves as a "mismatch" control for these
experiments).
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Figure 10. Superposition of zinc finger-DNA complex [coordinates are from ref 34] (blue)
and polyamide-DNA complex [coordinates are from ref 13] (red) oriented to highlight
differences in minor groove width. Such "allosteric" changes in the groove dimensions may
explain the "negative cooperativity" observed in our binding studies with polyamides and zinc
fingers.
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